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ABSTRACT
ABSTRACT
The enzymes dehydi’oquinase and shikimate dehydrogenase catalyse the third and 
fourth steps of the biosynthetic shikimate pathway, respectively. The work in this 
thesis investigates the active sites and overall structure of bacterial type II 
dehydroquinases, shikimate dehydrogenases and related proteins using biochemical 
and biophysical tecliniques.
The active site of Streptomyces coelicolor type II dehydroquinase (SCDHQase) was 
characterised by site-directed mutagenesis of the residues: Argll3, His 106, Glul04, 
Seri 08 and Tyr28, proposed to be important in previous structural studies of the 
enzyme. None of the mutations significantly altered the secondary or tertiary 
structure of the enzyme as shown by circular dichroism. All five mutantions 
significantly decreased the catalytic activity; the most effective mutation was the 
Y28F mutation with a 4700-fold reduction in activity. This has provided strong 
evidence of the role of each of the residues within the active site.
To date Bacillus subtilis is the only organism known whose genome encodes proteins 
that resemble both types of dehydroquinase. The type I dehydroquinase was shown 
to be the active form in cell extracts of B. subtilis by sodium borohydride trapping of 
the Schiff base involved in the mechanism of all type I dehydroquinases. The YqhS 
protein from B, subtilis has 47% identity to the S. coelicolor type II dehydroquinase. 
However, YqhS has been found to have an extremely low level of dehydroquinase 
activity (kcat < lO''^  s ' \  YqhS has a phenylalanine in place of the highly conserved 
tyrosine residue found to be catalytically important and implicated in proton 
abstraction at C2 of the substrate. Site-directed mutagenesis of the phenylalanine to a 
tyrosine (F23Y) effected a 2000-fold increase in Growth experiments on the 
disruption mutant of the yqhS gene (YqhSd) produced by the Japanese Bacillus 
Consortium show that the gene is essential for growth in minimal medium.
Detailed studies of the pH dependence, effects of salts on catalytic activity and the 
inhibitory effect of polyanions were performed on the type II dehydroquinases of S. 
coelicolor^ Mycobacterium tuberculosis (MTDHQase), Helicobacter pylori 
(HPDHQase) and B. subtilis (F23Y mutant). pH-dependence studies on all the 
dehydroquinases tested show that there is a seven-fold increase in Argat between pH 6.5 
and 8.0 indicating that all of these type II DHQases share the same catalytic
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mechanism. Low concentrations of chloride cause a moderate increase the catalytic 
activity of MTDHQase and a 4-fold increase in c^at for HPDHQase. In contrast, the 
of both SCDHQase and B. subtilis (F23Y mutant) decreases in the presence of 
low concentrations of chloride. The differences in the effect of chloride are thought 
to arise from variations in the flexibility of dehydroquinase structures. Polyanions 
(sulphate and phosphate) are competitive inhibitors of SCDHQase and HPDHQase. 
The interactions are more complex in MTDHQase and B. subtilis YqhS (F23Y). 
Analysis of the X-ray structures of SCDHQase and MTDHQase reveals contrasting 
modes of binding of polyanions between the two enzymes. The differences between 
the interactions and binding of polyanions in type II dehydroquinases may help to 
explain the relative potencies of rationally designed inhibitors.
The Haemophilus influenzae paralogs; shikimate dehydrogenase (HIAioE) and 
shikimate dehydrogenase related protein (HIYdiB) have been investigated using 
steady-state kinetics and detailed analysis of their sequences in relation to the 
published X-ray stmctures of Escherichia coli shikimate dehydrogenase and YdiB 
protein. Both HIAroE and HIYdiB are NADPH-dependent dehydrogenases and 
catalyse the oxidation of shikimate to form dehydroshikimate, with heat values of 194 
and 19 s"\ respectively. HIAroE is also able to oxidise quinate as part of the 
catabolic quinate pathway (A:cat of 50 s"^ ). Fluorescence quenching studies have 
demonstrated that shikimate is able to bind to HIAroE in the absence of cofactor. 
HIAroE is likely to follow a random sequential mechanism. The function of HIYdiB 
is still unclear as the catalytic activity of the HIYdiB protein is significantly lower 
than the HIAroE enzyme for all the substrates tested. The N-terminal amino acid 
sequence of the HIYdiB protein is significantly different from the E.coli YdiB and 
other members of the shikimate dehydrogenase family and it is proposed that the N- 
terminal region defines the function of this protein.
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ATP andenosine triphosphate
BSA bovine serum albumin
CAPS cyclohexylaminopropane sulphonic acid
CD circular dichr oism
CIAP calf intestine alkaline phosphatase
Da dalton
DHQase dehydroquinase
DMF dimethylformamide
DMSG dimethyl sulphoxide
DNA deoxyribonucleic acid
DNase deoxyribonuclease
dNTP deoxynucleotide
DTT dithiothreitol
s absorption coefficient
ECL electro chemiluminescence
EC YdiB Escherichia coli YdiB protein
EDTA ethylenediaminetetraacetic acid
GdmCl Guanidine hydrochloride
HIAroE Haemophilus influenzae shikimate dehydrogenase
HIYdiB Haemophilus influenzae YdiB protein
HPDHQase Helicobacter pylori dehydroquinase
HPLC High pressure liquid chromatography
HRP horse radish peroxidase
lEF isoelectric focusing
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IPG immobilisation pH gradient
Kai Michaelis constant
LB luria broth
MADLI-tof matrix-assisted laser desorption ionization-time of flight
mRNA messenger ribonucleic acid
MTDHQase Mycobacterium tuberculosis dehydroquinase
MW molecular weight
NAD^ nicotinamide adenine denucleotide (oxidised form)
NADH nicotinamide adenine denucleotide (reduced form)
NADP^ nicotinamide adenine denucleotide phosphate (oxidised form)
NADPH nicotinamide adenine denucleotide phosphate (reduced form)
NB nutrient broth
PBS Phosphate Buffer saline
PCR polymerase chain reaction
PGO phenylglyoxal
psi pounds per square inch
PVDF polyvinylidene difluoride
rpm revolutions per minute
SCDHQase Streptomyces coelicolor dehydroquinase
TCA tricarboxylic acid
Tris tris (hydroxymethyl) aminomethane
U units of enzyme activity
UV ultraviolet
X-gal 5-bromo-4-chloro-3-indoyl-p-d-galactoside
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CHAPTER 1 INTRODUCTION 
1.1 The shikimate pathway
The products of the shikimate pathway are the aromatic amino acids phenylalanine, 
tyrosine, and tryptophan, as well as vitamins E and K, folic acid, ubiquinone and 
plastoquinone and certain metal chelators, such as enterochelin (Bentley, 1990; 
Pittard, 1987). These products are assembled by the condensation of the 
cai'bohydrates; phosphoenolpyruvate (PEP) and D-erytlnose 4-phosphate in a series 
of seven biosynthetic steps (Dewick, 1998; Knaggs, 2001) that form the basic “trunk” 
of the pathway (Figure 1).
D-Erythrose 4-phosphate is a product of the Calvin cycle or the pentose phosphate 
pathway and PEP is a product of glycolysis (Mousdale and Coggins, 1993). The 
branching point of the “common shikimate pathway” occurs after the formation of 
chorismate; this leads to several diverse terminal pathways (Pittard, 1987; Haslam, 
1974). L-Tryptophan is formed from chorismate via antliranilate. L-Phenylalanine 
and L-tyrosine are formed either via prephenate, 4-hydroxyphenylpyruvate or L- 
arogenate, depending on the organism concerned. It is often possible for an organism 
to utilise more than one of these routes; this may be comiected to the availability of 
active enzymes (Dewick, 1998). Vitamin K and enterochelin branch from 
isochorismate (Bentley, 1990).
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Figure 1. Schematic of the biosynthetic shikimate pathway and the catabolic quinate 
pathway. The substrate intermediates of both pathways are: (1) erythrose-4- 
phosphate, (2) phosphoenolpyruvate (PEP), (3) S-deoxy-D-trra^mo- 
heptulosonic acid -7-phosphate (DAHP), (4) dehydroquinate (DHQate), (5) 
dehydroshikimate, (6) shikimate, (7) shikimate-3 -phosphate, (8) 5- 
enolylpyruvylshikimate 3-phosphate (EPSP), (9) chorismate, (10) quinate, 
(11) protocatechuate.
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The delineation of the pathway is a classic example of the combined use of 
auxotrophic mutants and isotopically labelled precursors. Analysis of the sequence of 
steps in the biosynthetic pathway is facilitated by the fact that each mutant may 
accumulate in its culture fluid the substrate for the enzymic reaction that is blocked 
and may utilise later members of the sequence to replace the required metabolites 
(Haslam, 1974).
The shikimate pathway was first studied by Eykman in 1885 (Eykman, 1885; 1891). 
The pathway is present in plants, fungi, bacteria (Bentley, 1990; Mousdale and 
Coggins, 1993; Haslam, 1974) and has been recently discovered in protozoa 
(Ranganathan and Mukkada, 1995; Roberts et aî., 1998; McConkey, 1999).
The shikimate pathway is not present in vertebrates such as mammals. These 
organisms lack the capacity for aromatic biosynthesis, other than the aromatization of 
the steroid ring A. Mammals depend on their diet to obtain the products of the 
shikimate pathway, therefore any anti-metabolites of is pathway will not act on 
humans making the shikimate pathway enzymes promising targets for the design of 
antimicrobials. (Bentley, 1990; Payne et ah, 2000). The aroA (1.1.1.6) gene of 
Aeromonas hydrophila was inactivated by the insertion of a DNA fragment 
containing kanamycin resistance into the aroA gene by means of a suicide vector. 
This resulted in a highly attenuated strain which was unable to survive in vivo and 
cause infection. The attenuated mutant strain confers significant protection against 
the wild type strain when used as a live vaccine in rainbow trout (Moral et al., 1988). 
Preliminary studies to isolate a disruption mutant of the aroK (1.1.1.5) gene of 
Mycobacterium tuberculosis proved unsuccessful this was attributed to the difficultly 
in gene replacement in all slow growing mycobacteria. The construction of a 
merodiploid strain containing an L5- integrated copy of the aroK gene allowed the 
disruption of the wild type aroK allele. Even in media with aromatic amino acids 
supplemented, M tuberculosis was not viable demonstrating that the shikimate 
pathway is essential in M. tuberculosis (Parish and Stoker, 2002).
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1.1.1 Enzymes of the shikimate pathway
1.1.1.1 3-deoxy-D-tïraômo-heptulosonate-7-phosphate synthase (DAHP) synthase
■O3PO
(DAMPS) (EC 4.1.2.15)
DAMPS + divalent cation
coy
OH
UH
OH
(3)
Figure 2. Schematic of the 3-deoxy-D-araômo-heptulosonate“7-phosphate synthase 
(DAMPS) reaction.
The first enzyme in the shikmate pathway is DAMPS which catalyses the aldol-like 
condensation of PEP (2) with D- erythi'ose 4-phosphate (1) giving 3-deoxy-D- 
araômo-heptulosonate-7-phosphate (DAMP) (3) (Figure 2) (Srinivasan et ah, 1955; 
Srinivasan et al.  ^ 1958). The enzyme mechanism is ordered with PEP binding first to 
the active site, possibly involving a ping-pong mechanism. ^^0-labelled substrates 
have shown that the formation of DAMP is associated with C-0 cleavage of the PEP 
phosphate group (DeLeo and Springson, 1968). This C-0 cleavage of PEP is 
analogous to that observed in 3-deoxy-D-manno-octulosonate-8-phosphate synthase 
(Hedstrom and Abeles, 1988). It has been suggested that the condensation is 
preceded by C-O cleavage and may involve an additional enzyme-thiol group bound 
to PEP as many DAHPSs have been shown to be susceptible to inliibition by thiol 
modifying reagents (Ganem, 1987).
Kinetic studies on the three E. coU DAMPSs isozymes using substrate analogues of 
D- erythrose 4-phosphate in which the C-O-P group was replaced by either C-P or 
C-CM2 -P led to significantly different reaction rates with the isosteric homophosphate 
analogue the better of the two analogues (Le Maréchal et al., 1980). The 
stereochemistry of DAMPS, involves the cis (si) attack of the C3 of PEP and the trans 
(re) attack of the Cl of D- erythrose 4-phosphate (Floss et a l, 1972). Kinetic studies 
using PEP analogue (Z)-phosphoenol-3-fluoropyruvate (F-PEP) showed that F-PEP 
boimd to DAMPS with a similai’ affinity to PEP. However, the Fmax is 85-fold lower
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for DAMPS with F-PEP as substrate than DAMPS with PEP as substrate. Additional 
kinetic experiments showed F-PEP to be a competitive inhibitor of DAMPS (Pilch 
and Somerville, 1976).
The regulation of DAMPS is different between plants and microorganisms. Isozymes 
from the latter are characterised by differential feedback inliibition by the aromatic 
amino acids. This plays an important part in the regulation of the pathway. Wild- 
type Escherichia coli has been shown to produce tliree feedback inhibitor-sensitive 
DAMPSs, namely a Phe-sensitive (DAMPS(Phe)), a Tyr-sensitive (DAMPS(Tyr)) and 
a Trp-sensitive (DAMPS(Tip)) enzyme (Doy, 1968). DAMPS(Phe), a homotetramer 
encoded by the aroG gene, is the major isoform, constituting nearly 80% of the total 
activity of the DAHPSs. DAMPS(Tyr) (aroF) and DAMPS(Trp) (aroH) are both 
homodimers, constituting around 20 and 1% of the total activity of the DAMPSs, 
respectively (Sehoner and Mermami, 1976). This arrangement provides the eell with 
the ability to modulate the overall rate of synthesis in response to changes in the 
availability of particular aromatic amino acids. Whereas the inhibition of Tyr- 
sensitive and Phe-sensitive isozymes by tyrosine and phenylalanine respectively is as 
high as 95%, inhibition of DAMPS (Tip-sensitive) by tryptophan is only 40% (Doy, 
1968). Different species of bacteria have different dominant isozymes (DeLeo et al, 
1973; Ahmad and Jensen, 1989). Random and site-directed mutagenesis of the 
aromatic amino acid-regulated DAMPSs of E. coli show that mutations leading to 
inactivation of feedback inliibition are not found in a specific region of the 
polypeptide chain, suggesting that feedback inliibition of the DAMPSs probably arose 
by divergent evolution rather than domain recruitment (Ray et al., 1988; Kikuchi et 
ah, 1997). The distribution of the three isozymes in microorganisms varies 
considerably; in some microorganisms such as Anabaena variahilis only two 
isozymes of DAMPS have been detected, one of which is tyrosine sensitive and the 
other sensitive to phenylalanine (Niven et ah, 1988). DAMPS(Phe) isozyme is 
thought to have evolved most recently since it is absent in most Gram-negative 
bacteria which posses the other two isoforms (Ahmad and Jensen, 1989). B. subtilis 
possesses a bifunctional enzyme complex which exhibits DAMPS and chorismate 
mutase (1.1.2.1) activity. This bifunctional polypeptide is also associated with the 
shikimate kinase (1.1.1.5) from this species forming a trifunctional enzyme complex 
(Nakatsukasa and Nester, 1972). Plant DAMPS isozymes are differentiated by their
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requirements for divalent cations Mn^”^ or Co^ ;^ the DAMPS which requires Co^  ^has 
a higher pH optimum than the DAMPS Mn^^-requiring isozyme (Suzuki et al., 1996; 
Mousdale and Coggins, 1993).
The DAMPS isozymes require a divalent metal ion for activity. The identity of the 
activating metal is unclear, however there is evidence for both Fe^ "^  and Cu^ .^ Metal 
variation significantly affects the apparent affinity for the substrate, D-erytlirose 
phosphate, but not for the second substrate PEP (Stephens and Bauerle, 1991). The 
3-dimensional X-ray stmcture of DAMPS(Phe) from E. coli complexed with PEP and 
Pb^  ^ revealed that mutations which reduce feedback inliibition are clustered about a 
cavity close to the dimer interface. The Pb^  ^ (which is only a weak activator) is 
bound at the active site, coordinating PEP. The binding position of PEP may be 
different in the presence of more active divalent cations such as Cu^ "^  (Shumilin et al., 
1999). Preliminary X-ray structural analysis has been performed on the DAMPS(Tyr) 
from S. cerevisiae complexed with Zn^  ^and PEP (Schneider et al., 1999).
1.1.1.2 Dehydroquinate synthase (EC 4.6.1.3)
coy
HOdehydroquinate synthaseOH OH
divalent cation + NAD'*' ^ ^ 2  ■UH
OHDH
(3 ) (4 )
Figure 3. Schematic of the dehydroquinate synthase (DMQS) reaction.
Dehydroquinate synthase (DMQS) is a NAD^-dependent metalloenzyme that converts 
DAMP (3) to dehydro quinic acid (4), the first cyclic intermediate of the shikimate 
pathway (Figure 3).
This catalytic conversion was first proposed by Sprinson et al., (1963). DAMP (the 
first intermediate of the shikimate pathway) was chemically synthesized to study the 
enzymic conversion. On structural grounds it would be assumed that the conversion 
of DAMP to dehydroquinate would be mediated by several stable intermediates. 
However, the rate of formation of dehydroquinate is equal to the rate of 
disappearance of DAMP suggesting that there are no stable intermediates (Srinivasan
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et al., 1963). Millar and Coggins (1986) characterised the amino acid sequence of the 
aroB from E. coli and calculated the molecular weight to be approximately 39 kDa.
The complex multistep mechanism of DHQS involves a sequence of several 
reactions: alcohol oxidation, a |3-elimination (Widlanski et ah, 1987), a reduction and 
an intramolecular exchange of the DAHP ring oxygen with Cl, driven by the 
cleavage of the phosphoester, and an intramolecular aldol condensation (Srinivasan et 
ah, 1963). It has been proposed that the phosphate catalyses its own elimination and 
that the final steps in the mechanism could occur spontaneously (Rotenburg and 
Sprinson, 1978; Bartlett and Satake, 1988; Widlanski et al., 1989a; Widlanski et al., 
1989b).
In the first step of the mechanism, C5 of DAHP is oxidised by NAD’*' (Rotenbm'g and 
Sprinson, 1978). The divalent metal ion may play a role in facilitating hydride 
transfer between the C5 hydroxyl and NAD"*" (Carpenter et al., 1998).
The second step in the mechanism is (3-elimination of the phosphate group at C6. 
Kinetic isotope effects studies using labelled substrate analogues revealed that the 
phosphate group is essential for the conversion (Rotenburg and Sprinson, 1978). The 
DHQS domain of the pentafunctional AROM enzyme from Neurospora crassa was 
shown to require Zn^  ^for activity (Lambert et al., 1985) where as, the E. coli enzyme 
requires Co^  ^ for activity (Srinivasan et al., 1963). The 3-dimensional X-ray 
structure of the DHQS domain of the AROM protein (1.1.3) from Aspergillus 
nidulans complexed with Zn^ '*’ and carbaphosphonate (a substrate analogue of DAHP 
and an inhibitor of DHQS (Bender et al., 1989) was solved by Cai'penter et al., 
(1998). The position of the inhibitor shows a phosphate-binding pocket and the 
interactions from the phosphate oxygens could remove the proton from C6 (Bender et 
al., 1989).
In the third step, a proton shuffling system is used: the C5 of a substrate intermediate 
is reduced by NADH (Rotenburg and Sprinson, 1978). This is a reversal of the first 
step with the hydride ion from C4 being transfeiTcd back to C5.
The two final steps of the reaction consist of ring opening and intramolecular aldol 
condensation. The ring-opening step involves deprotonation of the hydroxyl at C2. 
A water molecule is implicated in this part of the mechanism as it is the only 
neighbouring species (Cai'penter et al., 1998). Ring opening is followed by a rotation
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around the C5-C6 bond and an intramolecular aldol condensation to re-form the ring. 
These two steps can occur spontaneously in solution (Bartlett and Satake, 1988; 
Widlanski et ah, 1989a; Widlanski et aL, 1989b). However, unwanted by-products 
such as 1 -gpi-dehydroquinate are also formed, which are not present in the DHQS- 
catalysed formation of dehydroquinate. It is thought that DHQS channels the 
reaction to prevent the formation of side products (Baiflett et al., 1994;Carpenter et 
al., 1998).
1.1.13 Dehydroquinase (EC 4.2.1.10)
HQ Hs
+ HoO
QH
OH
(4) (5)
Figure 4. The reversible dehydration of dehydroquinate to dehydroshikimate.
The enzyme dehydroquinase (3-dehydroquinate dehydratase; DHQase) catalyses the 
reversible dehydration of dehydroquinic acid (4) to form dehydroshikimic acid (5) 
(Figui'e 4) (Mitsuhashi and Davis, 1954; Grewe and Haendler, 1966).
This reaction is part of two metabolic pathways, the shikimate pathway, and the 
quinate pathway (1.1.3) (Giles et al., 1968; Chaleff, 1974; Hawkins et al., 1982).
The dehydroquinase reaction, will be discussed in more detail in a later part of this 
chapter (1.3).
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1.1.1.4 Shikimate dehydrogenase (EC 1.1.1,25)
COo
OH
(5)
Shikimate dehydrogenase
HO' OH
NADP"^NAD(P)H OH
(6)
Figure 5. Schematic of the reaction catalysed by shikimate dehydrogenase.
The fourth step in the shikimate pathway is the reduction of dehydroshikimic acid (5) 
to shikimic acid (6) (Figure 5) (Salamon and Davis, 1953; Yaniv and Gilvarg, 1955). 
This reaction is also part of the two metabolic pathways associated with DHQase: the 
shikimate pathway, and the quinate pathway (1.1.3) (Chaleff, 1974; Hawkins et al., 
1982).
The E. coli isozyme is catalyzed by an NAD(P)H-dependent shikimate 
dehydrogenase with a molecular weight of 29 kDa. Isozymes found in other 
microorganisms are pyrrolo-quinoline quinone dependent (Duine, 1991).
The shikimate dehydrogenase reaction will be discussed in more detail in a later part 
of this chapter (1.4).
1.1.1.5 Shikimate kinase (EC 2.7.1.71)
coy
HO OH
OH
(6)
Shikimate kinase
Mg'
ATP
OH
(7)
Figure 6. Schematic of phosphorylation of shikimic acid to form shikimate-3- 
phosphate by shikimate kinase.
Shikimate kinase catalyses the fifth step of the shikimate pathway, namely the 
transfer of phosphate from ATP to the C-3 hydroxyl group of shikimate (6) forming 
shikimate-3-phosphate (7) (Figure 6). There are two isozymes of shikimate kinase in 
E. coli and S. typhimurium: shikimate kinase 1 and 11 encoded by aroK and aroL
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genes, respectively. The two isozymes are of comparable polypeptide chain length 
and molecular weight (approximately 19.5 kDa) but only share 30% sequence 
identity (Millar et al, 1986; Lobner-Olesen and Marinus, 1992, Whipp and Pittard, 
1995). The Km value for shikimate of shikimate kinase 1 is approximately 100 times 
greater than shikimate kinase II (20 mM compared with 200 p,M) (DeFeyter and 
Pittard, 1986b). It is suggested that isozyme 1 may not be a true shikimate kinase and 
has another function(s) within the cell. A random insertional mutagenesis study of E. 
coli revealed that mutation of the aroK gene confers mecillinam resistance. 
Mecillinam is a j3-lactam antibiotic specific to penicillin-binding protein 2 in E. coli, 
which blocks cell wall elongation and indirectly cell division. Shikimate kinase I 
possibly has some role in cell division (Vinella et ah, 1996).
Gene expression of shikimate kinase II {aroL) is regulated by cooperation between 
the trpR and tyrR repressor genes and is associated with a second gene designated as 
aroM, the function of which is unclear (DeFeyter and Pittard, 1986a; DeFeyter et ah, 
1986). However, shikimate kinase 1 (aroK) regulation is independent of amino acid 
concentration and the trpR and tyrR repressors (Ely and Pittard, 1979). It has been 
suggested that this enzyme is at a branch point of two distinct pathways (Millar et al,
1986). In R subtilis there is a single shikimate kinase which forms a trifunctional 
complex with the bifunctional DAHPS/chorismate mutase enzyme. When this 
complex is dissociated, shikimate kinase becomes inactive (Nakatsukasa and Nester, 
1972).
Shikimate kinase 11 has been shown to require Mg as a cofactor, this involves the 
direct interaction with two protein side-chains (Krell et a l, 1998). The optimum pH 
of the enzyme is alkaline (8.6-9.6) (Mousdale and Coggins, 1993). The thi’ee 
dimensional structure of shikimate kinase from Erwinia chrysanthemi has been 
determined by X-ray crystallography using multiple isomorphous replacement (Kiell 
et al., 1998). The enzyme undergoes substantial conformational modifications during 
catalysis, with two flexible domains shifting to fit the substrate (Krell et a l, 1998). 
Site-directed mutagenesis of E. chrysanthemi shikimate kinase identified lysine 
residue (K15) as an essential residue in the phosphorylation of shikimic acid. The 3- 
dimensional X-ray structure of the K15M mutant E. chrysanthemi shikimate kinase 
showed as well as the role in catalysis Lysl5 has a role in the structural organisation 
of the P-loop (Krell et al., 2001). Shikimate kinase in archaea is part of the GHMP-
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kinase superfamily and shares no homology with bacterial or eukaryotic shikimate 
kinases (Daugherty et al., 2001).
1.1.1.6 5-gMoZpyruvoylshikimate 3 -phosphate synthase (EC 2.5.1.19)
■O3PO
"O.P
CO9-
OH
(7)+
(2)
CO,
EPSP synthase
■QsPC
GO,
OH(8)
CO,
Figure 7. Schematic of the 5-gMoZpyruvoylshikimate 3-phosphate synthase (EPSP 
synthase) reaction.
The enzyme, 5-eno/pyruvoylshikimate 3-phosphate synthase (EPSP Synthase) 
catalyses the condensation of shikimate 3-phosphate (7) with a second PEP (2) to 
produce the enol ether, 5-eMoZpyruvylshikimate-3-phosphate (EPSP, 8) (Figure 7) 
(Levin and Sprinson, 1964). The E. coli gene aroA encodes for EPSP synthase 
(Duncan et al, 1984a), a monomeric enzyme with a molecular weight of 49 kDa 
(Duncan et al, 1984b). The 3-dimensional structure of EPSP synthase from E. coli 
has been determined by Stallings et al., (1991). The protein has two domains, each of 
which comprises two parallel a  helices and four (3 strands. The active site is located 
near the inter-domain crossover region of the protein.
The mechanism of EPSP synthase involves cleavage of a C-O bond of PEP. Labelled 
substrate studies revealed, a reversible addition-élimination mechanism where 
protonation of C3 of PEP is associated with nucleophilic attack on C2 by C5 of 
shikimate-3-phosphate (Bondinell et al., 1971; Grimshaw et ah, 1982). This reaction 
introduces the thiee-carbon fragment that is designated to become the main chain of 
phenylalanine and tyrosine and which is removed during the synthesis of tryptophan 
(Pittard, 1987). The mechanism of EPSP synthase is thought to proceed via a 
moderately stable tetrahedi'al intermediate formed from shikimate-3-phosphate and 
PEP by means of an ordered BiBi mechanism. There have been extensive studies
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involving the identification, characterisation and isolation of the enzyme 
intermediates of EPSP synthase (Anderson and Johnson, 1990)
The billion dollar broad-spectrum herbicide glyphosate [A-(phosphonomethyl) 
glycine] (commercially known as ‘Tumbleweed™ or ‘Roundup™) (Figme 8) was first 
reported to act on Lemma gibba by the Jaworski group at Monsanto (1972). On 
addition of L-phenylalanine the growth inliibition of glyphosate was reduced. The 
precise target of for glyphosate, EPSP synthase was identified by Steim'ucken and 
Amrhein (1980). It is an analogue of the PEP and the kinetic patterns are consistent 
with an ordered sequential mechanism in which either PEP or glyphosate can bind to 
an enzyme-shikimate-3-phosphate complex (Boocock and Coggins, 1983). 
Glyphosate is a competitive inliibitor with respect to PEP of EPSP synthase. Of 
several known PEP-dependent enzyme reactions, EPSP synthase is the only known 
enzyme inhibited by glyphosate. The PEP binding region of EPSP synthase therefore 
appears to be unique (Padgette et aL, 1991).
7 \ CO2-
Figure 8. Structure of glyphosate (A-phosphonomethyl glycine, commercially 
known as ‘Tumbleweed®’ or ‘Roundup®).
Site-directed mutagensis has identified several amino acid side chains as being 
essential in the catalytic mechanism of EPSP synthase. There is a conserved arginine 
(R104) in the B. subtilis enzyme which plays a key role in the discrimination between 
glyphosate and PEP. Site-directed mutagenesis of this side chain, in particular the 
loss of guanidium chain reduces the K{ by 14-fold {K\ 5 pM) (Selvapandiyan et ah, 
1995). Further site-direct mutagenesis was performed to characterise the active site 
residues of the E.coli EPSP synthase, including the identification of an essential 
arginine residue, and a lysine residue that increased the Km for PEP significantly 
(Shuttleworth et al, 1999). Fmthermore a critical glycine residue that interacts with 
the phosphate moiety of PEP has also been identified (Padgette et al., 1991). Despite 
over 20 years of extensive use of glyphosate the occurrence of spontaneous resistance 
to glyphosate in plants is rare. Recently goosegrass {Eleusine indica) was found to 
have developed resistance to glyphosate. Sequence analysis of the strain which had
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developed resistance showed two amino acids changes from the sensitive goosegrass 
strain (Baerson et aL^  2002).
The X-ray structure of shikimate-3-phosphate and glyphosate bound to EPSP 
synthase has been reported and allows a detailed visualisation of the interactions of 
the ligands with their target however, it is unclear whether glyphosate and PEP 
occupy the same binding site. It is thought that upon ligand binding the tertiary 
structure of EPSP synthase changes from an ‘open’ form to ‘closed’ form. It is also 
thought that the ‘closed’ form is not readily transpoided into plant chloroplasts 
(Alibhai and Stallings, 2001).
1.1.1.7 Chorismate synthase (EC 4.6.1.4)
COTCOT
Chorismate synthase
COT
OH
(8) OH(9)
Figure 9. Schematic of the elimination of phosphoric acid from EPSP to form 
chorismate catalysed by 5-enolpyruvylshikimate 3-phosphate-lyase 
(Chorismate synthase).
Chorismate synthase (5-enolpyruvylshikimate 3-phosphate-lyase) catalyses the 1,4- 
elimination of phosphate from EPSP (8) to give chorismate (9, Figure 9), introducing 
the second double bond into the aromatic ring system (Morell et al., 1967). The 
mechanism of chorismate synthase involves the 1,4-conjugate elimination of 
the phosphate group. Studies using labelled substrates showed that the chorismate 
synthase reaction is stereospecific involving the anti elimination of the pro-6R 
hydrogen (Hill and Newkome, 1969; Onderka and Floss, 1969; Floss et al,, 1972). 
The elimination requires a reduced flavin and NAD(P)H, although there is no change 
in oxidation state of the reduced flavin. FMN is the preferred flavin cofactor over 
FAD. The role of the flavin is unclear, but it appeal’s to be directly involved in 
catalysis. Studies using reduced 5-deaza-FMN gave conflicting results. In some 
studies reduced 5-deaza-FMN reconstituted the catalytic activity of inactive E. coli
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and N. crassa chorismate synthases, while other studies showed a significant decrease 
in catalytic activity in the presence of reduced 5-deaza-FMN (Bornemann et aî., 
1995; Osborne et a l, 2000). Pre-steady state kinetics studies do not show a burst or a 
lag phase in the reaction. It is thought that release of the phosphate occurs in parallel 
with the rate-limiting step of the reaction (Hawkes et al., 1990). The aroC gene 
encodes chorismate synthase in E. coli and N. crassa. Both purified enzymes are 
tetramers with subunit molecular masses of 38 kDa and 50 IcDa, respectively (Millai' 
et al, 1986; White et al., 1988).
There are two types of chorismate synthase defined by whether they ai'e active in 
anaerobic or aerobic conditions. E. coli chorismate synthase is oxygen sensitive and 
requires an anaerobic environment, whereas the Bacillus subtilis enzyme is aerobic. 
The essential difference between the isozymes is that the anaerobic type contains a 
diaphorase (flavoprotein) catalysing the redox reaction between a reduced pyridine 
nucleotide and a suitable acceptor (Mousdale and Coggins, 1993). Chorismate 
synthase is found in the chloroplasts of Pisum sativum L. and is likely to contain an 
amino terminal extension to direct chloroplast import (Mousdale and Coggins, 1986). 
Two distinct chorismate synthases have been identified in tomato (Lycopersicon 
esculentum L.); there is 85% cDNA sequence similaiity between the isozymes and 
both sequences contain regions involved in plastidic transit. The two isozymes are 
expressed at different levels one gene (LeCSl) has significantly higher expression 
levels compai ed with that of the other gene (LeCS2) (Gorlach et a l, 1993).
Initially chorismate synthase was thought to form the intermediate iso-EPSP. Baitlett 
et al., (1986) chemically synthesized this potential intermediate and found it be a 
competitive inhibitor of N. crassa chorismate synthase rather than an intermediate 
with a K\ of 8.7 gM (compared with a Xm(EPSP) of 2.7 juM).
Attempts to produce rational designed inhibitors of the shikimate pathway enzyme 
led Sutherland et al. (1989) to make the two stereoisomers of 6-fluoroshikimic acid. 
These compounds were designed to be substrates of shikimate kinase and EPSP 
synthase (Duggan et al., 1995). The substrate analogue (65)-6-fluoro-EPSP is a 
competitive inhibitor of Neurospora crassa chorismate synthase (Balasubramanian et 
al, 1991). This substrate analogue is converted into 6-fluorochorismate at a rate two 
orders of magnitude lower than the normal substrate. The spectral characteristics of 
the fluoro-substrate are different from the true substrate. (65)-6-fluoroshikimic acid
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is more likely to be an inliibitor of 4-aminobenzoic acid synthesis (Bornemann et al, 
1995). The results are consistent with the antimicrobial effect of 6-fluoroshikimate 
(Davis et al, 1994). Unfortunately spontaneous resistance to (65) arose in E. coli and 
other enterobacteria at high frequencies. The uptake of (65)-6-fluoroshikimate by E. 
coli was studied by performing exchange-diffusion experiments with [C^"^]shikimate 
(Jude et a l, 1996). A loss of susceptibility to (65)-6-fluoroshikimate was caused by a 
loss of activity of the shikimate transport system as a result of genetic changes at the 
shiA loci (Ewart et a l, 1995). These compounds have also been shown to have an 
inhibitory effect on Plasmodium falciparum which can be reversed by the 
supplementation of PABA (McConkey, 1999). Recently a series of 2(2)-2- 
benzylidene-6,7-dihydroxybenzofuran~3[2H]-ones have been identified by extensive 
chemical library screening as potential inhibitors of bacterial chorismate synthase 
(Thomas et a l, 2003).
1.1.2 Branches of the shikimate pathway
Chorismate is the major branch point of the synthesis of the aromatic amino acids L- 
phenylalanine, L-tyrosine and L-tryptophan (Figure 1). Chorismate is a substrate for 
several different enzymes including chorismate mutase (1.1.2.1) and anthranilate 
synthase/ isochorimate synthase (1.1.2.2).
There are also several other branch points of the shikimate pathway before the 
chorismate intermediate. A novel variant of the shikimate pathway involving 3- 
amino-5-hydroxybenzoic acid (AHBA) has been described; this pathway leads to 
rifamycin and other related antibiotics. A variety of antibiotics, notably the 
ansamycins that include rifamycin contain a biosynthetically unique moiety, called a 
mCyN unit. Production of the mC?N units is thought to involve DAHP synthase and 
shikimate dehydrogenase (Kim et a l, 1992). The branch point for this compound is 
the intermediate dehydroshikimate and the pathway has been characterised in 
Amycolatopsis mediterranei by Kim et a l (1998). Shikimate dehydrogenase is also 
the branch point for the synthesis of hydroylsable tannin from gallic acid. 
Hydrolysable tannins are involved in insect resistance in plants (Ossipov et a l, 2003) 
(6.1.3).
Two more unusual branch points of the shikimate pathway also found in 
Streptomyces appear to involve the dehydroquinase-catalysed reaction. They are the
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formation of cyclohexanecarboxylic acid and dihydroxycyclohexanecarboxylic acid, 
which are respectively an anti-fungal agent and a precursor of the 
immunosuppressant ascomycin (Wilson et aL, 1998).
1.1.2.1 Chorismate mutase (EC 5.4.99.5)
The first branch of the main trunk of the shikimate pathway occurs at the chorismate 
mutase reaction. This enzyme catalyses the Claisen-like arrangement of chorismate 
to prephenate. Prephenate is a precursor of L-phenylalanine and L-tyrosine. The 
PEP-derived side chain changes to form a direct bond to the cai'bocycle (Dewick,
1998). Prephenate is a relatively unstable compound and can be converted into 
phenylpyruvate at an acidic pH. The enzyme is a homo dimer with a subrmit 
molecular weight of about 42 kDa (Mousdale and Coggins, 1993; Pittard, 1987).
E. coli chorismate mutase has been puiified to homogeneity, and is present as part of 
a bifunctional polypeptide along with prephenate dehydrogenase (Sampathkumar and 
Morrison, 1982).
1.1.2.2 Antliranilate synthase/ Isochorismate synthase (EC 5.4.99.6)
Anthranilate synthase exhibits significant amino acid sequence homology with 
isochorismate synthase and j!?-aminobenzoate synthase (which forms the precursor to 
ubiquinone) suggesting a common mechanism (Dewick, 1998). These enzymes are 
involved in the biosynthetic pathways to anthianilate and p-aminobenzoate 
respectively. A glutamine amidotransferase activity provides ammonia from 
glutamine, which then reacts with chorismate to foim 4-amino-4-deoxychorismate or
2-amino-2-deoxyisochorismate. Anthranilate is an intermediate for the synthesis of 
L-tryptophan (Ganem, 1978; Dewick, 1998).
1.1.3 Organisation of enzymes
Although the same chemical intermediates are involved, the organisation of the 
enzymes concerned in the pathway varies considerably between organisms. In most 
bacteria, reactions two to six of the shikimate pathway are catalysed by five separate 
monofunctional enzymes, but in fungi, a single polypeptide called the arom protein 
which is a pentafuctional polypeptide, serves the same purpose (Figure 10) (Lumsden 
and Coggins, 1977; Coggins et al., 1985; Coggins and Boocock, 1986).
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Arom proteins have been studied from N. crassa (Giles et aL, 1967; Lumsden and 
Coggins, 1977), A. nidulans (Charles et ah, 1985), Saccharomyces cerevisiae 
(Duncan et ah, 1987), Schizosaccharomyces pombe, Cryphonectria parasitica 
(Lakshman et ah, 1998) and Pneumocystis carinii (the pathogen that is the principal 
cause of death in AIDS patients) (Banerji et al., 1993). No examples of the arom 
pentafuctional polypeptides are known in photosynthetic organisms (Coggins et ah,
1987). The pentafunctional polypeptide chains have a mosaic structure and are 
essentially the five monofunctional enzymes found in bacteria fused together to form 
a multifunctional polypeptide chain (Coggins and Boocock, 1986). Studies of 
controlled proteolysis by trypsin and subtilisin have shown the presence and location 
of distinct protein domains (Smith and Coggins, 1983; Coggins and Boocock, 1986). 
The N. crassa arom complex is also Zn^’*' dependent, with 1 atom per subunit of 
tightly bound zinc (Lambert et al., 1985).
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Figure 10. Organisation of shikimate pathway enzyme in different species and 
Taxonomies. Blue circles indicate monofunctional enzymes and green 
linked squares indicate multifunctional polypeptides. The red line indicates 
a functional complex is formed between these proteins. The numbers 
indicate the number of the known isozymes for a given enzyme in a specific 
organism.
In these complexes, the order of the enzymes along the polypeptide chain differs from 
the sequence of the reactions in the pathway. Components of protein domains 
corresponding to DHQ synthase and EPSP synthase form the N-terminal element, 
whereas the domains corresponding to shikimate kinase, dehydroquinase, and the 
shikimate dehydrogenase form the C terminal portion (Smith and Coggins, 1983; 
Coggins and Boocock, 1986). One of the advantages of multifunctional enzymes is 
that the ‘gene cluster’ encoding the multifunctional polypeptide supplies a 
mechanism which regulates the expression of the functional domains so that equal 
amounts of each polypeptide are made and only one set of control sequences are 
required to regulate the expression of the pathway (Coggins et al., 1987). There are a 
number of other proposed advantages of multifunctional enzymes, including the 
channelling of the substrate (Lamb et al., 1992), the protection of unstable 
intermediates and enliancement of catalytic activity.
In higher plants such as Phaseolus mungo, Physcomitrella patens, Nicotiana tabacum 
and Pisum sativum, reactions three and four of the shikimate pathway are catalysed 
by a bifunctional enzyme (3-dehydroquinate dehydratase-shikimate dehydrogenase) 
(Koshiba, 1978; Policy, 1978; Mousdale et al., 1987; Bonner and Jensen, 1994; Deka 
et al., 1994). The dehydration site is located in the amino terminal half of the 
polypeptide. The partial cDNA sequence encodes a type I dehydroquinase (Bonner 
and Jensen, 1994). The inhibition by sodium borohydride in the presence of the 
substrate indicates that the bifunctional enzyme catalyses the dehydration of 
dehydroquinate via a Schiff base mechanism (Deka et ah, 1994) and is therefore a 
type I dehydroquinase (1.3.3). The shikimate dehydrogenase domain of the 
bifunctional enzyme is homologous with the catabolic quinate dehydrogenase (qutB) 
of A. nidulans and N. crassa (Bonner and Jensen, 1994).
Enzymes catalysing the remaining three reactions of the shikimate pathway are 
structurally homologous to those found in prokaryotes. Plant shikimate kinase cDNA
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encodes an additional amino terminal sequence encoding plastid import (Schmid et 
al., 1992). Shikimate kinase is localised in the chloroplasts of plants and appears to 
be activated by the energy charge (Schmidt et ah, 1990).
B. subtilis possesses a bifunctional polypeptide which has two domains with DAHP 
synthase and chorismate mutase activity, respectively (Figure 10). The shikimate 
kinase of B. subtilis is only active when complexed with this bifunctional enzyme 
(Nakatsukasa and Nester, 1972) (1.1.1.1 and 1.1.2.1).
There are three isozymes of DAHP synthase and two isozymes of shikimate kinase in 
E. coli (Figure 10); these are discussed in sections 1.1.1.1 and 1.1.1.5.
The organisation of the shikimate pathway genes is very diverse. Several species 
have a cluster of genes associated with the shikimate pathway including 
Enterococcus faecalis, Clostridium acetobutylicum and Streptococcus pneumoniae.
1.2 Quinate Pathway
Quinic acid is an abundant plant metabolite constituting 2-10% of the dry mass of 
higher plants (Bentley, 1990). A. nidulans is a heterotrophic ascomycete, which plays 
a role in the decay of humus, and decaying leaves. Quinate is present in this decaying 
vegetation and A. nidulans has the ability to grow solely on this carbon source 
(Hawkins et al., 1982).
Three enzymatic reactions have been isolated in vitro'.- a dehydrogenase (qutB) 
converting quinate to dehydroquinate, a dehydroquinase (qutE) converting 3- 
dehydroquinate to 3-dehydroshikimate, and a dehydratase (qutC) converting 3- 
dehydroshikimate to protocatechuate. These genes seem to be regulated by the 
product of a tightly linked third gene (qutA) (Valone et al., 1971; Hawkins et ah, 
1982; Da Silva et ah, 1986; Beri et ah, 1990). In the A. calcoaceticus chromosome 
the genes are part of the PC A operon (Hawkins et ah, 1993; Elsemore and Ornston, 
1995). A number of organisms have quinate-shikimate dehydrogenases or shikimate 
dehydrogenase which can also act as a quinate dehydrogenase (1.4.1). Studies on 
mutant strains of N. crassa arom'^ which encodes the shikimate dehydrogenase 
domain of the pentafunctional enzyme are able grow on minimal medium since the 
qa-3 quinate pathway shikimate dehydrogenase is able to catalyse the reaction 
disrupted by the mutation of the arom complex (Case et ah, 1972). 
Dehydroshikimate is converted to proteocatechuate by dehydroshikimate
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dehydratase; the stereochemistry of the catalysis was determined using the crude 
extract of mutant N  crassa arom'^ and stereospecifically labelled substrate at C6 
(Scharf et al., 1971) this revealed that the reaction mechanism of dehydroshikimate 
dehydratase procédés via the elimination of the pro~6R hydrogen together with the 
hydroxyl group at C5. Protocatechuate can be processed by the p-ketoadipate 
pathway eventually feeding into the TCA cycle (Giles et al., 1985) (Figure 1),
The repressor proteins which regulate quinate catabolism in N. crassa (qutR) and the 
C-terminal domain of A. nidulans and S. cerevisiae arom protein have similar physical 
chai'acteristics (Anton et al., 1987; Lamb et al., 1996). It is thought that both these 
proteins evolved from the three functional domains of the pentafunctional protein 
corresponding to dehydroquinase, dehydroshikimate dehydrogenase and shikimate 
kinase (Bonner and Jensen, 1994; Lamb et al., 1996). N. crassa and A. nidulans both 
also possess a type II DHQase encoded by the genes: qa-2 and qutE, respectively 
(Hawkins et al., 1993).
Some fungi (N. crassa and A. nidulans) have both a type I domain within the arom 
pentafunctional enzyme and a type II dehydroquinase (1.3). In such organisms the 
type I enzyme is considered the anabolic form from the shikimate pathway and the 
type II enzyme the catabolic form in the quinate pathway (Giles et al., 1967; Hawkins 
et al., 1993; Dewick, 1998). The biosynthetic pathway enzyme is expressed 
constitutively and the catabolic enzyme is inducible. This allows the fungi to 
maintain flux tlrrough the shikimate pathway and respond to high levels of quinate in 
the environment (Giles et al., 1985).
1.3 Two types of dehydroquinase
3-Dehydroquinase (dehydroquinate dehydratase; DHQase) catalyses the conversion 
of 3-dehydroquinate to 3-dehydroshikimate (Figui'e 4). Two distinct classes of 
dehydroquinase (types I and II) are responsible for catalysing the dehydration of 
dehydroquinate by different mechanisms and they also show no significant sequence 
similarity (Giles et al., 1968; Charles et al., 1985; Moore et al., 1992; Lalonde et al., 
1994). It appears that the two types of dehydroquinase have arisen independently 
(Gourley et al., 1999). They have very different amino acid sequences, subunit 
molecular weights, secondary, tertiary and quaternary structures, thermal stability and 
catalytic mechanisms. The two DFIQases are generally well conserved within each
Page 41
CHAPTER 1 INTRODUCTION
type (Gourley et ah, 1999). These biophysical properties have been studied using the 
E. coll type I and the A. nidulans type II DHQases. The type I DHQase is a 
homodimer of approximately 56 kDa. The type II DHQase is a homododecamer of 
190 kDa. Thermal stability studies show that the Type I DHQase unfolds at STC  
while the type II DHQase unfolds above 82”C. The type II enzyme unfolds at 
concentrations of guanidinium chloride 4-times greater than are required for the type 
I enzyme. The type I enzyme unfolds in one transition while type II DHQase unfolds 
through a series of transitions (Kleanthous et al., 1992, Price et al., 1999). 
Stereochemical studies, using deuterated dehydroquinate and fluorinated substrates 
show that the reaction catalysed by the type II enzyme proceeds via an anti 
stereochemistry; in contrast in the type I DHQase the stereochemistry of the 
elimination is syn (Haslam et al., 1971; Shneier et al., 1993; Harris et al., 1993a; 
Parker et al., 2000). The substrate analogues 5-deoxy- and 4,5-dideoxy- 
dehydroquinic acid were used to test differences in substrate specificity between type
I and type II DHQases. 4,5-dideoxy-dehydroquinic acid was found to be a poor 
substrate of M. tuberculosis type II DHQase with a of 5 M'  ^ s'^  and was not a
substrate for the E. coli type I DHQase, highlighting the importance of the C4 
hydroxyl group in the type I mechanism (Harris et al., 1996).
Enzymes ai'e generally considered to catalyse reactions by optimised mechanisms. It 
is therefore very interesting, when two mechanistically distinct enzymes are found 
which catalyse the same reaction.
1.3.1 Distribution of types
NCBI Genbank fhttn://www.ncbi.nlm.nih.gov/BLAST). EBI Genbank 
fhttp://www.ebi.ac.ukf and TIGR Comprehensive Microbial Resource (CMR) 
fhttp://www.tigr.org/tigr-scripts/CMR2/CMRHomePage.snl) web sites were used to 
reveal approximately 50 DHQases from different species, comparisons of the primary 
structures were peformed using http://nrodes.toulouse.inra.fr/multalin/multalin.html 
(Corpet, 1988). There is a demographic representation of the distribution of type I 
and II DHQases across a variety of species in Chapter 4 Figure 24. The type I 
DHQases have only been found in the context of the shikimate pathway whereas type
II enzymes have been found to be involved in both the shikimate and quinate 
pathways. It should be noted that Bacillus subtilis has both forms of the enzyme. 
There does not seem to be any significant correlation between possession of either
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type of DHQase and gene clustering. However in certain species the type I DHQase 
gene (aroD) is found to be neighbouring that of the shikimate dehydrogenase (aroK) 
(data not shown). This may have some evolutionary link to the formation of the 
bifunctional enzyme found in photoautotrophic organisms.
1.3.2 Selective inhibition
The availability of these two types of DHQase opens the way for the design of highly 
specific enzyme inhibitors with a potential importance as selective therapeutic agents 
(Gourley et al, 1999). The stereochemical differences in the mechanism between the 
two types have been exploited in the design of specific inhibitors. (2/^)-2-Bromo-3- 
dehydroquinic acid and (2i?)“2-Fluoro-3-dehydroquinic acid are both substrates of the 
M. tuberculosis type II DHQase, while in the E.coli type I DHQase they are both 
irreversible inliibitors with K\ values of 3.7 mM and 80 pM, respectively (Bello et ah, 
2000).
A variety of known pathogens contain the type II enzyme, notably Helicobacter 
pylori (thought to cause stomach ulcers), M  tuberculosis (cause of tuberculosis) and 
Campylobacter jejuni (causes food poisoning) this makes it an interesting and novel 
antibiotic target. Since multiple drug resistance has evolved in M. tuberculosis it is of 
great importance that new drugs against this pathogen are found (Nachega and 
Chaisson, 2003). As more pathogenic organisms such as P. falciparum (McConkey, 
1999) and Chlamydia trachomatis (Stephens et al, 1998) are found to have the 
shikimate pathway the stronger the case becomes to develop novel drug compoimds 
that inhibit the pathway.
Although both types of enzyme are likely to have similar substrate recognition 
elements in the active site a greater understanding of their mechanisms may suggest a 
rational basis for selective drug design. Several inhibitors of type II DHQases which 
are poor inhibitors of the type I class have been identified (Frederickson et al, 1999; 
2002) and are discussed in Chapter 3 (3.1.1),
1.3.3 Type I DHQase
The amino acid sequence of type I enzyme was deduced from the nucleotide 
sequence of the aroD gene in E. coli by Duncan et al. (1986b) and the subunit 
molecular mass was calculated as 26 kDa. The E. coli enzyme exists in solution as a 
dimer. The enzyme has also been characterised as part of a bifunctional enzyme in
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Pisum sativum (Deka et al., 1994), In the presence of guanidine hydrochloride the 
bacterial enzyme unfolds in one continuous transition suggesting that the dimer 
imfolds in a single co-operative step (Kleanthous et al., 1991; 1992).
pH dependence studies on the E. coli type I dehydroquinase show that the enzyme is 
active over a broad range from pH 7.0 to 9.0 (Balinsky and Davies, 1961c). The type 
I enzymes catalyse a cz5'-dehydration of dehydroquinate involving elimination of the 
pro-^  hydrogen along with the Cl hydroxyl group via a covalent imine (Schiff base) 
intermediate (Butler et al., 1974; Chaudhuri et al., 1991) (Figure 11), the formation of 
which is thought to be the rate limiting step of the reaction (Rotenberg and Sprinson, 
1978; Hai'ris et ah, 1996a; Gourley et ah, 1999). Using sodium borohydride trapping, 
the mechanism of E. coli type I dehydroquinase and the dehydroquinase component 
of the pentafunctional arom enzyme from N. crassa were shown to involve the 
formation of a Schiff base (Butler et ah, 1974) between dehydroquinate and an active 
site lysine of the enzyme (Chaudhuri et ah, 1991). Stability studies using circular 
dichroism, guanidine hydrochloride (GdmCl) dénaturation, susceptibility to 
proteolysis and differential scanning calorimetry, showed that type I dehydroquinase 
from E. coli with covalently bound ligand was significantly more stable than 
unmodified enzyme. The concentration of GdmCl required to unfold the modified 
enzyme being 3-4-foId greater than for the unmodified native enzyme (Kleanthous et 
ah, 1991).
Radioactive labelling studies using iodo(2-^"^C)acetic acid were performed to identify 
residues in the active site of E. coli type I DHQase. This was achieved by sequencing 
radio labelled peptide fragments isolated after proteolytic digestion (Kleanthous et ah, 
1990a). Two residues, Met23 and Met205 were located in the active site pocket 
(Kleanthous et al, 1990b). The covalently linked imine product is linked at the centre 
of the barrel attached to Lysl70 (Figui'e 11), which is located on the |3-strand. This 
location is similar to that in several enzymes proceeding via a Schiff base 
intermediate (Gourley et ah, 1999).
In order to investigate the mode of binding of dehydroquinate to the E. coli type I 
DHQase, a series of affinity labels were synthesized. These were used to characterise 
the active site general base, the carboxlylate binding site and the C4 hydroxyl binding 
site (Bugg et ah, 1988). Type I DHQase will tolerate the absence of the C-5 hydroxy 
group, however the substrate specificity is significantly reduced suggesting that this
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group forms an important binding interaction with the enzyme (Harris et ah, 1996a). 
The loss of the C-4 hydroxyl group of dehydroquinate completely abolishes the 
catalytic activity. It is thought that the C4 hydroxyl group is important for imine 
formation by the type I enzyme. Studies on the type II DHQase show the C4 
hydroxyl group does not to contribute significantly to specificity of the enzyme. 
Kinetic studies show that the absence of the C5 hydroxyl group reduces the 
specificity of the enzyme. An apparent binding energy (AGgpp) for the 5-hydroxyl 
group was calculated from the kcJK^ values for dehydroquinate and 5-deoxy- 
dehydroquinate to be 17.2 kJ m o f\ This suggests that the 5-hydroxyl group makes a 
strong interaction with a charged side chain either a lysine or arginine (Harris et ah, 
1996b). Parker et al, (2000) have highlighted some of the differences between the 
two enzymes using fiuoro-analogues of the substrate {{6R)~ and (65)-6-fluoro-3- 
dehydroquinate). These analogues enable the enzyme-substrate imine to be trapped 
on the type I enzyme on treatment with sodium borohydride rather than the usual 
enzyme product imine.
HO, Ms
OHCO2
HO (4)
E n zy m e Enzyme
L ysl70HQ HN L ysl70HQ
OHHO
0 0 /
OH
OH(5)
Figure 11. Proposed mechanism for the enzymic conversion of dehydroquinate (4) 
into dehydroshikimate (5) catalysed by type I dehydroquinase (Harris et ah, 
1993; 1996b; Gourley et ah, 1999).
Mutagenesis of the active site residues performed by Leech et ah (1995) showed that 
mutation of Lysi70 to an alanine almost totally abolishes the activity. This makes it 
clear that formation of the Schiff base is indispensable for the catalysis in the 
enzyme. Chemical modification experiments using the group specific reagent diethyl 
pyrocarbonate (DEPC) implicated His 143 as the putative general base (B in Figure 
11) in the breakdown of the imine intermediate. Furthermore pH-dependence studies 
identified a single ionised group with a pKg of 6.2 (Deka et ah, 1992). His 146 was 
also thought to be a candidate for this role; accordingly both of these side chains were 
mutated to alanine. The HI43A mutant gave a similar Km to the wild type whereas
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there was a 5-6-fold reduction in c^at- However, the catalytic activity and Km were not 
affected by the HI46A mutation (Leech et al., 1995). The 3-dimensional X-ray 
structui'e of Samonella typhi type I DHQase reveals that His 143 lies at the centre of a 
hydrogen bonded triad with Lysl70 and Glu86 (Boys et al., 1992; Gourley et al.,
1999). His 143 and Glu86 residues interact through the protonated amine side chain 
of Lysl70 (Gourley et al., 1999). Studies using protein engineering and 2- 
dimensional ^H, ^^ C NMR and additional pH-dependence studies by Leech et al., 
(1998) proved that His 143 does not ionise over the pH range 6-9.5.
Glu86 is strictly conserved in type I DHQases suggesting an important functional role 
possibly in orientating His 143. Chemical modification experiments on E. coli type I 
DHQase using the arginine-directed reagent phenylglyoxal (PGO) revealed that 
Ai’g213 was hyper-reactive (Krell et ah, 1996). The X-ray structure shows that 
Arg213, which is located on a distorted helix at the subunit interface binds to the Cl 
carboxylate (Gourley et ah, 1999).
The subunit architecture of type I DHQase is an eight-stranded a/p-barrel, a very 
common fold that was first reported for triosephosphate isomerase.
1.3.4 Type II DHQase
Type II DHQase has been characterised from Actinobacillus pleuropneumoniae 
(Lalonde et ah, 1994), Streptomyces coelicolor (White et ah, 1990), H. pylori 
(Bottomley et ah, 1996b; Kwak et ah, 2001), Streptomyces hygroscopicus (Florova et 
ah, 1998) and several other organisms. The structure of the type II enzyme from the 
human pathogen M tuberculosis has been solved using multiple isomorphous 
replacement (MIR) to 2.0 A resolution (Gourley et ah, 1994; 1999). A type II 
DHQase subunit consists of a five-stranded parallel (3-sheet core flanked by four a- 
helices arranged with a similar overall topology to flavodoxin (Burnett et ah, 1974). 
The enzyme is a homododecamer and the subunits are arranged tetrahedrally as a 
tetramer of trimers. This type of dodecameric structure has also been observed in the 
catabolic ornithine carbamoyltransferase from Pseudomonas aeruginosa (Villeret et 
ah, 1995; Nguyen gf a/., 1996).
The thermal stability of the enzyme is substantially higher than the type I enzyme 
with unfolding commencing at 80°C (Kleanthous et ah, 1992). Unfolding in the 
presence of guanidine hydrochloride occurs in three stages. Low concentrations (0.5
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M) of guanidinium chloride are thought to cause the enzyme to dissociate into 
trimeric units, with little or no change in the secondary and tertiary structui’e. In S. 
coelicolor DHQase there is a 15% loss in activity while in M. tuberculosis DHQase 
there is a 55% increase in activity (Price et ah, 1999) in the presence of 0.5 M 
guanidinium chloride. The effect of addition of metal chelators and unfolding during 
refolding of the enzyme was examined by Bottomley et al., (1996b). These 
experiments showed that the type II DHQases are not metal-dependent dehydratases. 
The subunit of type II DHQase has a molecular weight of approximately 16.5 kDa. 
The position of the active site was suggested by the cluster of conserved residues near 
the C-termini of the p strands (Gourley et al., 1999).
Intial localization of the active site was performed using chemical modification in 
conjunction with electrospray mass spectrometry (Ki'ell et al., 1996). These 
experiments identified that the type II enzymes have an essential hyper-reactive 
arginine residue (Arg23 in S. coelicolor DHQase) and an essential tyrosine residue 
(Tyr28 in S. coelicolor DHQase). The role of the arginine residue was proposed to be 
in stabilising the carbanion intermediate. The active site has also been chaiacterised 
using the fluorescent properties of a single tryptophan (Tip66 in S. coelicolor 
DHQase). It was thought that this residue was unlikely to be involved in the catalytic 
mechanism but might help to identify the active site (Boam et al., 1997).
Type II DHQase catalyses an exclusively anti elimination of the pro~^ hydrogen 
along with the Cl hydroxyl group. Due to the fact that there is no conserved lysine 
residue in sequence alignments, and treatment of the type II enzyme with sodium 
borohydride or cyanoborohydride does not lead to the inactivation it can be 
concluded that a Schiff base mechanism is not involved (Harris et al., 1993). It is 
proposed that the type II enzyme adopts the step wise EiCB (elimination 
unimolecular via conjugate base) mechanism and involves an enolate intermediate 
(Harris et al., 1996a). The process involves a base-catalysed abstraction of the axial 
proton at the C2 leading to enolate formation (Goui’ley et al., 1999; Harris et al., 
1996a). Elucidation of the enzyme mechanism is discussed in detail in Chapter 3 
(3.1.1) and has been reported in Roszak et al., (2002).
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1.4 Shikimate Dehydrogenase
Shikimate dehydrogenase catalyses the reversible reduction of dehydroshikimate to 
shikimate (Salamon and Davis, 1953; Yaniv and Gilvarg, 1955) (Figure 5). Both the 
plant and bacterial enzymes require NADPH as a cofactor. A hydride is transferred 
from the nicotinamide ring of the cofactor to the C3 position of the substrate and a 
proton is also acquired stabilising the hydroxyl group at C3. Hydride transfer takes 
place from the A-side of the nicotinamide ring of NADPH (Dansette and Azerad, 
1974).
Shikimate dehydrogenase encoded by the aroE gene (Anton and Coggins, 1988) has 
been purified to homogeneity from E. coli (Chaudhuri and Coggins, 1985), and was 
shown to be monomeric (Maclean et al., 2000) with a molecular mass of 32 kDa. 
The enzyme shows a strong preference for NADP^ over NAD”^. The 3-dimensional 
X-ray structure of E.coli shikimate dehydrogenase reveals a novel binding site for 
NADP^ (Maclean et al., 2000; Michel et al., 2003). The plant shikimate 
dehydrogenase is part of a bifiinctional polypeptide which requires NADPH for 
catalysis (Mousdale et al., 1987; Deka et al., 1994).
Much of the work on this enzyme has been carried out by assaying the enzyme in the 
reverse direction of the biosynthetic pathway; this is because shikimate is readily 
available and dehydroshikimate is not. Several inhibitors of shikimate 
dehydrogenase have been synthesized. The analogues of dehydro shikimate including 
l,6-dihydroxy-2-oxoisonicotinic acid were found to be fairly potent inhibitors of the 
reverse reaction of shikimate dehydrogenase (B ai Hie et al., 1972). Analogues lacking 
the C4 and C5 hydroxyl group of the substrate have helped identify the mode of 
substrate binding (Bugg et al., 1988). Kinetic isotope studies and cofactor 
dissociation constants determined for the Pisum sativum enzyme suggest that 
shikimate dehydrogenase proceeds via an ordered BiBi mechanism, with the cofactor 
binding to the enzyme first (Balinsky et al., 1971; Dowsett et al., 1972). These 
inliibitors, analogues and isotope studies are discussed in more detail in Chapter 6 
section 6.1.3.
Page 48
CHAPTER 1 INTRODUCTION
1.4.1 Quinate-shikimate dehydrogenase
Quinate-shikimate dehydrogenases are thought to be distinct from the biosynthetic 
shikimate dehydrogenases catalysing the first step in the quinate pathway (1.2), 
namely the oxidation of quinate and shikimate to dehydroquinate and 
dehydroshikimate, respectively (Lopez Barea and Giles, 1978; Giles et al., 1985). 
The cofactor specificity of this group of enzymes varies between species. The largest 
group that includes enzymes from fungi such as A. nidulans (Hawkins et al., 1982) 
and N. crassa (Hawkins et al., 1993) and bacterial enzymes such as that fiom R. 
rhodochrous (Bruce and Cain, 1990) are NAD^ specific. The NAD’*’ cofactor is 
normally associated with catabolic functions. The NADP^ specific shikimate 
dehydrogenase from some organisms may also be able to catalyse the oxidation of 
both quinate and shikimate. In A. calcoaceticus the reaction is catalysed by an 
unrelated pyrrolo-quinoline quinone (PQQ) dependent enzyme (Elsemore and 
Ornston, 1994).
1.4.2 Isozymes of shikimate dehydrogenase
Two isozymes of shikimate dehydrogenase have been isolated in a variety of plant 
species including tomato (Lycopersicon esculentum) loblolly pine {Pinus taeda) and 
pea {Pisum sativum). Some species of plants have three isozymes (Koshiba, 1978; 
Lourenco and Neves, 1984; Ossipov et al., 2000). These genes have been used as 
genetic mai'kers in agriculture.
Several bacterial genome projects have also identified a protein with some sequence 
homology to the shikimate dehydrogenase family, these proteins are denoted YdiB. 
The function of this group of proteins is unknown. The 3-dimensional structure of 
the E. coli YdiB protein (25% identity to E. coli shikimate dehydrogenase) has been 
recently solved (Michel et al., 2003). The E. coli YdiB has the same overall fold as 
E. coli shikimate dehydrogenase (Michel et al., 2003). However, the YdiB protein is 
dimeric in contrast with the E. coli shikimate dehydrogenase, which is monomeric. 
The structures and catalytic parameters of both these proteins are discussed in detail 
in Chapter 6 (6.1).
1.5 Project aims
The studies performed in this thesis were undertaken to investigate in more detail the 
mechanism, inhibition and substrate specificities of bacterial type II dehydroquinases
Page 49
CHAPTER 1 INTRODUCTION
and shikimate dehydrogenases. This work should provide a greater understanding of
the species specific differences in the enzymes and improve the prospect of rational
drug design. The major experiments undertaken are outlined below.
• Several amino acid side chains were proposed to be located in the active site 
and involved in catalysis in type II DHQases. This was tested by site-directed 
mutagenesis on the S. coelicolor enzyme using a clone (pT7.7 aroQ 
(SCDHQase)) donated by Prof. Iain Hunter, University of Strathclyde. The 
residues mutated were ArglI3, His 106, Glul04, Seri08 and Tyr28. 
Characterisation of these mutant enzymes has provided strong evidence of the 
role of each of the residues within the active site (CHAPTER 3).
• The tyrosine residue shown by mutagensis to be involved in proton abstraction 
at C2 of the substrate is conserved in all type II dehydroquinases except the 
enzyme from B. suhtilis (YqhS). B. subtilis YqhS has a phenylalanine residue 
in this position. The B. subtilis protein has been purified (A. Herbert) and fully 
characterised by site-directed mutagenesis, kinetics and biophysical studies 
(CHAPTER 4).
• The type II DHQases which have been previously characterised kinetically 
appear to fall into two main groups. The enzymes from organisms such as S. 
coelicolor and Aspergillus nidulans have relatively high values of kcah in the 
range 100 to 1000 s'^ By contrast, the enzymes from Helicobacter pylori, M 
tuberculosis and Neurospora crassa have much lower values of in the range 
10 s'^  or lower. Detailed studies of the pH dependence, pre-steady state 
kinetics, effects of salts on catalytic activity and the inhibitory effect of 
polyanions were performed on the enzymes of S. coelicolor, M. tuberculosis, H  
pylori and B. subtilis (F23Y mutant). This has provided a better overall 
understanding of these enzymes (CHAPTER 5).
• The gene encoding shikimate dehydrogenase from Haemophilus influenzae has 
been cloned into an expression vector pTB361 aroE (donated by Dr. S. 
Campbell, University of Glasgow). Several species of bacteria possess an 
isozyme of shikimate dehydrogenase called YdiB which has a significantly 
different N-terminal amino acid sequence. The 3-dimensional structure of the 
YdiB protein from E. coli has recently been solved and shown to be NAD'*'
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dependent. H. influenzae also possesses the isozyme YdiB, however the N- 
terminal region of this protein differs significantly from the E.coli YdiB and 
other shikimate dehydrogenases. The YdiB protein from H. influenzae has 
been cloned, over expressed purified and characterised by a variety of 
techniques including steady-state kinetics, dynamic light scattering, circular 
dichi'oism and fluorescence (CHAPTER 6).
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CHAPTER 2 MATERIALS AND METHODS
2.1 General Reagents
Chemicals and bio chemicals were generally either analytical grade or the highest 
grade available. Unless otherwise stated all reagents were purchased from Sigma 
Aldrich Company Ltd., Fisher Scientific or Gibco BRL. See Appendix B for 
addresses of companies. Elga deionised water was used to make all buffers.
2.2 Reagents for molecular biology
Reagents used for moleculai’ biology were supplied from Invitrogen Life 
Technologies, Promega, New England Biolabs, Amersham Pharmacia, Boeliringer 
Mannlieim and Difco. DNA markers used on agarose gels were EZ Load lOObp 
Molecular Ruler DNA marker and DNA Markers X and XIV (Roche). Protein 
markers used were Mark 12™ Novex wide range protein standard, low-range mai'ker 
fi'om Boehi'inger Mannheim and Promega Low-range protein moleculai- weight 
marker. See Appendix B for addresses of companies.
2.2.1 Enzymes for molecular biology
Restriction enzymes and their buffers were obtained from New England Biolabs 
Incorporated, Promega Corporation and Boehringer Mannheim. Several polymerases 
were used: Vent DNA polymerase was obtained from New England Biolabs, pfu 
turbo was obtained from Stratagene and Taq polymerase from Promega. 
Bacteriophage T4 DNA ligase was obtained from Boehringer Mannheim and 
Invitrogen. Calf intestine alkaline phosphatase (CIAP) (1 U/pl) was supplied by 
Promega. Restriction enzymes, polymerases and ligases were stored at -20°C. 
Sequencing grade modified trypsin (0.54 mg/ml) supplied from Promega was stored 
at-70°C.
2.2.2 Bacterial strains
The bacterial strains used in this project are listed with genotype and antibody 
resistance in Table 1.
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Table 1. Bacterial strains used for general cloning expression and in vivo 
studies
Strain Relevant genotype Notes
Escherichia coli
BL21 (DE3) HsdS gal OmpT~ lon~ (kclts%51 High level expression of
indl Sam7 ninS /acUV5-T7 gene genes cloned into expression
I) vectors containing 
bacteriophage T7 promoter 
(Studier and Moffatt 1986) 
(gifted by B. Lohkamp).
DH5a SupE44 AlacU169((j)80 lacZ Plating and growth of
AM 15) hsR17 recAl endAl plasmids (Hanahan 1983)
gyrA96thi-l relAl (gifted by B. Lohkamp).
JMI09 el4”(McrA") recAl endAl gyrA96 Plating, growth of plasmids
thi-1 hsdRlJ (rCniK )^ SupE44 and allows blue-white
relAl A(lac~proAB) screening on X-gal (Yanisch-
F’[traD36 proAB^ lacH lacZ Perron et al., 1985)
AM15] (Stratagene).
PIRl F~ Alacl 69 rpoS(Am) robAl Also called PIRl One Shop"
creC510 hsdR514 endAl recAl competent cells part of
uidA(AmluI): :pir-116 Invitrogen Echo™/TOPO® 
cloning system (2.7.5).
XLI-Blue SupE44 hsR17 recAl endAl Competent Cells part of
gyrA96 thi-1 relAl lac" QuikChange^'^ site-directed
F’[proAB‘*' lacH lacZ AMI 5 TnlO mutagenesis kit (Bullock et
(tet )^] ah, 1987) (Stratagene)
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Strain Relevant genotype Notes
Bacillus suhtilis
Derivative 168 ATCC Number: 33234 (Gifted by Dr. Blackburn)
Disruption Inserted pMUTIN 3: Erthromycin (Gifted by Prof. Sato)
mutant YqhSd antibiotic resistance
2.2.3 Plasmids
The plasmids used in this project aie listed with antibody resistance and promoters in 
Table 2.
Table 2. Plasmids used for molecular cloning
Plasmid Source Selection Promoters Notes
pGEM®
5Zf(+/-)
- S. Campbell Ampicillin T7/SP6 (Summerton et al., 
1983; Promega) 
Used for blue/ 
white screening 
(2.8.3)
pLysS S. Campbell Chloramphenicol T7 (Moffatt and 
Studier, 1987)
pT7.7 I. Hunter Ampicillin T7/SP6 (Tabor and 
Richardson, 1985)
pTB361 A. Herbert Tetracycline T7 (Horsburgh, 1995)
pUni/V5-His-
TOPO®
Invitrogen Kanamycin Unil
forward/
reverse
Used to clone ydih 
from H. influenzea 
(2.7.5).
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2.2.4 Genomic DNA
S. Campbell gifted genomic DNA for Haemophilus influenzae (ATCC 51907). 
Genomic DNA was stored at -20°C at a concentration of 0.5 ng/pl (total of 10 ng)
2.3 Growth media and supplements
2.3.1 Media
The preparation of growth media and 1.5% agar growth media plates is described in 
Table 3.
Table 3. Growth media
Media Composition per litre Notes
Luria-Bertani (LB)^ lOgNaCl Adjust pH to 7.0 and
lOgtryptone autoclave.
5 g yeast extract For standard growth of E.
coli strains
Spizizen minimal medium 2g ammonium sulphate
(SMM) 14g dipotassium phosphate
6g monopotassium
phosphate
Ig sodium citrate*2H20
0.2g magnesium
sulphate-7H20
Following autoclave add:
20 ml filter-sterilised 25% 
(w/v) glucose.
Filter sterilise, final 
concentration of glucose 
is 0.5% (w/v).
(Anagnostopoulos and 
Spizizen 1960).
1.5%(w/v) Bacto-agar for solid media plates
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Media Composition per litre Notes
Nutrient broth (NB)^ 15g Standard II nutrient For standard growth of B.
broth
Final pH of 7.5.
suhtilis (section 2.5.2).
NZY+ Broth lOg NZ (caesein Filter sterilise.
hydrolysate) For growth of super-
5g yeast extract competent E. coli cells
5gNaCl.
Following autoclave add:
12.5 m llM M gC h
12.5 ml IM MgS0 4
10 ml 2M glucose, (filter- 
sterilised).
(Stratagene).
SOC medium 20g tryptone Filter sterilise.
5 g yeast extract For growth of competent
0.5g NaCl.
Following autoclave add:
10 ml IMMgCh
10 ml lM M gS 0 4
10 ml 2M glucose, (filter- 
sterilised).
E. coli cells (section 2.8).
 ^ 1.5%(w/v) Bacto-agar for solid media plates
Page 56
CHAPTER 2 MATERIALS AND METHODS
2.3.2 Antibiotics
Antibiotics were used at the following final concentrations: ampicillin 100 pg/ml, 
tetracycline 12.5 pg/ml, kanamycin 50 pg/ml, erythromycin 1 pg/ml and 
chloramphenicol 34 pg/ml. A stock solution of 100 mg/ml of ampicillin was 
dissolved in distilled water and was sterilised by filtration through a 0.2 pm filter. A 
stock solution of 12.5 mg/ml of tetracycline was made up in 70% ethanol; filter 
sterilisation was not required. A 1 mg/ml stock solution of erythi'omycin was 
dissolved in 100% ethanol; filter sterilisation was not required. A 100 mg/ml stock 
solution of chloramphenicol was dissolved in 100% ethanol; filter sterilisation was 
not required. Kanamycin was made up as a 10 mg/ml stock in distilled water and 
filter sterilised. The antibiotic stock solutions were all stored at -20°C.
When making Agar plates which required antibiotics, the medium was allowed to 
cool to 50°C before the antibiotic was added. After mixing the medium was poured 
on to 90 mm petri dishes. All plates were stored at 4°C and if not used within four 
weeks were discarded.
2.3.3 Induction and chromogenie supplements
Isopropyl-p-D-thiogalactoside (IPTG) is an analogue of lactose, which targets lac O 
regulation and triggers expression of T7 RNA polyermase. IPTG was used at a final 
concentration of 0.8 mM. A 0.8 M stock solution was filter sterilised and stored at - 
20°C.
Bacteria with a non-functional (3-galactosidase protein (/ncZAM15) can be reactivated 
by the addition of a plasmid containing the lacZ gene tliis codes for an amino- 
terminal fragment of the (3-galactosidase protein. The combined peptide fragments 
make a flinctional (3-galactosidase protein; a process termed a-complementation. 5- 
bromo-4-chloro-3-indoyl-(3-D-galactoside (X-gal) is hydrolysed by (3-galactosidase 
and produces a dark blue colour; this is used in blue-white screening of bacterial 
constructs (section 2,8.3). X-gal was used at a final concentration of 80 pg/ml. A 
stock solution of 80 mg/ml of X-gal was prepared in dimethylformamide (DMF) and 
stored at ~20°C.
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2.4 General laboratory methods
2.4.1 pH Measurements
pH measurements were made with a Orion model 420A+ pH meter with a Orion 81- 
72BN probe, calibrated at 20°C.
2.4.2 Storage of bacteria
Bacterial strains were stored as glycerol stocks. These were made by the addition of 
0.5 ml of 50% (v/v) glycerol and deionised water (filter sterilised) to 0.5 ml of a 
rapidly growing culture (Aeoo >0.6) to give a final concentration of glycerol of 25% 
(v/v). Glycerol stock cultures were stored at -80°C. Some cultures were temporarily 
stored by streaking onto Agar plates and kept at 4°C for up to four weeks.
2.5 Growth of bacteria
2.5.1 E. coli
E. coli was grown in liquid culture by taking a single colony from a LB Agai’ plate 
and inoculating LB medium (Table 3) containing the appropriate antibiotic. Cultures 
were grown at 37°C with vigorous shaking (-200 rpm) either overnight or for the 
planned induction time com’se (section 2.3.3). Incubation was performed either on a 
Grant shaking water bath (model OLS 200) or on a large shaker incubator 
(Gallenkamp). Cultures were monitored by measuring the optical density at 600 mn. 
Bacteria were harvested by centrifugation at 5,000 x g for 15 minutes at 4°C using a 
Beckman model J-6B centrifuge fitted with a swinging bucket rotor. Smaller scale 
cultures were harvested in an Eppendorf (model 5415C) centrifrige at 16,000 x g for 
4 minutes at room temperature; pellets were either used immediately or were stored at 
-20°C. Agar plate cultures of E. coli were grown overnight at 37°C in a Eurotherm 
controls model 2216L incubator.
2.5.2 B. subtilis
B. subtilis was grown in either NB or minimal media (Table 3) under the same 
conditions as E. coli (section 2.5.1); some growth periods were extended to 32 hours.
2.5.3 Cell lysis
All steps during and after cell lysis were carried out at 4°C unless otherwise stated. 
Cells were resuspended in 10 ml of appropriate extraction buffer maintained at 0°C.
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Cells were lysed by two passages tlirough an automatic French pressure cell D118- 
00106 (Aminco®) at 15,000 psi. The pressure cell was pre-chilled on ice before use.
Lysis of volumes of less than 1 ml of bacterial cells for crude extract experiments 
involved a rapid freeze-thaw method followed by sonication in a 1.5 ml Eppendorf 
tube. The cells were subjected to 5 cycles of rapid freezing and thawing using liquid 
nitrogen and a Grant QBT2 heat block set at 25°C. Bacterial cells were further 
disrupted by five 1-minute cycles of sonication and incubation on ice a Decon model 
FS 100 water bath sonicator.
2.6 Polymerase Chain Reaction (PCR)
2.6.1 Primer Design
PCR Primers were designed to be at least 25 bases in length and the melting 
temperature (Tm) of the primers were matched with the primer on the opposite strand.
The following formula was used for Calculating Tm'
T,n = 8L5 + 0.41 (%GC) - 675/N- % mismatch
Where %CG referrers to the percentage of cytosine and guanine within the primer, N  
is the primer length in bases and % mismatch is applicable only for site-directed 
mutagenesis. Further details of this formula can be obtained from Stratagene 
(Appendix B).
Both mutagenic oligonucleotide primers contained the desired mutation (1-3 base 
changes within a codon) and anneal to the same sequence on the opposite strand of 
the plasmid. The mutation was always placed in the middle of the primer. Primers 
external to the gene had restriction sites incorporated to facilitate cloning of the PCR 
product into a vector. The 3 ’ end was designed not to finish with a thymine or a run 
of 3 or more cytosine or guanine bases. It was not always possible to meet all of 
these criteria in every case especially because of the high GC content of the gene 
encoding S. coelicolor DHQase (approximately 70%GC).
Primers were supplied by MWG-Biotech at a concentration of approximately 45 
pmol/pl having been purified by HPLC and phosphorylated at 3’ end.
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2.6.2 PCR reactions
PCR reactions were carried out using several different polymerases along with the 
buffers and salts provided by the manufacturer. The reaction was set up to have a 
total volume of 50 pi comprising the following:
Table 4. Standard PCR reaction mixtuie
Reagent Concentration of stock Volume
Polymerase 2000 U/ml 1 pi
Buffer and salts as supplied 5 pi
dNTPs 80 mM 1 pi
Primers 10 pmol/pl 5 pi
Vaiying quantities of template DNA (genomic 
or plasmid).
N/A N/A
Varying quantities of enhancing agents were used in the PCR reaction for example 
MgS0 4  at final concentrations ranging between 0.5-2 mM, DMSO and glycerol at 
final concentrations of 1-10% (v/v) (Chakiabarti and Schutt, 2002). The total volume 
was made up to 50 pi with sterile water; reactions were set up in 0.2 ml BioRad thin 
walled PCR tubes.
BioRad Gene cycler'""'^  version 1.7 was used for all thermal cycles. Programs varied 
but usually comprised an initial ‘hot start’ step at 94-95°C for 5minutes, followed by 
30 cycle repeats of a 1 minute annealing step (temperatui'e depending on Tm), an 
elongation step at 68-72°C (time depending on length in bases of desired PCR 
product) and a denatuiation step at 94-95°C for 1 minute. A final elongation step of 
between 5 and 10 minutes at the elongation temperatine was performed at the end of 
the amplification reaction to ensure that all amplified material was full length.
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2.6.3 Site-directed mutagenesis strategies
2.6.3.1 Two stage PCR using Vent polymerase
PCR was used in a two-stage procedure to generate site-directed mutants (Higuchi et 
al., 1988). To reduce primer-dimer and non-specific priming a hot start polymerase 
was employed (Vent® polymerase from NEB.)
The template for all these reactions was plasmid DNA. External primers PI and P2 
(Figure 12) were designed to include restriction sites within the original multiple 
cloning site of the plasmid. Internal primers (P2 and P3) (Figure 12) with the 
mismatch were designed with a Tm similar to that of the external primers so that any 
mismatch would not generate problems during thermal cycling.
The first step was to generate two overlapping fragments with the desired mutation; 
these were made in independent reactions as described in section 2.6.2. The products 
from the PCR reaction were analysed on a 1% (w/v) agarose gel as described in 
section 2.7.1. The PCR product of the coiTect size was excised and pui’ified using 
QIAquick® spin purification system (2.7.4) and used as the template DNA for the 
second round of PCR.
The second step of the PCR strategy was to amieal these fragments together and 
extend at the 3’ end to generate a full-length cDNA with the mutation (Figure 12). 
PCR was again carried out as described in section 2.6.2. The full length mutated 
DNA fragment was visualised by staining with ethidium bromide on a 1% (w/v) 
agarose gel (section 2.7.1) excised and purified with QIAquick® spin purification 
system (section 2.7.4). The purified DNA was then digested by the appropriate 
restriction endonuclease(s) using the sites present in the external primers (section 
2.7.3) and ligated to an expression vector (section 2.7.5).
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Figure 12. PCR two stage site-directed mutagenesis strategy (Higuchi et al., 1988). 
Primers are shown as red and blue arrows, the black arrows represent PCR 
reactions.
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2.6.3.2 Site-directed mutagenesis using Quikchange™ site-directed mutagenesis kit 
from Stratagene
The two stage site-directed mutagensis strategy described in section 2.6.3.1 proved to 
be rather inefficient; hence in the majority of the work the Quikchange' '^^ site-directed 
mutagenesis kit fi'om Stratagene was employed. Two mutagenic primers each 
complementary to opposite strands of the template plasmid DNA are extended to 
amplify the whole length of the plasmid during temperature cycling by pfuTurbo 
DNA polymerase. Incorporation of the mutagenic primers generates a mutated 
circular plasmid containing staggered nicks. Dpn I is then used to digest parental 
template DNA as the parental DNA retains its methyl groups. The nicked mutated 
plasmid can then be transformed into XL I-blue competent cells. Further details of 
this procedure are can be obtained from Stratagene (Appendix B).
2.7 DNA cloning procedures
2.7.1 Electrophoresis of DNA on agarose gel
DNA strands were separated by electrophoresis using TAE (Appendix A) agarose 
gels ranging from 0.7-1.5% (w/v) depending on the size of the DNA strands; the gel 
also contained 0.5 pg/ml of ethidium bromide to visualise the DNA under UV light. 
Samples were loaded with a 1:10 dilution of agarose gel sample loading buffer 
(Appendix A). A variety of standard markers were used to estimate the size and 
quantity of separated bands. Gels were run at 80V at 20°C in a Mini-sub® cell GT 
BioRad tank until the bromophenol blue in the agarose gel sample-loading buffer had 
migrated at least two thirds of the way down the gel. The DNA was then visualised 
using a UVP Bio Doc-It^"  ^ system and UVP camera model J6 x 11 Macro. Prints 
were produced when appropriate using a Sony video graphic printer UP-895CE.
2.7.2 Isolation of Plasmid DNA from bacteria cells
Bacterial colonies growing on selective media were picked and grown overnight in 
from 1.5 to 5 ml of LB at 37°C shaking at 200 rpm with the relevant antibiotic. 
Plasmids were then isolated by the alkaline lysis procedme (Birnboin and Doly, 
1979) using either the Qiagen QIAprep® Spin Mini prep kit or the Sigma Genelute® 
Miniprep system. Bacterial cells are lysed under alkaline conditions, the lysate is 
subsequently neutralised and adjusted to high salt conditions favourable for plasmid
Page 63
CHAPTER 2 MATERIALS AND METHODS
DNA to bind to silica-based resins. Plasmid DNA is eluted in a low salt buffer. 
Plasmid yield with both systems vaiies depending on the copy number per cell, the 
individual insert in a plasmid, factors that affect growth of the bacterial culture, the 
elution volume and the elution incubation time. Typically a 1.5 ml cultuie will yield 
from 5 to 15 pg of plasmid DNA (maximum of 20 pg of plasmid DNA). Further 
details of these procedures are can be obtained by contacting Qiagen or Sigma 
(Appendix B).
2.7.3 Endonuclease restriction of plasmid DNA and PCR product
DNA was digested using restriction enzymes from Boehringer Mannheim, Promega 
or New England Biolabs. Typical digests contained target DNA (plasmid or PCR 
product); the amount of DNA depended on the downstream application.
The digests were performed using between 1-50 imits of restriction enzyme and the 
appropriate restriction enzyme buffer. If two restriction enzymes were used in the 
reaction, the buffer best suited to both enzymes was used or Promega multicore® 
buffer. The mixture was made up to its final volume with sterile water. Digestion 
reactions were incubated at 37°C for at least 1 hour. Analysis of digested DNA was 
performed by agarose gel electrophoresis (section 2.7.1) and if necessary DNA was 
pmified by excising the relevant band from an agraose gel (2.7.4).
2.7.4 Purification of restriction digested DNA and PCR product
The restriction digested DNA and PCR product are separated from contaminants such 
as primer-dimers, amplification primers or restriction enzymes by agarose gel 
electrophoresis (section 2.7.1). 45 pi of the PCR product was separated on a 1% 
(w/v) agarose gel and excised with a scalpel on a Clare chemical research Dark reader 
UV box and purified using Qiagen QIAquick® spin purification procedure. The 
excised gel fragment is solubilized in a binding buffer at 50°C for 10 minutes. The 
QIAquick® uses the same purification technique for DNA as is used in the isolation 
of plasmid DNA from bacterial cells (2.7.2) involving salt exchange on a silica 
membrane (Birnboin and Doly, 1979). The purified DNA was eluted in 50 pi of 
sterile water for use in further cloning procedures. This procedure yielded 
approximately 10 pg of DNA depending on the concentration of DNA within the 
PCR product or restriction digest.
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2.7.5 Ligation of digested fragments and PCR product
The concentration of DNA was estimated by agarose gel electrophoresis using 
molecular weight standards of known concentrations (section 2.7.1). After the DNA 
has been prepared for ligation the following calculation was applied to work out the 
molar ratio of vector and insert (Further information on this formula can be obtained 
by contacting Promega: Appendix B):
 ^ ng of vector X kb size of insert . _ insertng of insert = — ------;--------------------------- x molar ratio o f --------kb size of vector vector vector
Typically several ratios of vector DNA and insert DNA were used in separate 
ligations. Ligation reactions used between 50-200 ng of vector DNA. Ligations were 
performed in a total volume of either 10 or 20 pi. Between 1-3 units of T4 ligase 
from Promega, Boehringer Mannlieim or Invitrogen were incubated at room 
temperature overnight with the relevant buffer and sterile water was added to correct 
the volume if required. The ligation mixtui'e (1 to 20 pi) was used to transform 
competent cells (section 2.8.2). pGEM® -5Zf(+/-) vector digested with restriction 
endonuclease EcoKV was used in blunt end ligations; insertion of blunt ended 
fragments into the lacZ gene allowed for blue-white screening in E. coli JM109.
A one-step cloning strategy (TOPO® cloning, Invitrogen) was also utilised for direct 
insertion of A-tailed PCR products into recombinant plasmid. The TOPO® cloning 
procedure involves topoisomerase I from Vaccinia virus that binds to specific DNA 
sites and cleaves the phosphodiester backbone after 5'-CCCTT. The energy from the 
broken bond is conserved by the formation of a covalent phospho-tyrosyl bond 
between the 3' phosphate of the cleaved DNA and Tyr274 of topoisomerase I. This 
forms a linearized vector (pUniA^5-his-T0P0®) with a overhanging 3' 
deoxythymidine; the phospho-tyrosyl bond can subsequently be attacked by 5' 
hydroxyl of a PCR product releasing the topoisomerase I. This allows efficient 
ligation of PCR product without the use of ligase. The reaction mixture contains 
between 0.5 to 4 pi of PCR product (dependent on DNA concentration), 1 pi of 200 
mM NaCl, 10 mM MgCli, 1 pi of pUni/V5-his-T0P0® and the volume is then 
adjusted to 6 pi with sterile water (all reagents are supplied by Invitrogen). Further 
details of this procedm e are can be obtained by contacting Invitrogen (Appendix B).
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2.7.6 Dephosphorylation of plasmid DNA
Removal of 5’ phosphates from linearised vector DNA can help prevent self-ligation 
and improve ligation efficiency. Alkaline phosphatase (Promega ) was used to 
dephosphorylate restricted plasmid DNA. 1 pi of calf intestinal alkaline phosphatase 
(CIAP)(10 U/pl) diluted 1:10 with CIAP buffer were added to the plasmid restriction 
digest and made up to the final volume with distilled water. The volume was 
corrected with sterile water. The reaction was incubated for 40 minutes at 37°C. 
DNA was then purified by agarose gel electrophoresis (2.7.4).
2.8 Preparation of competent cells and transformation
2.8.1 Preparation of competent cells
An adaptation of the method of Hanahan (Hanahan and Meselson, 1980; Hanahan et 
al., 1980) was used to make competent cells; this involved employing potassium 
chloride rather than rubidium chloride in the buffers. 10 ml of LB was inoculated 
with an E. coli strain from an -80°C glycerol stock and was grown at 37°C shaking at 
200 rpm overnight (with antibiotic if required). The aborbance at 600 mn of the 
overnight culture was measured and the cultme diluted to 0.1 OD in 80 ml of LB. 
The cells were then grown at 37°C shaking at 200 rpm for 1 hour or mitil they 
reached mid log phase (Aeoo in the range of 0.35-0.6). The cells were then placed on 
ice for 15 minutes and were kept below 4°C throughout the rest of the procedure. 
The culture was then transferred to chilled centrifuge tubes and centrifuged at 3000 x 
g in a Beckman model J2-21 using a JA-20 rotor for 15 minutes to pellet the cells. 
The pellet was then resuspended in 30 ml of ice cold RFl (Appendix A) and 
incubated on ice for 1 hour after which the cells were re-pelleted by centrifugation. 
The pellet was resuspended in 7 ml of ice cold RF2 (Appendix A) and incubated on 
ice for 15 minutes. The cell suspension was then divided into 200 pi aliquots in 1.5 
ml Eppendorf tubes and each aliquot was either used for transformation or flash 
frozen in a dry-ice/ ethanol bath and stored at -80°C.
Competent cells can be stored indefinitely at ~80°C, without showing any significant 
reduction in transformation efficiency.
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2.8.2 Transformation protocol
An Eppendorf tube containing a 200 pi aliquot of cells was allowed to thaw on ice or 
was used directly from a preparation of competent cells made immediately before 
transformation. Plasmid DNA or ligation mixture was added to cells and mixed by 
inverting gently after which the cells were incubated on ice for 1 hour. The cells 
were heat shocked at 42°C for 45 seconds and were then returned to ice for a fuither 
30 minutes. 0.8 ml of either SOC or NZY+ broth (Table 3) was added to the 
transformation mixture and was incubated at 37°C for 45 minutes to aid recovery. 
The cells were then pelleted in an Eppendorf centrifuge at 16,000 x g for 3 minutes 
and were re-suspended in 100 pi of the same media and plated out on selective plates.
2.8.3 Blue-white screening using the lacZ gene
Blue-white screening was used to identify successfully ligated plasmid within 
bacterial cells. It is necessaiy to use a bacterial strain which has the /acZAM15 gene 
on the F’ episome, such as JM109 and a vector which has the lacZ gene like pGEM V 
and the chromogenic supplement; X-gal (2.3.3). The ligated gene disrupts the lacZ 
gene, so that the bacteria are unable to hydrolyse X-gal. Therefore the bacterial cell 
colony will not exhibit a blue phenotype. The lacZ gene in pGEM V can be disrupted 
using the blunt end restriction site EcoRV.
2.9 Sequencing of plasmid DNA
Sequencing of recombinant genes was canied out by the Functional Genomics 
Sequencing Facility at the University of Glasgow. Typically a total of 600 ng of 
DNA was supplied for sequencing. The concentration of sequencing primers used 
was between 3.2 to 5 pM (pmol/pl). Sequencing reactions were set up using varying 
volumes of deionised water and plasmid DNA depending on DNA concentration, 4 pi 
of the Big Dye, dideoxynucleotide (ddNTPs) reaction mixture (Applied Biosystems), 
and 1 pi of sequencing primer in a total volume of 10 pi. All components were added 
to a 96-well plate and centrifuged at 16000 x g for 30 seconds. Sequencing reactions 
were carried out in a PCR machine PE9700, hot start (95°C) for 5 minutes, then 30 
cycles of 50°C for 5 minutes, 60°C for 4 minutes and 95°C for 10 seconds. DNA 
samples were then precipitated using 2 pi of 1.5 M sodium acetate, 0.25 M EDTA 
(pH 8.0) and 80 pi analytical grade ethanol, and centrifuged for 60 minutes at 4°C at 
16000 X g and then washed in 200 pi 70% ethanol and centrifuged again for 20
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minutes. Samples were resuspensed using 2 pi of loading buffer (25 mM EDTA, 25 
mg/ml blue dextran, 50 % (v/v) deionised formamide) and loaded on to a 4.5 % 
acrylamide sequencing gel using Long Ranger XL PreMix Gel Solution and run using 
TBE buffer. Each ddNTPs contains a specific fluorescent dye that can be excited by 
a laser. The signals are then collected and a coloured electropherogram is produced 
which is analysed by Sequencing Analysis Version 3.4.1 ABI PRISM® (Applied 
Biosystems) software.
2.10 Over Expression of proteins in E, coli
The BL21 (DE3) strain from E. coli was used for over expression of proteins. This 
strain is deficient in the OmpT and Ion genes which code for proteases that could 
degrade expressed protein. BL21 (DE3) also has the gene for T7 RNA polymerase 
integrated into its chromosome under the control of a lac promoter and operator. 
This will specifically recognize the T7 promoter region of an expression plasmid and 
will not efficiently transcribe from other promoters. T7 RNA polymerase can also be 
induced by the lactose analogue, IPTG. The pLysS plasmid encodes T7 lysozyme 
which binds and inhibits T7 RNA polymerase; this controls the basal levels of the 
expressed protein prior to induction with IPTG.
The strain BL21 (DE3) pLysS transformed with the relevant expression vector was 
used to inoculate (fr'om a plate) a 2 litre conical flask containing 500 ml LB, 
chloramphenicol and the relevant antibiotic for the expression vector. The culture 
was grown overnight at 37°C with continuous shaking at -200 rpm. The following 
day, eleven 2-litre flasks containing 500 ml LB, chloramphenicol and the relevant 
antibiotic for the expression vector were inoculated with the overnight culture to a 
starting optical density of 0.1 Aeoo; these cultures were grown at 37°C with 
continuous shaking at 200 rpm until the Aeoo reached between 0.4-0.6. Adding IPTG 
and growing the cells for a further 5-6 hours induced protein expression. E. coli cells 
were then harvested, as outlined in section 2.5.1. The typical wet weight of the 
harvested cells from 11 flasks was between 10 and 15g. The cell pellet was stored at 
-20°C until required.
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2.11 Sodium dodecyl sulphate poly acrylamide gel electrophoresis 
(SDS PAGE)
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used 
to identify and chamcterise proteins as described by Laemmli (1970) using a BioRad 
mini gel apparatus with a 5% acrylamide stacking gel and separation gels of either 12 
or 15%. Samples were loaded in SDS-PAGE sample loading buffer (Appendix A). 
A variety of protein markers were used to estimate the molecular weight of protein 
bands. Unless otherwise stated Low molecular weight markers from Boelninger 
Mannheim were diluted 1:10 with the loading buffer. Gels were usually run at 30 
mA for 45 minutes or until the dye front (bromophenol blue) reached the bottom of 
the gel.
2.11.1 Protein staining.
After electrophoresis, proteins on a SDS-PAGE were visualised by staining with 
Coomassie Blue. The staining reagent was 0.05% (w/v) Coomassie brilliant blue R- 
250 in 50% (v/v) methanol and 10% (v/v) acetic acid for at least 30 minutes at 40°C. 
Destaining was carried out at 40°C in 10% (v/v) methanol and 10% (v/v) glacial 
acetic acid until the background was fully destained and the protein bands clearly 
visible.
2.12 Purification of proteins
All purification steps following cell breakage were performed at 4°C unless otherwise 
stated.
2.12.1 S. coelicolor type II dehydroquinase
The type II dehydroquinase from Streptomyces coelicolor was purified using an 
adaptation of the method of White et ah, (1990) as outlined below.
2.12.1.1 Step 1 : Extraction and centrifugation
The type II DHQase was over expressed in E. coli strain BL21 (DE3) pLysS using 
the expression vector pT7.7 (2.3.3). The Cells were suspended in 20 ml of 50 mM 
Tris'HCl, pH 7.5 containing 0.4 mM DTT and a Complete'^^ EDTA free protease 
inliibitor cocktail tablet (600 mg) (buffer A). Cells were lysed using a French 
pressure cell (2.5.3). The volume of the lysed cells was increased to 80 mi. 0.5 mg
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of DNase was added and the lysate was stiiTed on ice for 45 minutes. The lysate was 
then centrifuged at 40,000 x g for 1 hour in a MSE high speed-18 centrifuge; type II 
dehydroquinase was purified from the resulting supernatant fraction.
2.12.1.2 Step 2: Anion exchange chi'omatography on DEAE-Sephacel
The supernatant was loaded on to a DEAE-Sephacel (Amersham Pharmacia) anion 
exchange column (11.5 x 5.0 cm diameter) equilibrated in buffer A at a flow rate of 
80 ml/hour. The column was washed with buffer until the A2 8 0 of the eluate was less 
than 0.1. The column was then washed with 100 mM NaCl until the A2 8 0  of the 
eluate was again less than 0.1. A linear' gradient of 100 mM to 400 mM NaCl in 800 
ml of buffer A was set up to elute the protein (flow rate of 30 ml/hour). 10 ml 
fractions were collected and A2 8 0  and enzyme activity were monitored (2.16.1). 
Fractions containing activity >1.2 AA2 3 4mifr^pF^ were pooled and dialysed into 50 
mM Tris-HCl, pH 7.5 containing 0.4 mM DTT and IM ammonium sulphate (buffer 
B) overnight or concentrated to 20 ml using an AMICON® protein concentrator with 
a 30 kDa filter and were adjusted to 1 M ammonium sulphate.
2.12.1.3 Step 3: Hydrophobic interaction chromatography on phenyl-Sepharose
The dialysed material was applied to a phenyl-Sepharose hydrophobic interaction 
column (8.0 x 4.5cm diameter) equilibrated in buffer B at a flow rate of 40 ml/hour. 
A l.O-OM gradient of ammonium sulphate was applied to the column in 600 ml of 50 
mM Tris-HCl, pH 7.5 (flow rate of 10-40 ml/hour). The column was washed with a 
further 300 ml of 50 mM Tris-HCl, pH 7.5 (flow rate of 40ml/hour). 5 ml fi-actions 
were collected and analysed as before, samples containing high activity were pooled 
and dialysed overnight against 50 mM Tris-HCl, pH 7.5 to remove ammonium 
sulphate.
2.12.1.4 Step 4: Gel filtration Clii’omatography on Sephacryl 200
The dialysis buffer was then changed to 50 mM Tris-HCl, pH 7.5 containing 150 mM 
NaCl (buffer C) and dialysed for 3 houi's. The dialysed material was then 
concentrated to a volume of 1.5 ml using an Amicon^"  ^concentrator. The concentrate 
was applied to a Sephacryl 200 Size sepaiation (Gel filtration) column (165 x 2.5 cm 
diameter) equilibrated in buffer C at a flow rate of 10 ml/hour. The protein was 
eluted using buffer C in 2 ml fractions. After assaying for DHQase activity
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appropriate fractions were pooled and concentrated. A sample of the concentrate was 
analysed by SDS-PAGE (section 2.12.1.1) to check the purity of the dehydroquinase 
and then dialysed into 50 mM Tris-HCl, pH 7.5 containing 50% (v/v) glycerol for 24 
hours and stored at -20°C.
2.12.2 B, subtilis YqhS (dehydroquinase related protein) mutant F23Y
The B. subtilis YhqS mutant F23Y, was overexpressed in BL21 (DE3) pLysS using 
expression vector pTB361 (section 2.10). The purification protocol was similar to 
that for S. coelicolor dehydroquinase. Some adjustments to the protocol were made, 
as it was not possible to monitor the dehydroquinase activity of the B. subtilis YqhS 
mutant F23Y during the purification.
2.12.2.1 Stepl : Extraction, heat treatment and centrifugation
The heat stability of the protein was exploited by heat-treating the cell extract after 
step 1 (section 2.12,1.1) prior to loading on to the DEAE-sephacel column. The 
soluble cell extract was heated to 65°C for 10 minutes in a stainless steel beaker using 
a Grant OLS 200 water bath and then kept on ice for 10 minutes. The heat-treated 
lysate was then centrifuged at 40,000 x g for 40 minutes in a MSE high speed-18 
centrifuge. The supernatant was collected and dialysed against 50 mM Tris-HCl, pH
7.5 containing 100 mM NaCl and for 2 hours.
2.12.2.2 Step 2: Anion exchange clnomatography on Q-Sepharose
The dialysed material was applied to a Q-Sepharose (Phannacia Biotech) anion 
exchange column (24.5 x 2.5 cm diameter) equilibrated in 50 mM Tris-HCl, pH 7.5 
containing 50 mM NaCl, 0.4 mM DTT and a Complete^"^ EDTA free protease 
inhibitor cocktail tablet (600 mg) at a flow rate of 60 ml/hour. The column was 
washed with buffer until the A2 8 0  of the eluate was less than 0.1. A linear gradient 
from 50 mM to 500 mM NaCl in 500 ml of buffer A was set up to elute the protein 
(flow rate of 70 ml/hour). 10 ml fractions were collected and A2 8 0  measurements and 
analysed by SDS-PAGE (section 2.11) were performed to locate the desired protein 
fractions. These fractions were pooled and dialysed against 50 mM Tris-HCl, pH 7.5 
containing 150 mM NaCl.
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2.12.2.3 Step 3: Gel filtration Chromatography on Sephacryl 200
Purification of the B. subtilis YqhS F23Y using Sephacryl 200 gel filtration column 
followed the same purification protocol as S. coelicolor DHQase see section 2.12.1.4. 
Detection of the appropriate fractions was performed using A2 8 0  measurements and 
analysed by SDS-PAGE (section 2.11). Fractions were concentrated to 5 ml and 
dialysed into 50 mM Tris-HCl, pH 7.5 containing 50% (v/v) glycerol for one day and 
stored at -20°C.
2.12.3 Purification of Lf. shikimate dehydrogenase
Shikimate dehydrogenase from Haemophilus influenzae was purified using the 
methods described for the purification of E. coli shikimate dehydrogenase by of 
Chaudhuri and Coggins, (1985) and Maclean et al. (2000), as outlined below.
2.12.3.1 Step 1: Extraction and centrifugation
Shikimate dehydrogenase from Haemophilus influenzae, was over-expressed in BL2I 
(DE3) pLysS using expression vector pTB361 (section 2.10). The cells were 
suspended in 20 ml of 100 mM Tris-HCl, pH 7.5 containing 1.3 mM EDTA, 0.4 mM 
DTT and a Complete™ EDTA free protease inliibitor cocktail tablet (600 mg) 
(Extraction buffer). Cells were lysed and centrifuged as in section 2.5.3. Shikimate 
dehydrogenase was purified from the supernatant fraction.
2.12.3.2 Step 2: Fractionation with ammonium sulphate
Benzamidine was added to a final concentration of 1 mM and the crude extract was 
then adjusted slowly to 30% saturation with solid ammonium sulphate stining on ice, 
for 20minutes. The precipitate was then removed by centrifugation at 40,000 x g for 
30 minutes in a MSE high speed-18 centrifuge. The supernatant was adjusted to 55% 
saturation with ammonium sulphate and stirred on ice for 20 minutes. The resulting 
precipitate was collected by centrifugation at 40,000 x g for 30 minutes in a MSE 
high speed-18 centrifuge. The precipitate was re-dissolved in 100 mM Tris-HCl, pH
7.5 containing 0.4 mM DTT (buffer D) and dialysed over night in buffer D with 50 
mM KCl.
2.12.3.3 Step 3; Anion exchange chromatography on DEAE-Sephacel
The dialysed material was applied to a DEAE-Sephacel (Amersham Pharmacia) 
anion exchange column (11.5 x 5.0 cm diameter) that had been pre-equilibrated in
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buffer D with 50 mM KCl at a flow rate of 80 ml/hour. The column was washed with 
buffer D with 100 mM KCl until the A2 8 0  of the eluate was less than 0.2. A linear 
gradient of 100 mM to 400 mM KCl in 800 ml of buffer D was set up to elute the 
protein (flow rate of 30 ml/hour). 10 ml fractions were collected and A2 8 0 and assays 
(2.16.2) were performed. Fractions containing activity >0.15 AA3 4 omin’'|il'^ were 
pooled and dialysed into buffer D and 500 mM KCl overnight.
2.12.3.4 Step 4; Gel filtration Chromatography on Sephacryl 200
Purification of the H. influenzae shikimate dehydrogenase using a Sephacryl 200 gel 
filtration column followed the same purification protocol as S. coelicolor DHQase see 
section 2.12.1.4. Detection of the appropriate fractions was performed using A2 8 0  
measurements and enzyme assays (section 2.16.2). Fractions containing shikimate 
dehydrogenase activity were pooled and dialysed against 100 mM Tris-HCl, pH 7.5 
containing 150 mM KCl (buffer E).
2.12.3.5 Step 5: Affinity chi'omotography on 2’5’ ADP Sepharose
The dialysed enzyme was concentrated to 5 ml and applied to an ADP-Sepharose 
column (3 x 3.5 cm diameter) (Pharmacia Biotech) that had been pre-equilibrated in 
buffer E. The column was washed in buffer E until the A28 0 of the eluate was less 
than 0.1 (flow rate of 10 ml/hour; 4 ml fractions). A solution of 1 mM NADP^ in 
buffer E (flow rate of 1 ml/hour: 1 ml fractions) was then used to elute the shikimate 
dehydrogenase. The pooled fractions with shikimate dehydrogenase activity were 
concentrated to 5 ml. A sample of the concentrate was analysed by SDS-PAGE 
(section 2.11) to check the pmity. The concentrated enzyme was dialysed into 100 
mM Tris-HCl, pH 7.5 containing 50% (v/v) glycerol for 24 hours and stored at -  
20°C.
2.13 Protein estimation.
Protein concentrations were determined using the methods of Bradford (1976) and 
Lowiy (1951) using BSA as a standard. Six standard points were used from dilutions 
of a 100 mg/ml BSA stock.
Protein concentration was also estimated using a JASCO (model V-550) 
spectrophotometer in a 1 ml, 1 cm path length quartz cuvette. Absorbance was 
measured at 280 nm. The absorbance of a protein at 280 nm depends on the content
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of tryptophan, tyrosine residues and cystine disulphide bonds; the extinction 
coefficient at 280 nm was calculated by using the frequency of these cliromophores in 
the protein (Pace et ah, 1995; Edelhoch, 1967). The sample protein concentration 
was calculated in terms of mg/ml.
2.14 Western blotting.
Following SDS-PAGE as described in section 2.11, proteins separated on a gel can be 
transferred to a positively charged polyvinylidene difluoride (PVDF) membrane 
(Matsudaira, 1987). The proteins can then be probed with specific antibodies.
The transfer of proteins on to the PVDF membrane (Hybond-P fi'om Amer sham) was 
performed in a Bio-Rad mini trans blot apparatus in which the gel and the membrane 
are sandwiched between foam and filter paper with the membrane closest to the 
anode (Figure 13). The filter paper (BioRad 1 mm) and foam were pre-soaked in 
transfer buffer (CAPS) (Appendix A) for 30 minutes. The PVDF membrane was pre­
soaked first in 100% methanol for 50 seconds and then washed in distilled water for 
30 minutes changing the distilled water every 10 minutes. Finally the membrane was 
pre-soaked in transfer buffer (CAPS) for 45 minutes. The gel was washed in transfer 
buffer (CAPS) for 30minutes. All soaks and washes were conducted on a Stuait 
Scientific (model STR9) 3D rocking platform. The transfer components were 
arranged in a transfer sandwich shown in Figure 13. Air bubbles were removed by 
gently rolling a test tube over each layer. Cutting the corner of the PVDF membrane 
marked the orientation of the gel. Proteins were transferred onto the membrane at 
60V for 90-120 minutes in transfer buffer (CAPS).
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Figure 13. Schematic o f western blot apparatus, the sponge and filter paper are 
shown in cream and light grey, respectively. The gel is represented in light 
blue and the PDVF membrane is in dark grey.
Once transfer was complete, the membrane was rinsed in distilled water for 10 
minutes and then blocked in PBS (Appendix A) 0 .l%(v/v) Tween-20 and 3%(w/v) 
Marvel for 45 minutes to prevent non-specific binding. The membrane was then 
incubated with primary antibody supplied by Dr. Craig Roberts at the University o f  
Strathclyde (section 2.14.1) at a 1/500-1/2000 dilution in PBS 0. l%(v/v) Tween-20 
and 3%(w/v) Marvel for at least 1 hour (usually overnight) on a Stuart Scientific 
(model STR9) 3D rocking platform. The membrane was then washed extensively in 
PBS 0 .l%(v/v) Tween-20 for 45minutes with 3 buffer changes. The horseradish 
peroxidase (HRP)-conjugated secondary antibody (section 2.14.1) which is directed 
against the species o f origin o f the primary antibody was then applied at a 1/2500 
dilution in PBS 0 .l%(v/v) Tween-20 and 3%(w/v) Marvel for 45 minutes. The 
membrane was then washed in PBS 0. l%(v/v) Tween-20 for 15minutes with 3 
changes o f buffer.
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Immunoreactive products were visualised using an electrochemiluininescence (ECL) 
detection kit (Pierce) using Super Signal® West Pico chemiluminescence substrate. 
Equal volumes of each ECL solution were mixed and then applied to the membrane 
for 1 minute. Konica medical film (18 x 24 cm) was exposed to the membrane inside 
an X-ray film cassette for 30-60 second exposure or until bands are visible. X-ray 
films were developed using a Kodak X-OMAT 2000 processor. This procedure was 
carried out in a dark room to minimise background film exposure
Membranes were stained with Coomassie brilliant blue to ensure transfer on to 
membrane after ECL visualisation. Gels were stained as in section 2.11.1. All steps 
were carried out at room temperature.
2.14.1 Preparation of Antibodies
Antibodies against B. subtilis type 11 dehydroquinase were supplied by Dr. Craig 
Roberts at the University of Strathclyde. Antibodies were raised by injecting 0.1 ml 
of B. subtilis F23Y dehydroquinase (YqhS) (0.5 mg/ml) in PBS buffer into 3 
BALB/C mice and 3 C57BL6 mice. After a period of approximately 4 weeks, 
polyclonal antibodies termed IgG (immunoglobulin G) that react specifically with the 
introduced protein were harvested from the animal’s serum.
Specific polyclonal antibodies against denatm-ed E.coli type 1 dehydroquinase were 
raised in rabbits by A. Likidlilid (MSe project 1989). The E. coli type 1 
dehydroquinase was denatured by reduction and carboxymethlation. Antisei-um was 
raised in a New Zealand white rabbit. An initial immunisation of 400 pg of protein 
followed by a second (boost) after 6 weeks of 200 pg of protein. Polyclonal 
antibodies that react with denatured E. coli type 1 dehydroquinase were produced.
HRP-conjugated secondary antibodies for mice were donated by Dr. Craig Roberts 
and also supplied by Pierce Scientific, Pierce Scientific also supplied Immuno Pure® 
antibody goat-anti-rabbit IgG (H+L) HRP labelled. All antibodies were stored in 50 
% (v/v) glycerol in 40 pi aliquots at -20°C.
2.15 Mass spectrometry
To identify a cellular protein by mass spectrometry it is necessary to separate the 
protein of interest from the complex protein mixture extracted from the cell. Two 
approaches are outlined below for the protein separation:
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2.15.1 Two-dimensional electrophoresis (2-DE)
This teclniique soits proteins according to two independent properties in two steps: 
The first-dimension step, isoeleetric focusing (lEF), separates proteins according to 
their isoelectric points (pi); the second-dimension step, SDS PAGE separates proteins 
according to their molecular weight (2.11) (O'Farrell, 1975). Each spot corresponds 
to a single protein species in the sample. All 2-DE separations were performed in 
duplicate.
All electrophoresis equipment and reagents for 2-DE were supplied by Amersham 
Pharmacia Biotech Ltd unless otherwise stated. Frozen Bacterial cell pellets 
(approximately 200 \ig of protein) were disrupted in 40 pi of lysis solution containing 
8 M urea, 4% (w/v) CHAPS, 40 mM Tris (stored at -20°C) and subjected to 5 cycles 
of rapid freeze and thawing using liquid nitrogen and a Grant QBT2 heat block set at 
25°C. Bacterial cells were further disrupted by five 1-minute cycles of sonication 
and incubation on ice a Decon model FS 100 water bath sonicator. Solubilisation 
was aided by subsequent addition of a rehydration buffer containing 8 M urea, 2% 
(w/v) CHAPS, 22 mM DDT, 0.5% (v/v) immobilisation pH gradient (IPG) buffer and 
a trace quantity of bromophenol blue, to a final sample volume of 125 pi. Insoluble 
material was removed by centrifugation at 16000 x g for 5 minutes at 20°C.
Proteins were sepai’ated in the first dimension using IPGphor '^^ isoelectric focusing 
system, employing a 7 cm immobilised pH 4-7 linear gradient iimnobilisation strip. 
The sample in rehydration buffer was loaded into a ceramic strip holder and the IPG 
strip was placed gel side down orientating the anodic end of the strip towards the 
pointed end of the strip holder. The IPG strip was covered with IPG cover fluid to 
minimise evaporation and placed on the electrode pads of the IPGphor '^^ system. The 
protocol for the isoelectric focusing was optimised by A. Foucher (University of 
Glasgow) and included a rehydration step of 15 hours at 20°C series and three 
voltage steps that gradually increased from 500 V to 6000 V over 18 hours. After the 
IPG strip had been treated for 15,000-20,000 voltage hours (Vh), the proteins focused 
on the IPG strip were equilibrated for the second dimension separation by soaking the 
strip in 10 ml of SDS equilibration buffer (50 mM Tris-HCl, 6M urea, 30% (v/v) 
glycerol, 2% SDS) containing lOOmg DTT for 15 minutes. A second equilibration
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was performed with equilibration buffer containing 250 mg of iodoacetamide instead 
of DTT for 15 minutes.
After equilibration, the proteins were separated in the second dimension by SDS 
PAGE (2.11). The equilibrated IPG strip was applied to a 15% acrylamide gel 
without a stacking gel and sealed using agarose sealing solution (SDS PAGE running 
buffer (Appendix A), 0.5% (w/v) agarose NA, trace quantity of bromophenol blue). 
After second dimension electrophoresis the duplicate 2-DE gels were analysed 
separately one Coomassie stained (2.11.1) and the other western blotted (2.14).
2.15.2 Immunoprécipitation
Using the Pierce Seize^ "^  Classic (A) Immunoprécipitation kit, all reagents and 
disposable spin cartridge apparatus were supplied within the kit.
Frozen Bacterial cell pellets (3 ml of culture grown for 48 hours and then centrifuged 
at 16,000 X g for 4 minutes at 20°C) were disrupted by sonication in 200 pi of 
Tris-HCl (pH 7.5) and subjected to 5 cycles of rapid freeze and thawing using liquid 
nitrogen and a Grant QBT2 heat block at 25°C. Bacterial cells were fuither disrupted 
by five 1 -minute cycles of sonication and incubation on ice using a Decon model FS 
100 water bath sonicator. Disrupted cells were centrifuged for 5 minutes at 16,000 x 
g to remove cell debris. The supernatant was incubated with approximately 1,5 
mg/ml of antibody (2.14.1) for 1 hour at 20°C on a Stuart Scientific (model STR9) 
3D rocking platform. 0.4 ml of ImmunoPure® Plus Immobilized Protein A (50% 
slurry) was equilibrated with 3 washes of BupH' '^  ^binding/wash buffer (0.14 M NaCl, 
8 mM Na2P0 4 , 2 mM potassium phosphate, 10 mM KCl pH 7.4). All washes were 
performed in a spin X cup and centrifuged at 16,000 X g. The immune complex 
(antibody and cell lysate) was added to the equilibrated immobilized Protein A and 
incubated for 30 minutes at 20°C on a rocking platform. The spin X cup containing 
the immune complex and protein A was washed 3 times with Binding/wash buffer 
and then eluted with 190 pi of ImmunoPure® Elution buffer (pH 2.8) containing 
primary amine, the elution step was repeated two further times. Both the washes and 
the eluants were analysed by SDS PAGE (2.11).
Preliminary experiments with the Seize™ X Protein A immunoprécipitation kit were 
performed using a similar- method to the Seize™ Classic (A) immunoprécipitation kit.
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In this method antibodies were cross-linked to the immobilized Protein A overcoming 
the problem of antibody contamination in the eluant.
2.15.3 Protein Digests
After 2-DE (2.15.1) or immunoprécipitation (2.15.2) separated proteins of interest 
were recovered from SDS PAGE, for in situ proteolytic digestion (Heilman et ah, 
1995). Proteins were excised from a destained polyacrylamide gel (1 mm x 1 mm 
square) and washed for 1 hour in 500 pi of 100 mM ammonium bicarbonate. The 
wash was discarded and the gel fragment was washed in 50% (v/v) acetonitrile, 100 
mM ammonium bicarbonate for 1 hour. The wash was discarded and the gel 
fragment was shrunk in 50 pi of 100% acetonitrile for 10 minutes. The solvent was 
removed and the gel fragment was dried in a fume hood for 25 minutes at 20°C. 
Proteolytic digestion was performed using 0.2 pg of sequencing grade modified 
trypsin (Promega) in 30 pi of 20 mM ammonium bicarbonate and the solution was 
incubated for 16 hours at 37°C shaking at 200 rpm using a Grant OLS 200 
shaker/water bath. Digested protein samples were then either stored at -20°C or 
analysed directly using mass spectrometry.
2.15.4 MALDI-tof and electrospray mass spectrometry
Protein masses were determined using a QStar Pulsar mass spectrometer running 
AnalystQS software (Applied Biosystems) fitted with a Protana nano spray source 
(Protana) or an API 3000 Triple Quadripole instrument. Buffers salts were first 
removed from the sample on a C l8 ZipTip (Millipore) (before use ZipTips were 
conditioned by washing three times with each of the following: (1) 10 pi of 
acetonitrile in 0.5% formic acid, (2) 50% acetonitrile in 0.5% formic acid and finally 
(3) 0.5% formic acid). Protein samples were absorbed on to the tip by repeated 
pipetting of the solution. The pH of the adsorbed proteins was approximately pH 3.5 
due to the formic acid. The samples were then desalted by extensive washing with 
0.5% formic acid (at least 10x10 pi). Proteins were then eluted from the tip with 2-3 
pi of 50% acetonitrile in 0.5% formic acid and loaded immediately into the nanospray 
tip (Protana). Samples for electro spray ionisation (ESI) were spotted on to a gold 
plate for ionisation and left to dry for 30 minutes. Key parameter settings were for 
the QStar Pulsar: spray voltage lOOOV, curtain gas 25, declustering potential 85, and 
pulsar settings of 5 and 6 for IRD and IRW respectively. Data were collected from
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400-2000 m/z using settings optimised for horse heart myoglobin, and deconvoluted 
to zero charge using the Bio Analyst software. Deconvolution was performed using a 
step mass of 0.5 Da running 20 iterations. Mass accmacies were estimated at +/- 
0 .01%.
2.16 Enzyme assays
All assays were can-led out at 25°C in a 1 ml quartz cuvette, 1 cm path length on a 
Jasco V-550 dual beam spectrophotometer unless otherwise stated.
2.16.1 Type II dehydroquinase assay
Type II dehydroquinase activity was determined by monitoring the formation of 
dehydroshikimate at 234 nm (a = 12x10^ M'^cm'^) (Salamon and Davis, 1953: 
Mitsuhashi and Davis, 1954; White et al., 1990). Assays were performed using 50 
mM Tris-acetate buffer, pH 7.0 in a total volume of 1ml. Reactions were initiated by 
the addition of enzyme (0.015 pg, 0.5 pg, 3 pg and 34 pg of SCDHQase, 
MTDHQase, HPDHQase, and B. subtilis YqhS (F23Y) respectively). Kinetic 
parameters were determined by vaiying the substrate (3-dehydroquinate) 
concentration over an appropriate range (between 10 pM and 2 mM).
2.16.2 Shikimate dehydrogenase assays
Shikimate dehydrogenase and shikimate dehydrogenase related protein (YdiB) 
activity was measured by following the conversion ofNADP"^ to NADPH or NAD"  ^to 
NADH at 340 nm (s = 6.18xlO^M"^ciiT^) (Chaudhuri and Coggins, 1985) during the 
either the oxidation of either shikimate to dehydroshikimate (reverse direction of the 
shikimate pathway) or quinate to dehydroquinate (forward direction of the quinate 
pathway). Assays were performed using 100 mM Glycine NaOH buffer, (pH 10) in a 
total volume of 1 ml. Reactions were initiated by the addition of enzyme (0.1 pg and 
1.0 pg of K  influenzae shikimate dehydrogenase and YdiB protein, respectively). 
Each substrate of the reaction (NADF^ or NAD^ and either shikimate or quinate) was 
varied in turn over an appropriate range. The ranges were between 25 pM and 60 
mM for shikimate, between 10 mM and 200 mM quinate, 25 pM and 1.5 mM NADP 
and between 2.5 mM and 20 mM for NAD keeping the concentration of the other 
substrate constant.
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2.17 Preparation of substrates
2.17.1 3-dehydroquinate
3-dehydroquinate was gifted by Prof. John Coggins from a batch prepared in 1991 
using the method of Grewe and Haendler (1966). The principle of the method is to 
oxidise quinic acid with nitric acid and then crystallise dehydroquinate as an 
ammonium salt. The substrate may be purified using ion exchange resin. Substrate 
prepared by this method proved unsatisfactory for studying enzymes with low 
activity for two reasons: - (i) there was high background absorption at 234 nm and (ii) 
both the 5- and the 3- forms of dehydroquinate are produced. It is thought that 5- 
dehydroquinate could have an inliibitory effect on dehydroquinases. The 
dehydroquinate also proved difficult to handle as it forms a sticky solid.
An alternative preparation was performed by Lorna Noble via a multi-stage chemical 
synthesis (Evans et al., 2002). This yielded extremely pure DHQate which in 
solution had a very low A2 3 4  and which was stable for at least one hour- at 25 °C. 2 
and 20 mM stocks of substrate were kept at -20°C; once defrosted stocks were kept 
for up to four weeks at 4°C.
The concentration of solutions of substrate were determined on the basis of the 
limiting change in absorbance at 234nm, on addition of 1 pg of of SCDHQase, taking 
into account the equilibrium constant for the reaction which is 15 (Kleanthous et al, 
1991).
2.17.2 Substrates for shikimate dehydrogenase assays
Substrates for the shikimate dehydrogenase assays were bought from Sigma and 
BoeMnger Mamilieim.
2.18 Analysis of kinetic data
The values and Knax were obtained by performing a non-linear regression plot, 
fitting the change in absorbance per minute (AAmin’') against a range of substrate 
concentrations ([S]) to the Michaelis-Menten equation (1913) using Microcal Origin 
software version 5.0. Values of A:cat were calculated from the data by dividing by 
the enzyme concentration. For inhibition studies Lineweaver-Burk (Lineweaver and 
Burk, 1934) plots were drawn in which the inverse of A Amin" ^ (1/v) was plotted
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against the inverse [S] (l/[Sj) which gives a straight line with an intercept at the x- 
axis equal to -1/Xm and an intercept on the y-axis equal to 1/ Fmax-
F  inax[S]v=
X.n +  [S ]  
(Michaelis-Menten equation)
I Km 1 1+
V [S] F n a x  F n a x
(Lineweaver-Burk transformation o f Michaelis-Menten equation)
Two substrate reactions are more complex and are categorised depending on the order 
in which the enzyme substrate complexes are formed. SDHase is thought to involve 
a ternary complex where the enzyme binds to both substrates before the products are 
formed. The initial rate (v) of the reaction is calculated from the equation:
F  i n a x [ A ] [ B ]
K 'a K b ^  Kb[A] + K a[B ] + [A] [B]
(Ternary complex mechanism equation Huang, (1979))
Values of 16.5,18.0, 20.6 and 16 kDa were used for the subunit molecular masses of 
SCDHQase, MTDHQase, HPDHQase, and (F23Y) BSDHQase respectively. Using a 
his-tag purification system David Robinson purified the HPDHQase and the 
MTDHQase the his-tag is included in the molecular weight calculations. The kinetic 
parameters of these enzymes were very similar to those previously reported for the 
corresponding native enzymes (Bottomley et al., 1996a).
The subunit molecular masses for H. influenzae SHDase and YdiB are 29.76 and 
29.9kDa respectively.
2.19 Stopped Flow assays
Pre-steady state kinetics of S. coelicolor DHQase, H. pylori DHQase and B. subtilis 
YqhS (F23Y) were measured by stopped flow using an Applied Photophysics 
stopped flow reaction analyser. Absorbance at 234nm was measured with a path 
length of the observation chamber 2 mm. These measurements were carried out at 
room temperature (20°C) the two syringes (A and B) are mixed in less than 2
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milliseconds with a mixing ratio of 1:10 respectively. Syringe A was filled with a 
knovm dilution of enzyme, syringe B was filled with the appropriate buffer and 
substrate typically 50 mM Tris-acetate, pH 7.0 and 1 mM 3-dehydroquinase.
2.20 Dénaturation experiments on Type II dehydroquinases
The stability of proteins was studied using dénaturation reagents. 0.1-0.5 mg/ml 
protein samples were incubated for between 1-24 hour’s at 20°C with either the 
dénaturant guanidine hydrochloride (GdmCl) or urea at a range of concentrations 
(0.25-8 M GdmCl and 0.5-4 M urea). Concentration of dénaturant was determined 
using refractive index measurements (Nozaki, 1972; Pace 1986).
2.21 Fluorescence spectroscopy
Changes in the quantum yields and emission maxima of intrinsic fluorescence can be 
used to monitor conformational changes in protein structure and their interaction with 
ligands.
When a molecule is exposed to electromagnetic radiation it is transformed from a 
‘ground’ state to an ‘excited’ state. The energy of the absorbed photon of light 
corresponds to the energy difference between these two states. The molecule can 
retinn to its ‘ground’ state by the emission of a photon of light which corresponds to 
the energy difference of the ‘exeited’ state this emission is known as fluorescence 
(Szabo, 2000).
Fluorescence scans were carried out duiing dénaturation of proteins and ligand 
binding experiments. The fluorimeter was set up to selectively excite either 
tryptophan or tyrosine residues at a wavelength of 290 nm or 280 nm, respectively. 
Emission was monitored either between 340 and 350 mn if the tryptophan was 
solvent exposed or between 308 and 340 mn if the tryptophan was buried in the 
interior of a native protein (Eftink and Shastry, 1997). The tyrosine emission signal 
is much weaker and therefore the environment of the tyrosine residues is more 
difficult to analyse. Fluorescence measurements were made at 20°C with 1 cm path 
length cell with a 1 ml volume and with the slits set at 5.0 mn bandpass using a 
Perkin-Elmer LS50B spectrofluorimeter.
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2.22 Circular dichroism
Circular dichroism (CD) measures the difference in absorption of left and right 
circularly polarised radiation. Plane-polarised light is split into two components by 
subjecting the radiation to an alternating (50 kHz) electric field using a modulator 
containing a piezoelectric quartz crystal tightly coupled to a thin quartz plate. When 
left and right circularly polarised light passes tlnough a protein sample the chirality of 
secondary and tertiary structures of the protein results in one of the components of the 
circular polarised light being absorbed to a greater extent then the other resulting in 
elliptically polarised light. CD data are presented as ellipicity in degrees (0).
In the far UV region (240-190 nm), which corresponds to absorption of peptide 
bonds, spectra can be analysed to give an indication of secondary structure content. 
The CD spectrum in the neai’ UV region (320-260 nm) reflects the environments of 
the aromatic amino acids and thus gives information about the tertiary structure of the 
protein, it can also give information about disulphide bonds and non-protein cofactors 
which might absorb in this spectral region (Kelly and Price, 2000; Kuwajima, 1995).
CD spectra were recorded at 20°C on a JASCO J-600 spectropolarimeter at protein 
concentrations ranging from 0.5 to 1.5 mg/ml in 100 mM potassium phosphate buffer 
(pH 7.0). All spectra were recorded in at a path length of either 0.02 cm (near 
UVCD) or 0.5 cm (far UVCD). All spectra were recorded by Dr. S. Kelly 
(University of Glasgow). The spectra were analysed for secondary structure content 
using SELCON (Sreerama and Woody, 1994a; 1994b).
2.23 Dynamic light scattering
Dynamic light scattering can be used to analyse single species protein solutions to 
determine quaternary structure and the effect of different metal ions, pH or salt 
concentrations on the aggregation states. If the molecular weight of the protein is 
known, predictions about the shape and density of the protein can be made by taking 
into account that the predicted mass from light scattering relies on the assumption 
that the protein in question is spherical and has an average protein density.
When a polarised light beam from a monochromatic laser passes through a solution it 
interacts with the particles and causes the electron distribution to oscillate. This 
oscillation results in the scattering of light of the same wavelength as the incident
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beam. When the diameter of the particles is significantly less than the incident beam 
this type of scattering is termed Rayleigh scattering. However, macromolecules in 
solution are subject to Brownian motion and this can cause fluctuations in the 
scattered light intensity. When measuring static light scattering on a second time- 
scale the information about the fluctuations is lost as they are averaged. These 
fluctuations result in a deviation from Rayleigh scattering, which can be used to 
calculate the diffusion coefficient. It is possible to measure these fluctuations using a 
highly sensitive detector, which measures on a microsecond time-scale, this is termed 
dynamic light scattering (Santos et aL, 1996). A DynoPro"^  ^ system was used to 
measure dynamic scattering samples of 200 pi with a protein concentration between 
of between 0.5-2.5 mg/ml of protein were injected into the observation chamber 
(20°C). From the diffusion coefficient, the hydrodynamic radius can be calculated 
using the Stokes-Einsteiii equation (Santos et al., 1996):
D = GtttjR
(Stokes-Einstein equation)
Where D is the diffusion coefficient, k is the Boltzmann constant, T is the 
temperature, r) is the solvent viscosity and R is the hydrodynamic radius.
Using the radius of gyration the mass of the protein can be estimated assuming that 
the protein is spherical and of an average protein density.
2.24 Protein Crystallisation
Protein crystals were grown using the sitting drop vapour diffusion method. Using a 
Crystchem^'^ 24 well plate (Hampton Research) a sparse matrix screen was set up. 
Sparse matrix screens cover a wide range of crystallisation conditions, varying the 
precipitant, buffer and additives over a series of concentrations and types of 
precipitant and additives; and pH levels.
A 2 pi drop composed of 1 pi of 10-20 mg/ml protein solution (>95% purity, section 
2.12) and I pi of crystallisation reagent from the sparse matrix screen is placed in the 
concave depression on a raised post; 0.8 ml of the same crystallisation reagent is 
placed in the reservoir. The drop contains a lower crystallisation reagent 
concentration than the reservoir. The wells are then sealed with Crystal Clear Sealing
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Tape (Hampton Research). The Crystallisation screen is left at 20°C for an indefinite 
amount of time screening for crystal growth intermittently using an Olympus 
microscope model S240. Pictures were taken of the crystals using a JVC TK-1280E 
colour video camera.
The formation of crystals depends on the solubility of the protein solution which can 
be manipulated using a precipitant. It is necessary for the protein to be supersaturated 
to form crystals, this is achieved by the equilibration between the protein solution and 
crystallisation reagent. To achieve equilibrium, water vapour- leaves the drop and 
eventually ends up in the reservoir. As water leaves the drop, the sample undergoes 
an increase in relative supersaturation (McPherson, 1989).
Once a condition is found that produces crystals it can be optimised to produce laiger 
crystals, which maybe easier to handle and yield better results from X-ray diffraction.
Protein crystals were tested by X-ray diffraction at the Daresbury synchi’otron on 
Beam Line 9/6 by B. Lohkamp and A. McEwen.
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CHAPTERS SITE-DIRECTED MUTAGENESIS OF A. 
COELICOLOR TYPE II DEHYDROQUINASE.
3.1 Introduction
The type II dehydroquinase from S. coelicolor was first purified by White et al 
(1990); this was the first micro-organism to be found to possess a biosynthetic type II 
dehydroquinase rather than a type I. The differences between the two types of 
enzyme are discussed in detail in section 1.3. It is well known that the catalytic 
mechanism of type I dehydroquinase involves the formation of a Schiff base between 
the substrate and the active site lysine 170 {Salmonella typhi numbering of amino 
acids) (Chaudhuri et ah, 1991). This is not the case in type II dehydroquinases which 
do not have a conserved lysine and in which no imiiie intermediate can be 
demonstrated by borohydride trapping experiments (Kleanthous et al., 1992). The 
stereochemistry also differs between the two types, type I enzymes catalyse a syn 
elimination of water with the loss of the pro-R hydrogen from C-2, whereas type II 
enzymes catalyse an anti elimination reaction with the loss of the more acidic axial 
pro-S hydrogen from C-2. To demonstrate this, ’H NMR experiments were 
performed using dehydroquinate labelled in either the C-2 pro-i? or pro-6' positions 
with deuterium and used as the substrate for both type I and II dehydroquinase 
(Slineier et al, 1993). Type II enzymes are thought to proceed via an enolate 
intermediate (Harris et al, 1996a). Studies with (66)/(67()-6-fiuoro-3 -dehydroquinate 
and E. coli type I dehydroquinase also revealed an imine intermediate by NMR 
(Parker et al, 2000). Understanding the catalytic mechanism and the differences in 
the mechanism between the two mechanistically and structurally distinct forms of 
dehydroquinase is important for the development of novel selective therapeutic 
agents.
3.1.1 The active site and proposed catalytic mechanism
The identification of an essential hyper-reactive aiginine residue (Arg23 in 6  
coelicolor) using the arginine-specific reagent phenylglyoxal (PGO) in conjunction 
with electrospray mass spectrometry led to the identification of the active site of type 
II dehydroquinase (Krell et al., 1995 and 1996). Thiee site-directed mutants of 
Arg23 were constructed; R23K, R23Q and R23A. All three mutants had significantly 
lower with R23A being 30,000 times less active than the wild-type enzyme.
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Arg23 was attributed to a role in substrate recognition as well as a possible catalytic 
role. Chemical modification with tetranitromethane (TNM) also identified Tyr28 as 
being at or close to the active site (Krell et al., 1995).
The 3-D X-ray crystal structui'es of M tuberculosis (Gourley et al, 1999), S. 
coelicolor and mutant S. coelicolor R23A dehydroquinases (Roszak et al., 2002) 
confirmed the location of the active site. The SCDHQase R23 A structui’e was solved 
with dehydroshikimate bound within the active site. The active site is located in the 
cleft formed at the carboxy edge of the p sheet between strands pi and p3 (Figure 
14). The active site is partially covered by helix a3 from the neighbouring subunit 
forming a salt bridge between Argl 17 and Asp92* {S. coelicolor numbering of amino 
acids with residues from a neighbouring subunit denoted with an asterisk). This 
intersubunit salt bridge maintains the orientation of a flexible loop that forms a lid 
domain (residues 21-31) over the active site (Price et al, 1999), which includes 
residues Ai'g23 and Tyr28. In addition residues Gly21 and Asp3I show a significant 
hinged movement resulting in a difference of over 5 Â between apo and complexed 
structures of the S. coelicolor enzyme (Roszak et al., 2002).
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Lid domain
r|2-4
Figure 14. Solid ribbon representation o f the X-ray structure o f  S. coelico lor  type 11 
dehydroquinase. a  helix (red) are labelled a l -a 4  and P strands (blue) 
labelled p i-p5 and 3io helices are labelled q 1-4. The ligand 2,3-anhydro- 
quinic acid is shown as a ball and stick representation to highlight the 
location o f  the active site.
The proposed catalytic mechanism for type II dehydroquinase utilises a stepwise 
EiCB (elimination unimolar via conjugate base) mechanism proposed to involve an 
enolate intermediate. This was first suggested by substrate and solvent isotope 
studies, where the proton abstraction was shown to be rate limiting for M  
tuberculosis and A. nidulans type II dehydroquinase (Harris et al, 1996b).
Analysis o f  the crystal structure o f  S .coelicolor  dehydroquinase with various ligands 
bound in the active site, such as phosphate, transition state analogue 2,3-anhydro-
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quinic acid and dehydroshikimate (R23A mutant SCDHQase) revealed that the 
carboxylate group of the substrate is bound to the main chain of SeiTOS and Ilel07. 
The phosphate ion, which is a competitive inliibitor of SCDHQase, mimics the 
carboxlate group. The hydroxyl of Seri08 also binds to the Cl carboxylate of 
dehydroquinate (Roszak et al, 2002; Evans et al, 2002 and section 5.4.5).
Arg 113
y
,Tyr28
y
OH
‘o , c
Ala 82/
DHQ
ÎHis 106 C^H
/  'a ...
. / y
Asn79
HN CH 16
Pro 15
Arg 113
HjN^ \ h/ %
,Tyr28
" /  ^ d
His 106
UN— CH A sn ie
Asn 79
Pro 15
Arg 113
H.lZ NH/ \
"'S. 'X y
His 106
HN—CH Asn 16
Aia 82
Pro 15
Figure 15. Schematic representation of the proposed mechanism of S. coelicolor type 
II dehydroquinase.
The substrate and solvent isotope effects show that proton abstraction is partially rate 
limiting and occurs at or before the highest transition state (Harris et al, 1996b). 
Abstraction of the more acid axial pro S  hydrogen from C2 of dehydroquinate by the 
side chain of Tyr28 is thought to be the first step in the mechanism. Since the
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hydroxyl group of free tyrosine has a pX^ of 10.0, it would be expected that the 
tyrosine residue would be fully protonated at pH 7.0. It is thought that the pX  ^of the 
tyrosine is shifted by the proximity of Argl 13 and perhaps to a lesser extent by 
Arg23 (Figure 15). This environmental shift of the pKa of a tyrosine residue has been 
observed in human aldose reductase (Tarde et al., 1993) where a neighbouring lysine 
residue forms a hydrogen bond to the tyrosine thought to be involved in proton 
abstraction. A similar interaction with two lysine residues is thought to alter the 
enviromnent of the active site in Class C p-lactamase from Citrobacter freundii 
lowering the pXg of a tyrosine residue (Oefner et al., 1990). The side chains of Tyr28 
and A rgils in SCDHQase are thought to be orientated by the side chain of Seri08. 
It is proposed that the transition state produced by the abstraction of the pro S 
hydrogen will lead to a double bond being formed between C2 and C3 presumably 
forming a enolate intermediate (Figui'e 15). The intermediate is characterized by a 
flattening of the carbocyclic ring and is likely to involve stronger hydrogen bonding 
to the enolate oxygen in the transition state. However, the absence of a positively 
charged amino acid to interact with the oxygen at C3 makes an enolate intermediate 
unlikely. A conserved water molecule (present in all S. coelicolor enzyme-ligand X- 
ray structures) is positioned to form an enol intermediate. The water molecule is held 
in a specific orientation 2.8 Â away from the carbonyl of dehydroshikimate by 
invariant residues Asn 16 and the carbonyl of Pro 15 and the main chain amide of 
Ala82. The next step is the elimination of the hydroxyl group at Cl with His 106 
acting as a proton donor (Figure 15). The side chain of Asn79 orientates the hydroxyl 
group at Cl to accept the proton.
It was originally thought that the Hisl06 formed a His-Glu pair with the invariant 
residue Glul04 and could act as base in the removal of the pro S  hydrogen at C2 of 
the substrate (Gourley et al, 1999). But crystallographic studies on SCDHQase in 
complex with 2,3-anhydro-quinic acid show that His 106 interacts with the Cl 
hydroxyl of the substrate and does not have a role in proton abstraction (Roszak et 
al, 2002).
The release of the products (dehydroshikimate and water) is probably triggered by the 
fact that the active site is not large enough for both to occupy the eavity: on removal 
of the hydroxyl from Cl, the intermediate undergoes a structural change and becomes 
planar as the product dehydroshikimate is formed.
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Table 5. Ki values (|iM) for iiiliibitors against type I and II dehydroquinases 
from Frederickson et al. (1999 and 2002)
S, typhiminium A. nidulans M. tuberculosis S. coelicolor
type I DHQase type II DHQase type II DHQase type II DHQase
nOoHOK
'OH 3000+ 1000 60+10 200 + 20 30+10OH
2,3 -anliydroquinic 
acid
O K  .COgH
4500 + 500 1500 + 200 1200 + 200
OH
3-deoxyquinic acid
OH. XOaNa
Oxime
OK XO2H
> 25000 15 + 1 20 + 2
F" Y  OH 1500 + 500 50 ±5
5 h
10 + 2
Vinyl fluoride
600 + 200
500 + 0.2
15 + 2
Inhibitors of type II dehydroquinase were designed exploiting the two key differences 
between type I and II dehydroquinases: the stereochemistry of the initial elimination 
of the proton at C2 and the formation of different intermediates (Frederickson et al, 
1999). 2,3-anhydro quinic acid and 3-deoxyquinic acid were synthesized; they are 
both structurally similar to the substrate but lack the C3 carbonyl group needed to
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form the imine intermediate formed in type I dehydroquinases. 2,3-anhydro quinic 
acid possesses a double bond between C2 and C3 and thus acts as a mimic for the 
planar ring of the transition-state. An oxime was synthesized exploiting the 
carboxylate-binding pocket with the aim of decrease the K\ of the inhibitor. Recent 
studies by Frederickson (2002) have developed a vinyl fluoride that closely mimics 
the geometric and electronic features of the transition-state. These compounds were 
tested on both type I and II dehydroquinases with the results summarised in Table 5.
3.1.2 Site-directed mutagenesis as a tool
Substitution of amino acids by site-directed mutagenesis is a powerful tool in testing 
hypotheses in regard to the importance of a particular residue in catalysis. 3-D 
structui'es of type II dehydroquinase were used to select amino acid residues to be 
replaced.
The first site-directed mutagenesis strategy that was adopted was developed by 
Higuchi (1988), outlined in section 2.6.3.1. Unfortunately this method proved to be 
time consuming, as it required the optimisation of tliree PCRs for each mutation. The 
fragments in the first stage that were generated were very small and thus difficult to 
process. The fact that two rounds of PGR were necessary to produce the desired 
mutation within the gene meant that there was more chance of introducing unwanted 
mismatches. The high G + C content of the S. coelicolor genome (Wright and Bibb, 
1992) made the optimisation of these PCRs more difficult (for example, the G+C 
content of the S. coelicolor aroQ gene is 70%). Dimethyl sulphoxide (DMSO) has 
been shown to increase the level of amplification of PCRs; it is thought that DMSO 
enliances PCR by hydrogen bonding to the major and minor grooves of the template 
DNA and destabilising the double helix (Pomp and Medrano, 1991; Chakrabarti and 
Schutt, 2002). DMSO was used as an additive in the site-directed mutagenesis PCRs 
of the G+C rich aroQ', other additives such as glycerol were also tested, but was 
found to be less potent.
The second site-directed mutagenesis strategy was the Stratagene® QuikChange'*''  ^
site-directed mutagensis kit (2.6.3.2), This strategy had many advantages over the 
two-stage PCR strategy including the replication of the whole vector with the desired 
mutation in one round of PCR and the direct transformation of the PCR DNA into E. 
coli without a ligation step. The Stratagene® proceduie also used Pfu turbo DNA
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polymerase that has 2-fold higher fidelity in DNA synthesis than Vent polymerase 
(Cline et al, 1996). The Invitrogen® Ex Site™ mutagenesis kit was also tested but was 
not successfully used.
3.1.3 Target residues for site-directed mutagensis
The residues chosen for site directed mutagenesis were Glul04, His 106, Argl 13, and 
Series and were all mutated to alanine; Tyr28 was mutated to phenylalanine. These 
residues are highly conserved across the type II dehydroquinase family (Appendix C: 
Error! Reference source not found.). Alanine was chosen for the first four 
mutations, as its small side chain would not be expected to disrupt the tertiary 
structure. In addition, the methyl group of the alanine residue would also not be able 
to perform the same function as the residues that being were replaced.
Phenylalanine was chosen to replace Tyr28, as it lacks the hydroxyl group in the 
aromatic ring and thus would not be able to act as a proton donor or acceptor in the 
catalytic mechanism. Phenylalanine was also chosen as sequence alignments had 
already revealed the B. subtilis YqhS (that shows 47% identity to S. coelicolor 
DHQase) possessed a phenylalanine in this position (4.1).
As previously described in section 3.1.1 Argl 13 is believed to alter the environment 
of Tyr28 and lower pX  ^of this residue. Thus exchanging this residue for an alanine 
should affect the piQj of the tyrosine and reduce the Acat of the enzyme. The role of 
the invariant Glul04 in the catalytic mechanism is not established; originally it had 
been thought to be involved in abstraction of the pro S proton of dehydroquinate and 
hence, it was mutated to establish whether the residue was directly involved in 
catalysis or played a structural role. The mutation of His 106 was designed to 
establish its importance in the catalytic mechanism as a possible proton donor to the 
hydroxyl at Cl of dehydroquinate. Seri08 is thought to be involved in substrate 
recognition and orientation by binding to the carboxlyate group at Cl of 
dehydroquinate. Elence substituting this residue should lead to an increase in the 
of the enzyme.
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3.2 Construction and over-expression of site-directed mutants, of S, 
coelicolor type II dehydroquinase.
A two-stage site directed mutagenesis strategy was followed for the H I06A mutation 
of S. coelicolor type II DHQase as outlined in section 2.6.3.1, using a construct of 
pT7.7 with S. coelicolor aroQ inserted into the multiple cloning site between the 
Ndoi and Hind III, (gifted by Prof. Iain Hunter, Strathclyde University) as the 
template for the amplification. The four primers for the procedui’e were as follows:
PI 5’GATATACATATGCCCCGCAGCCTGGC 3’
P2 5’CGTCTGCAGAAGCTTCTGCACAGGAAC 3’
P3 5’GTGGTGGAGGTCGCCATCTCCACCATCCAC 3’
P4 5 ' ATGTTGGAGATGGCGACCTCCACCACCGG 3’
The mutagenesis primers (P3+4) were designed with the desired codon change 
(shown in bold) to allow the substitution of the histidine by an alanine. The first step 
generated two fragments of aroQ cDNA, the first fragment was 257 bp (PI+4) and 
the second was 342 bp (P2+3). The PCR reaction for the P2 + P3 fragment contained 
«3 ng of template DNA, 50 pmol of both primers, 0.2 mM of each dNTPs, 2 units 
VentR® polymerase (NEB), 1:10 dilution of lOx ThermoPol reaction buffer (lOmM 
KCl, lOmM ammonium sulphate, 20mM Tris-HCl pH 8.8, 2 mM MgS0 4  and 0.1% 
(v/v) Triton X-100) an additional Ipl of 0.5 mM MgS0 4  and 10% (v/v) DMSO in a 
total volume of 50 ql made up with sterilised water. The PI + P4 PCR reaction was 
the same apart from the addition of MgS0 4  to a final concentration of 80 pM.
The BioRad Gene Cycler program included 3 elements: a hot start at 94°C for 5 
minutes, 35 cycles of amplification consisting of an annealing temperature of 68°C 
for one minute, an extension period of 1 minute at 72°C and a dénaturation step of 
94°C for 1 minute followed by a segment of annealing for 1 minute and elongation 
for 4 minutes. 5 pi of the PCR product was separated and analysed by agarose gel 
electrophoresis using XIV DNA marker (Roche) and EZ Load 100 bp Molecular
Page 95
CHAPTER 3 S. coelicolor MUTAGENESIS
Ruler (BioRad) (Figure 16). Fragments o f  the appropriate size were purified by 
extraction from the gel (2.7.4).
1 2 3 4 5 6 7 8
3 4  5 6 7 8
Figure 16 .1% DNA agarose gels o f  pT7.7 S. coe lico lor aroQ  construct, two-stage 
site-directed mutagensis (H106A), first round o f  PCR. (A) Lane 1: XIV 
DNA marker (Roche), lanes 2-7: PCR fragment PI + P4, lane 8: DNA  
molecular weight marker X (Roche). (B) Lane 1 : EZ Load 100 bp Molecular 
Ruler (BioRad), lanes 2-3: PCR fragment P2 + P3, lane 8: XIV DNA marker 
(Roche). (5 pi o f  PCR product).
The two fragments o f  PCR product (P i + P4 and P2 + P3) were used as the template 
for the second stage o f  PCR. The second stage PCR reaction contained «5 ng o f  both 
o f  the fragments from the first stage, 50 pmol o f  both external primers (P I+2), 0.2 
mM o f  each dNTP, 10% (v/v) DMSO, 2 enzyme units VentR® polymerase, 
IxThermoPol reaction buffer with an additional Ipl o f  0.25mM M gS0 4  in a total 
volume o f  50pl made up with sterilised water. The BioRad Gene Cycler program 
included 3 elements: a hot start at 94°C for 5 minutes, 30 cycles o f  amplification 
consisting o f  an annealing temperature o f  64°C for one minute, an extension period
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o f  1 minute at 72°C and a dénaturation step o f  94°C for one minute followed by a 
final step o f  annealing for 1 minute and elongation for 5 minutes. 4 pi o f  the PCR 
product was separated and analysed by agarose gel electrophoresis using DNA  
Marker X and XIV (Roche) (Figure 17).
1 2 3 4  5 6 7 8 9 10 11 12 13 14 15
Figure 17 .1% DNA agarose gels o f  pT7.7 S. coelico lor aroQ  construct, two-stage 
site-directed mutagensis (HI 06A), second round o f  PCR. Lane 1: XIV DNA  
marker (Roche), lanes 2-14: fused PCR fragments, lane 15: DNA Marker X 
(Roche), (4 pi o f  PCR product).
Mutated aroQ  H I06A was ligated into cloning vector pGEM®-5Zf(+/-) using the 
EcoR  V restriction site. Both pGEM-5 plasmid and the PCR product were digested in 
a reaction containing 45 pi o f  the PCR product or 15 pg plasmid DNA, 6 units o f  
EcoR  V (NEB) with Ixdigestion buffer 2 (NEB). The digestion reaction was 
incubated at 37°C for 3 hours and purified by gel electrophoresis before being used in 
the ligation reaction (2.7.5). The ligation reaction consisted o f  «100 ng o f  insert 
DNA {aroQ  H I06A), «50 ng o f  vector DNA (pGEM-5), 1 unit o f  T4 DNA ligase 
with lxT 4 ligase buffer (Boehringer Mannheim) with sterilised water added to a total 
volume o f  lOpl. The reaction was incubated for 16 hours at room temperature. lOpl 
o f  the ligation reaction product was transformed into JM109 competent cells (as 
described in section 2.8.2). Plasmid purifications were performed using colonies 
resistant to ampicillin (100 pg/ml) and which exhibited a white phenotype in the 
presence o f  20 mM IPTG and 80pg/ml o f  X-gal. Restriction digest analysis was used 
to identify successful ligations and to establish the orientation o f  the gene within the 
vector. The pGEM-5 aro Q  H I06A construct was ligated into expression vector
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pT7.7 using the restriction sites Nde I and Hind III. Both the pGEM-5 aroQ H I06A 
construct and pT7.7 with an unknown 1.3 kb insert (gifted by Prof. Hunter) were 
digested in a reaction containing 150 pi pGEM-5 aroQ H I06A or 50 pi pT7.7 with an 
unknown 1.3 kb insert, 30 units of each restriction enzyme {Nde I and Hind III from 
NEB) with Ixdigestion buffer 4 (NEB). The digestion reaction was incubated at 
37°C for 3 hours and purified by gel electrophoresis before use in the ligation 
reaction (2.7.5). The ligation reaction consisted of #150 ng insert DNA {aroQ 
H106A), #20 ng vector DNA (pT7.7), 1 unit T4 DNA ligase with lxT4 ligase buffer 
(Boelii'inger Mannheim) in a total volume of lOpl and was incubated for 16 hours at 
room temperature. 10pi of the ligation reaction was transformed into DH5a 
competent cells (2.8.2). Plasmid purifications were performed using colonies 
resistant to ampicillin. Restriction digest analysis was used to identify successful 
ligations.
The Stratagene Quikchange'""'  ^ site-directed mutagenesis kit was used to make the 
point mutations El 04 A, R113A, SI OSA and Y28F in S. coelicolor type II 
dehydroquinase (AroQ) as outlined in section 2.6.3.2 (All reagents were supplied by 
Stratagene unless otherwise stated). Plasmid pT7.7 with S. coelicolor aroQ inserted 
into the multiple cloning site between the AWel and Hind III, was used as the template 
for the amplification. Forward and reverse primers were designed using the criteria 
outlined in section 2.6.1. The eight primers for the procedure were as follows 
(MWG) with the desired codon change (shown in bold):
E104A
Forward primer 5’GCTGCCGGTGGTGGCGGTCCACATCTCC 3’
Reverse primer 5’GGAGATGTGGACCGCCACCACCGGCAGC 3’
R113A
Forward primer 5’CCAACATCCACCAGGCTGAGCCGTTCCGGCACC 3’
Reverse primer 5’GGTGCCGGAACGGCTCAGCCTGGTGGATGTTGG 3’
SI 08 A
Forward primer 5’GGAGGTCCACATCGCCAACATCCACCAGC 3’
Reverse primer 5’GCTGGTGGATGTTGGCGATGTGGACCTCC 3'
Page 98
CHAPTER 3 S. coelicolor MUTAGENESIS
Y28F
Forward primer 5’CCAGCCGGAGATCTTCGGCTCCGACACC 3’
Reverse primer 5’GGTGTCGGAGCCGAAGATCTCCGGCTGG 3’
The PCR reaction contained #15 ng template DNA, 125 ng of forward and reverse 
primer for each mutation, 0.2 inM of each dNTPs, 2.5 units PfuTurbo® DNA 
polymerase, Ix reaction buffer (200 mM Tris-HCl (pH 8.8), 20 mM MgS0 4 , 100 mM 
KCl, 100 mM (NH4)S0 4 , 1% Triton® X-100, 1 mg/ml nuclease-free BSA); 8% (v/v) 
DMSO was added to the recommended reaction. The total volume was made up to 
50 pi with sterilised water.
The BioRad Gene Cycler program included 2 elements: a hot start at 95°C for 1 
minutes, 14 cycles of amplification consisting of a further 30 seconds at 95°C 
(dénaturation step), an annealing temperature of 55°C for one minute, followed by an 
extension period of 6 minutes at 68°C. 10 pi PCR product was separated and
analysed by agarose gel electrophoresis using X and XIV DNA marker (Roche) 
(Figui’e 18) to check for amplification. PCR product was then digested with Dpn I 
and transformed into XL 1-Blue super competent cells as described in section 2.8.2.
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Figure 18. Stratagene Quikchange^'^ site-directed mutagenesis strategy o f  pT7.7 S. 
coelico lor a roQ  construct. 1% DNA agarose gels: (A) Lane 1: XIV DNA  
marker (Roche), lanes 2-6: PCRs, lane 7: DNA Marker X (Roche). (B) Lane 
1: XIV DNA marker (Roche), lanes 2-6: PCRs, lane 7: DNA Marker X 
(Roche), (10 pi o f  PCR product).
The mutations were checked by the University o f  Glasgow Functional Genomics 
Sequencing Facility (section 2.9). The pT7.7 aroQ  mutant constructs were 
transformed into the over-expression strain BL21 (DE3) pLysS (as desribed in 
sections 2.8.2 and 2.10). Cell growth was monitored by Aôoo and once the absorbance 
had reached 0.6, the expression o f  protein was induced by addition o f  0.8 mM IPTG; 
Figure 19 shows the time course o f  the induction o f  Y28F mutant. Each o f  the 
mutants were grown for a further 5.5 hours after induction, yielding 8.27 g, 12.25 g, 
16.37 g, 12.43 g and 12.8 g wet weight o f  cells for E l04A, H106A, R I 13A, S I08A 
and Y28F respectively from 11 x  0.5 litres o f  LB medium.
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Figure 19. SDS PAGE analysis o f  expression time course o f S. coelico lor  type 11 
dehydroquinase mutant Y28F in pT7.7 BL21 (DE3) pLys S construct. Lane 
1; Boehringer Mannhiem marker low-range, lanes 2,4,6,8: induced by 
addition o f 0.8 mM IPTG from 0-6 hours. Lanes 3,5,7; control without 0.8 
mM IPTG from 0-6 hours (two hour increments).
The purification protocol is described in section 2.12.1 with the omission o f the gel 
filtration step on Sephacryl 200. It was not possible to locate fractions by the level o f  
catalytic activity. Fractions that had a high absorbance at A280 were analysed using 
SDS PAGE, fractions containing S. coelico lor  dehydroquinase monomer (molecular 
mass 16.5 kDa) were pooled and concentrated using an AMICON" protein 
concentrator with a 30 kDa cut-off membrane. Figure 20 shows the DEAE-Sephacel 
(A) and phenyl-Sepharose (B) elution gradient profile for mutant Y28F 
dehydroquinase. The purified mutant dehydroquinases were analysed on SDS PAGE 
to check the purity (Figure 21). The final purified proteins were stored at -20°C  in 
50% glycerol (v/v). The protein concentration for SCDHQase mutants E104A, 
HI06A, Rl 13A, S I08A and Y28F was determined by using the Lowry method (2.13) 
as 4.3, 6.7, 20.5, 2.1 and 6 mg/ml respectively in the pooled peak fractions.
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Figure 20. Elution gradient profile o f  S. coe lico lor  mutant Y28F showing A 280 
measurements (green triangles) and concentration o f  salt in linear gradient 
(blue line) (A) DEAE-Sephacel and (B) phenyl-Sepharose. Fractions that 
were pooled are shown between the black lines.
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Figure 21. 15% SDS PAGE o f purified S. coelicolor  mutant type 11 dehydroquinases. 
Lane I: Boehringer Mannhiem low-range, lanes 2-6: have between 5 and 10 
pg o f mutant dehydrogenase H106A, S108A, E104A, R113A and Y28F, 
respectively.
In early experiments, an initial heat treatment step at 65°C for 10 minutes was tested, 
as type II dehydroquinases have been shown to be thermally stable. Although the 
heat treatment was a very effective purification step it was not possible to recover 
more than 80% o f the catalytic activity (results not shown). Hence this step was 
abandoned for purification o f  the mutants.
3.3 Protein structure comparisons.
3.3.1 Mass spectrometry
The mass o f the purified mutant proteins was determined using electrospray mass 
spectrometry (2.15). The protein concentration was between 1.1 and 1.8 mg/ml in 
50mM Tris acetate (pH 7.0); samples were passed through C18 zip tips to remove 
ions. The molecular masses o f  all the dehydroquinases tested showed 100% 
processing o f the N-terminal methionine. N-terminal methionine process in 
SCDHQase has been reported by Krell et al. (1995). The mass o f the wild type, type 
11 dehydroquinase from 5. coelico lor  was found to be 16549.68 Da, very close to the 
theoretical mass o f 16550.6 Da (Figure 22A). The Y28F mutant has a mass o f 
16535.08 Da; 14.6 Da less than the wild type, which corresponds to the difference 
between a tyrosine and a phenylalanine amino acid residue, i.e. one oxygen atom 
(Figure 22B).
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Figure 22. Electrospray mass spectrometry data of S. coelicolor wild-type and mutant 
type II dehydrogenases. (A) Wild type, (B) Y28F, (C) SI08A, (D) H106A, 
(E) E104A and (F) R113A.
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The spectrum of the S108A mutant displays two peaks, one at 16533.72 Da, which 
exactly matches the substitution of serine by alanine. The second peak is at 227 Da 
less than the major peak and has approximately 50% of its intensity (Figme 22C). 
Two peaks aie also present in the R113A mutant spectrum (Figure 22F) although in 
this case the minor peak is only about 20% as intense as the major peak. The major 
peak in the R113A spectrum corresponds precisely to the mutation of arginine to 
alanine; the minor peak has the same difference in mass (227 Da) as the minor peak 
in the SI08A mutant spectrum. This indicates that the minor peak is not an impurity 
and is likely to be the result of C-terminal processing as the difference in mass 
observed is the same as the combined molecular mass of an arginine and alanine, 
residues present at the C-terminal. Processing at the N-terminus is less likely as the 
sequence starts with a proline followed by an arginine. Proline residues usually 
impede cleavage and the combined molecular weight is 26 Da larger than observed 
difference in mass (227 Da) between the peaks. Analyses of the 3-D X-ray structures 
of SCDHQase suggest that loss of two amino acids at C-terminal is unlikely to affect 
the activity. To confirm C-terminal processing the C-terminal sequencing could be 
performed. Enzymatic C-terminal sequencing based on carboxypeptidase cleavage 
employing protein digestion using ^-enriched H2 O can be used to identify the C- 
terminal peptide.
The spectrum of the H106A mutant also displays two peaks (Figure 22D). The major 
peak is 66 Da smaller (16483.6 Da) than the wild type SCDHQase peak 
corresponding exactly to the substitution of histidine by alanine. The second minor 
peak that corresponds to the C-terminal processing of two amino acids makes up 
about 33% of the protein in solution. The E l04A spectrum shows approximately 
15% C-terminal processing of the protein in solution. The major peak is equivalent 
to the substitution of glutamate by alanine (16491.6 Da) (Figure 22E).
Each protein spectra has a small peak on average 22.8 Da larger than the major 
dehydroquinase peak. This corresponds to the atomic weight of sodium and these 
small peaks are likely to be a sodiiun atom bound to the unfolded protein. This is a 
residual salt contamination as the C l8 zip tips are not totally effective.
Page 105
CHAPTER 3 S. coelicolor MUTAGENESIS
3.3.2 Circular diehroism
The CD spectrum of the wild type SCDHQase and each of the mutants was recorded 
in both the near UV (0.5 cm path length) and far UV (0.02 cm path length) at protein 
concentrations of 1.6 and 0.5 mg/ml respectively in 50mM potassium phosphate 
buffer pH 7.0. Evidence from the far UV CD spectroscopy demonstrated that the 
secondary structure of the protein was not altered significantly in any of the mutants 
(Figure 23A). The differences in the percentage distribution of secondary structural 
features were calculated using the SELCON procedure (Sreerarna and Woody, 
1994a) and are shown in Table 6.
Table 6. Secondary structure estimates (%) using the SELCON procedure of 
Sreerarna and Woody (1994b).
Alpha helix Antiparallel 
beta sheet
Parallel beta 
sheet
Turns Other
SC WT 30.7 13.6 8.6 15.1 32.9
E104A 28.8 14.9 8.5 14.4 34.0
H106A 31.1 13.2 8.5 13.5 33.6
R113A 29.9 14.0 7.9 12.7 35.3
S108A 29.9 12.5 9.2 10.9 37.8
Y28F 30.0 13.1 9.0 13.1 34.8
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Figure 23. Superimposed circular diehroism spectra o f wild type and mutant S. 
coelicolor  dehydroquinases. See inserted legend for colour o f mutants and 
wild type (A) Far UV CD (B) near UV CD.
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The near UV CD spectrum shows little difference in the enviromnents of the aromatic 
amino acids between the wild type and the mutant S. coelicolor dehydroquinases 
(Figure 23B). The overall shapes of the spectra are similar throughout, suggesting 
that the tertiary structure is unaffected by the mutations. Slight alterations in the in 
the spectra could reflect the conformational mobility of the protein in solution. There 
is a subtle shift in the peak at 290 nm of mutants; E l04A, H106A and SI08A, this 
maybe attributed to a minor change in the enviromnent of the tryptophan, residue 65. 
The E l04A mutant is the only mutation to have a higher intensity than the wild type 
between 280 and 260 mn; this indicates greater rigidity in the residues that absorb 
within this region (3 phenylalanine and 3 tyrosine residues).
3.4 Functional assays of mutants.
Enzyme assays were carried out as described in section 2.16.1. 10 pg of enzyme was 
used for each assay of mutants E l04A and H106A, 0.5 pg, 25 pg and 50pg of 
enzyme were used for each assay of the S108A, Y28F and R113A mutant, 
respectively and 0.015 pg of wild type SCDHQase. The kinetic parameters were 
detennined as described in section 2.18, and ai*e summarised in Table 7. The eiTors 
in Kxa and c^at ai’e less than 5% of the stated values.
Table 7. Catalytic parameters of S. coelicolor DHQase site-directed mutants.
pmol/min/mg
(pM)
^cat
(s"')
kcat/-^m
(s'* M‘‘)
Wild type 454 99 124.8 1.26 X 10*^
E104A 1.16 44 0.318 7.16x10^
Hi 06 A 0.5 92 0.137 1,49 X 10^
R113A 0.21 360 0.057 1.59 X 10^
SI 08 A 14.1 430 3.872 9.00 X 10^
Y28F 0.1 100 0.026 2.63 X 10^
All of the mutations of S. coelicolor type II dehydroquinase resulted in a decrease in 
c^at- The Y28F mutation reduced the catalytic activity (kcat) by 4700-fold, although
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the Km. was not affected. The Km of the HI 06A mutant is also unaffected, but shows 
a 910-fold decrease in kcat Rom the wild type. The catalytic activity of the SI08A 
mutation is the least affected, but kcat is still 32-fold lower than the wild type, with the 
Km showing a 4.3 fold increase. R113A mutation showed an increase in Km of 3.6- 
fold and a decrease in of 2200-fold compared with the wild type enzyme. The 
El 04A mutation is the only mutation to exhibit a decrease in Km of approximately 2- 
fold; the kcat is also decreased by 3 3-fold.
3.5 Chapter summary.
All of the site-directed mutants show a loss in catalytic activity. According to the 
proposed catalytic mechanism (Roszak et ah, 2002) Tyr28 is essential for catalytic 
activity, and this is supported by the very large decline in kcat with no effect on Km in 
the Y28F mutant. A rg il3 also seems to be involved catalysis as kcat is almost as low 
as the Y28F mutant. In addition the Rl 13 A mutant has an effect on substrate binding 
a significant increase in Km which may be due to electrostatic effects of removing a 
charged residue from the active site. The wild type S. coelicolor dehydroquinase 
shows a seven-fold increase in catalytie activity between pH 6.5 to 8.0 (section 5.4.1). 
Additional experiments analysing the pH dependence may reveal a different degree 
of dependence in these mutants. The mutants Y28F and R113A could be used to 
verify that the chemical modification experiments using TNM and PGO performed 
by T. Krell (1996) were specifically affecting the mutated residues.
The catalytic properties of the H106A mutant concur with the hypothesis that the 
residue is the proton donor for the hydroxyl at Cl of the substrate. The reduction in 
kcat is not as great as either R113A or Y28F. The role of the invariant Glul04 is less 
clear; the substitution of this residue by alanine caused tighter binding of the substrate 
and a more radical effect on the c^at than expected. A possible explanation of the 
effect on catalytic activity is the proximity of Glul04 to His 106 (X-ray structure 
analysis) implying that Glul04 maybe important in the reprotonation of His 106 as 
well as the correct orientation of this residue. Interestingly the near UV CD spectrum 
of the E l04A mutation suggests a greater rigidity in the overall tertiary structure, 
which could account for the lower Xm. It would be extremely valuable to generate 3- 
D X-ray structures of each of the mutants bound with a ligand for fiirther 
characterisation, especially the E l04A mutant. It is possible that this mutant would 
crystallise under similar conditions to the wild type as the secondary structure is
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equivalent and the mutated residue is unlikely to be exposed on the surface of the 
macromolecule, as it is involved in an ionic interaction with His 106.
The substitution of Seri08 by alanine supports the proposed mechanism; the role of 
Seri 08 is recognition of the substrate through the binding of the carboxylate group of 
the substrate. The affinity for substrate becomes weaker as reflected in the Km and 
although the turnover is impaired this is not to anything like the same degree as any 
of the other mutations. The loss in activity of the SI08A mutant maybe due to the 
role of Seri08 in orientating Tyr28 and Argll3. Additional phosphate and inhibitor 
binding studies should be performed on the SI08A mutant to characterise the binding 
of ligands further.
All of the mutants retain a small amount of activity, even though the major functional 
groups of the amino acids have either been replaced or completely lost. Site-directed 
mutants of Bacillus amyloliquefaciens subtilisin (a serine protease) also show small 
amounts of residual activity. Replacement of each of the subtilisin catalytic traid 
residues Asp32, His64 and Ser221, by alanine reduced the kcat by factors of 3 xlO"^ , 2 
xlO^ and 2 xlO^, respectively. A triple mutation of all three residues to alanine also 
decreases activity by 2 xlO^. The Km values of all the site-direeted mutants of 
subtilisin were increased by only a factor of two. However, it is unlikely that the 
residual activity is a result of the presence of a small amount of wild type enzyme, 
sinee the mutants are resistant to inhibition by phenylmethanesulfonyl fluoride, an 
irreversible inhibitor of the subtilisin wild type enzyme. The mechanism of the triple 
mutant Is thought to have changed, as the catalytically important hydroxyl group of 
the Ser221 is no longer present. The residual activity is thought to be due to direct 
nucleophilic attack by a water molecule on the substrate (Carter and Wells, 1988). It 
is possible that the overall properties of the active site of the SCDHQase creates a 
favomable environment for catalysis and that a bound water molecule may perform 
the role of a catalytic residue to a certain extent. Detailed analysis of X-ray structures 
of the mutants may help to answer this problem. It is unlikely that there is 
contamination of any of the mutants with wild type enzyme, as the mass spectrometry 
data do not show a peak, corresponding to the mass of the wild type in any of the 
mutant speetra. Although low levels of contamination of between 0.1-0.01% would 
be very hard to identify. If mutant that had absolutely no activity, but wild type
Page 110
CHAPTER 3 S. coelicolor MUTAGENESIS
enzyme was present at a level of 0.1%, the result would be a 10^-fold lower kcat value 
than the wild type, but the Km would remain the same.
Alanine was chosen for the majority of the mutations, as it is a small amino acid and 
would be unlikely to interfere with the tertiary struetuie. In order to eharacterise the 
role of these residues further it would be desirable to mutate them to another residue 
or perform double or triple mutations. Seri 08 eould be mutated to an aspartic acid 
that would be expected to repel the carboxylate at Cl of dehydroquinate and interact 
with Argl 13. Argl 13 could be mutated to a lysine and the change in the tyrosine 
environment could be studied.
There are also several other mutations that would be interesting to study. For 
example the oxime inhibitor of M tuberculosis dehydroquinase does not bind very 
well to the S. coelicolor dehydroquinase, analysis of the 3-D X-ray strueture by D. 
Robinson has revealed that AlaSl, which is a glycine in M  tuberculosis 
dehydroquinase, may cause a steric clash with the inliibitor (Robinson, 2003). It 
would be interesting to replace AlaSl with a glycine to see if the inhibitor bound 
more tightly. It is thought that the release of dehydroshikimate from the active site is 
brought about by the fact that there is not enough spaee in the active site for both 
dehydroshikimate and the water molecule. The likely route for the water molecule to 
exit is through a solvent cavity close to the dimer interface. The cavity is formed by 
the presence of residues Seri23, Vail29 and Alai 31 conserved over many 
dehydroquinases, and it might be possible to block this route by replacing one or 
more of these amino acids with a lai’ger residue, such as a methionine or lysine, 
although this could disrupt the tertiary structure. Asn 79 and He 107 are both 
implicated in the binding of the carboxylate on Cl of the substrate. It would be 
interesting to mutate both of these residues in the wild type and perform a double 
mutation using the SI08A mutant, which would be expected this to increase the Km 
further. It might be possible to destabilise the enol intermediate by mutating Asn 19 
(which binds to the water molecule within the active site) to a hydrophobic residue 
sueh as a valine or a leueine.
Directed evolution may highlight some previously unidentified contributions from 
other residues and help to answer the question of why the native enzyme is so large.
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CHAPTER 4 CHARACTERISATION OF BACILLUS 
SUBTILIS TYPE II DEHYDROQUINASE RELATED 
PROTEIN (YqhS)
4.1 Introduction
To date, Bacillus subtilis is the only bacterium known to have genes coding for both 
the type I and type II dehydroquinase enzymes. There are only gene data for four 
other members of the Bacillus family (Figure 24). B. stearothermophilus possess a 
type I DHQase while B. anthracis possess a type II DHQase. There does not seem to 
be any pattern of distribution of type I and type II dehydroquinases and it is thought 
that this is a result of horizontal gene transfer. The start codon of the yqhS gene is 
GTG, which is quite rare in B. subtilis', 9% of genes start with this codon (Kunst et 
ah, 1997). The organisation of shikimate enzymes in B. subiilis is distinct from all 
other organisms in which the shikimate pathway has been studied (Nakatsukasa and 
Nester, 1972; 1.1.3).
An aligmnent of the amino acid residues of YqhS shows high homology with the 
other type II dehydroquinases, for instance there is 45, 47 and 43% identity with 
MTDHQase, SCDFIQase and HPDHQase, respectively (Appendix C; Error! 
Reference source not found.) (Corpet, 1988; Altschul et al., 1997). All the residues 
in the active site thought to be involved in the catalytic mechanism are present in 
YqhS apart from the tyrosine 28 which is substituted by phenylalanine, believed to be 
involved in proton abstraction (Roszak et al., 2002). In previous work YqhS had 
been over-expressed in E. coli strain BL21 (DE3) pLysS and purified by A. Herbert. 
Preliminary assays performed by A. Herbert suggested that YqhS was catalytically 
inactive. The purified YqhS was also crystallised and high resolution structural data 
were obtained by Dr. Lapthorn and D. Robinson; these studies confirmed that the 
residues thought to be involved in the catalytic mechanism of type II DHQase (apart 
from the tyrosine) are in the correct orientation (Figure 25). Interestingly it was 
possible to resolve the active site lid domain in YqhS; this flexible region of the 
polypeptide chain has not been resolved in MTDHQase or HPDHQase.
Site direeted mutagenesis was used to mutate the phenylalanine (Phe23) of YqhS to a 
tyrosine in an attempt to restore catalytic activity to YqhS.
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B. ovis
R. meliloti 
Rho. capsulaius
C. crescentus
E. coU
Sal. typhimurium 
H. influenzae 
Pse. cepacia
F. tularensis 
Myxo. xanthus 
Chi. trachomatis 
Chi. pneumoniae 
Bor. burgdorferi 
Cyto. irutchinsonii 
FI. ferrugineum 
The. roseum
Syn. sp. PCC7942 (1) 
Sy. sp. PCC6803 (I) 
Syn. sp. PCC7942 (2)
D. radurians 
Ther. aquatic us 
Bac. subtilis 
Bac. anthracis 
Bac. stearotherm.
Sta. aureus 
Strep, pyogenes 
Strep, pneumoniae 
L. lactis
Ery. rhusiopaihiae 
Af. pneumoniae 
M. capricolum 
Clo. acetobutyl.
Clo. perfringens 
Meg. elsdenii 
Meth. mazei 
Myc. leprae 
Myc. tuberculosis 
Str. coelicolor 
Str. griseus 
Th. acidophilum 
Met. thermoauto. 
Hal. marismortui 
Hal. cutirubrum 
T. maritima
Figure 24. Taxonomic tree o f  bacteria showing the distribution o f elasses 
dehydroquinases the type I DHQase are highlighted in blue, type II in red, 
parasitic bacteria in green and unknown in blaek. B. subtilis is highlighted 
in both red and blue. Modified from Consensus neighbour-joining tree for 
prokaryotic organisms based on Hsp70 protein sequences (Gupta, 1998).
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Arg 18
Arg 111
Tyr/Phe 23
His 80
i \ His 10
Asn 74
Figure 25. Overlay o f subunits from Bacillus subtilis  (green), M ycobacterium  
tuberculosis (orange) and Streptom yces coelicolor  (blue). Residues thought 
to be involved in catalysis are highlighted using the numbering system from 
B. subtilis. Dehydroshikimate is bound in the active site.
Microarray data from B. subtilis (derivative 168) grown in aerobic conditions showed 
that mRNAs for both the type I dehydroquinase {aroC ) and the yqhS  gene are present 
during aerobic vegetative growth (personal communication from Rick W. Ye). In 
order to study whether YqhS is expressed in vivo. Western blots were performed 
using antibodies raised against F23Y mutant YqhS to probe cell extracts from B. 
subtilis.
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4.2 Construction, over expression and purification of site-directed 
mutant of B, subtilis type II dehydroquinase related protein 
(YqhS)
A two-stage site directed mutagenesis strategy was followed as outlined in section 
2.6.3.1, using a construct o f  pTB361 with B. subtilis yqh S  inserted into the multiple 
cloning site between the N doi and K pn\, (gifted by A. Herbert) as the template for the 
amplification. The four primers for the procedure were as follows:
PI 5 ’GAT CCC GCG AAA TTA ATA CGA CTC ACT ATA 3’
P2 5’GAG GAT GCA TTA CAG ATC TGG TAG 3’
P3 5’CGG CCG TAT ACT TCA GGC TCA 3 ’
P4 5’TGA AGT ATA CGG CCG CCA GAC ACT 3’
The mutagenesis primers (P3+4) were designed with the desired codon change 
(shown in bold) to allow the substitution o f  the phenylalanine by a tyrosine. The first 
step generated two fragments o f  yq h S  cDNA, the first fragment was 171 bp (P I+3) 
and the second was 411 bp (P2+4). The PCR reactions for both fragments contained 
»3 ng o f  template DNA, 50 pmol o f  both primers, 0.2 mM o f  each dNTPs, 2 units 
VentR® polymerase (Life technologies), IxThermoPol reaction buffer (lOmM KCl, 
lOmM ammonium sulphate, 20mM Tris-HCl pH 8.8, 2mM M gS0 4  and 0.1% (v/v) 
Triton X-100) an additional Ipl o f  2mM M gS0 4  in a total volume o f  50pl made up 
with sterilised water. The BioRad Gene cycler program included 3 elements: a hot 
start at 94°C for 5 minutes, 30 cycles o f  amplification consisting o f  an annealing 
temperature o f  55°C for one minute, an extension period o f  1 minute at 72°C and a 
dénaturation step o f  94°C for one minute followed by a segment o f  annealing for 1 
minute and elongation for 4 minutes. 4 pi o f  PCR product was separated and 
analysed by agarose gel electrophoresis using EZ Load lOObp molecular Ruler 
(BioRad) (Figure 16). Fragments o f  the appropriate size were purified by extraction 
from the gel (2.7.4).
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Figure 2 6 .1% DNA agarose gels o f  pTB361 B. subtilis yqh S  construct, two-stage 
site-directed mutagenesis, first round o f  PCR. Lane 1: EZ Load 100 bp 
Molecular Ruler (BioRad), lane 2: PCR fragment PI + P3 (171 bp), lane 3: 
PCR fragment P2 + P4 (411 bp), lanes 4 -  7: failed PCR, lane 8: EZ Load 
100 bp Molecular Ruler (BioRad) (5 pi o f  PCR product).
The two small fragments o f  PCR product were used as the template for the second 
stage o f  PCR. The second stage PCR reaction contained »5 ng o f  both o f  the 
fragments from the first stage, 50 pmol o f  both external primers (P I+2), 0.2 mM o f  
each o f  dNTP, 1% (v/v) DMSO, 2 enzyme units VentR® polymerase, IxThermoPol 
reaction buffer with an additional 1 pi o f  0.5mM M gS0 4  in a total volume o f  50pl 
made up with sterilised water. The BioRad Gene cycler program included 3 
elements: a hot start at 94°C for 5 minutes, 30 cycles o f  amplification consisting o f  an 
annealing temperature o f  65°C for one minute, an extension period o f  1 minute at 
72°C and a dénaturation step o f  94°C for one minute followed by a final segment o f  
annealing for 1 minute and elongation for 5 minutes. 4 pi o f  PCR product was 
separated and analysed by agarose gel electrophoresis using Marker X (Promega) and 
EZ Load lOObp molecular Ruler (BioRad) (Figure 27).
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Figure 2 7 .1% DNA agarose gels o f  pTB361 B. subtilis yqh S  construct, two-stage 
site-directed mutagenesis, second round o f  PCR. Lane 1 : DNA Marker X 
(Roche), lanes 1-6, 8- 10: unsuccessful PCRs, lane 7: fused PCR fragments 
amplified using PI and P2 primers. Lane 11: EZ Load 100 bp Molecular 
Ruler (BioRad) (4 pi o f  PCR product).
Mutated F23Y was ligated into expression vector pTB361 using the restriction 
sites Ndol and K pnl. Both pTB361 plasmid and the PCR product were digested in a 
reaction containing 45pl o f  PCR product or 15 pg o f  plasmid DNA, 40 units o f  N de\ 
(NEB) and 20 units o f  K pnl (NEB) with Ixdigestion buffer 1 (NEB). The digestion 
reaction was incubated at 37°C for 3 hours and purified by gel electrophoresis to be 
used in the ligation reaction (2.7.5). The ligation reaction consisted o f  «100 ng o f  
insert DNA {yqhS  F23Y), «50 ng o f  vector DNA (pTB361), 1 unit o f  T4 DNA ligase 
with lxT 4 ligase buffer (Boehringer Mannheim) in a total volume o f  20pl and was 
incubated for 16 hours at room temperature. lOpl o f  the ligation reaction was 
transformed into D H 5a competent cells (2.8.2). Plasmid purifications were 
performed on colonies resistant to tetracycline and restriction digest analysis was 
used to identify successful ligations. The preliminary confirmation o f  the mutation 
was by restriction digest analysis, using 5 Units B s tZ ll l ,  an endonuclease, which 
would only cut when the mutation was present. Plasmids that it was possible to cut 
were then sent for sequencing at the University o f  Glasgow Functional Genomics 
Sequencing Facility (2.9).
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Figure 28. SDS PAGE analysis o f the time course expression o f expression o f B. 
subtilis dehydroquinase related protein YqhS (F23Y) in pTB361-BL21 
(DE3) pLysS construct. Lane 1: Novex'"^ mark 12 Wide range protein 
standard. Lanes 2 to 7: samples induced by addition o f 0.8 mM IPTG from 
0-5 hours (one hour increments). Lane 8: Promega low-range protein 
molecular weight marker.
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Figure 29. The elution profile from Q sepharose column during purification o f B. 
subtilis YqhS mutant F23Y. Absorbance at 280 nm represented by green 
triangles. The liner NaCl gradient is represented by the blue line. Fractions 
that were pooled are shown between the dash black lines.
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Figure 30. SDS PAGE analysis o f the purification o f B. subtilis YqhS (F23Y) from Q 
Sepharose. Lane 1; Promega low-range protein molecular weight marker. 
Lanes 2 to 12: fractions 67, 70, 77 to 83 and 85, respectively. Lane 13: 
Novex^^ mark 12 Wide range protein standard.
The PTB361 yqh S  F23Y construct was transformed into the over expression strain 
BL21 (DE3) pLysS. When the A6oo reached 0.6, the expression o f  protein was 
induced by addition o f 0.8mM IPTG; Figure 28 shows a time course o f the induction, 
yielding 16 gm wet weight o f cells. The purification protocol is described in section 
2.12.2. Step 2 consisted o f Q Sepharose anion exchange chromatography; the elution 
profile can be seen in Figure 29. Pooled fractions were analysed by SDS PAGE 
(Figure 30). The pooled protein fractions were concentrated and then split into two 
1.5ml volumes, which were applied to the Sephacryl S200 gel filtration column with 
a 24-hour interval. 3 ml fractions were collected and the absorbance at 280 nm was 
recorded (data not shown). Fractions with Aiso measurements over 0.5 were analysed 
by SDS PAGE (Figure 31) to check the purity fraction were then pooled and 
concentrated using an AMICON" protein concentrator with a 30 kDa cut-off 
membrane. The protein concentration o f  the purified YqhS F23Y was determined as
57.3 mg/ml by the Lowry method (2.13) giving a total o f 573 mg o f protein.
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Figure 31. SDS PAGE analysis o f  the purification o f B. subtilis  YqhS (F23Y) from 
Sephacryl 200. Lane 1: Promega low-range protein molecular weight 
marker Lanes 2 to 13: fractions 110, 114, 117, 122, 127, 131, 134, 138, 147 
and 157, respectively.
4.3 Structural studies of YqhS using circular diehroism, 
fluorescence and dynamic light scattering
4.3.1 Unfolding experiments on YqhS
4.3.1.1 Circular Diehroism results
Experimentson the unfolding o f B. subtilis YqhS by GdmCl were performed, YqhS at 
0.13 mg/ml was incubated for 24 hours at 20°C with varying concentrations o f  
GdmCl (0 to 6 M) in Tris-acetate buffer pH 7.5. Far UV spectra were recorded using 
a cuvette with a pathlength o f  0.05 cm (2.22). The far UV CD spectra showed that 
there was no significant loss in secondary structure up to at least 4.75 M GdmCl, and 
even at 6 M, 50% o f the native signal at 222 nm still remains (Figure 32). Unfolding 
studies on the type 11 dehydroquinase from M  tuberculosis, have shown that only 
13% o f the native signal at 222 nm remains at 6 M GdmCl (Price et a i ,  1999). This 
residual CD signal o f the M tuberculosis DHQase is likely to be due to other 
structural elements.
Page 120
CHAPTER 4 B. subtilis YqhS
"TT
0 M GdmCl
1 M GdmCl
2 M GdmCl
3 M GdmCl
4 M GdmCl
5 M GdmCl
6 M GdmCl 
8 M GdmCl
260
Wavelength (nm)
Figure 32. Far UV circular diehroism spectra o f the unfolding o f B. subtilis YqhS by 
guanidine hydrochloride (GdmCl) see figure insert for concentration o f  
GdmCl.
Further unfolding experiments on B. subtilis YqhS in 8 M GdmCl required the 
GdmCl to be dissolved directly into the protein solution. 0.5448 g o f GdmCl was 
slowly added to 0.3 ml o f 255 pg/ml YqhS giving a final concentration o f 107 pg/ml 
o f protein and 8 M GdmCl in a volume o f  0.713 ml. The solution was incubated for 
24 hours at 20°C along with a native protein solution o f the same concentration. The 
far UV CD spetrum was recorded as reported above In 8 M GdmCl only 20% o f the 
native YqhS signal at 225 nm is preserved (Figure 32).
4.3.1.2 Fluorescence spectroscopy results
The B. subtilis YqhS protein has no tryptophan residues so the fluorescence signals 
arise from the six tyrosine residues per subunit. When excited at 290 nm, the 
emission peak is at 308 nm. On addition o f  GdmCl, three distinct phases are noted 
(Figure 33):
There is a large increase in fluorescence (85%) in the range o f 0-1 M GdmCl In this 
range the far UV CD spectra indicate there is no change in the secondary structure. It
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is possible that this change in fluorescence might be associated with dissociation o f  
the dodecameric structure into trimers (Price el a i ,  1999).
Between 1 and 4.75 M GdmCl there is effectively no change in the signal, which is
consistent with the results o f the far UV CD spectra.
Above 4.75 M GdmCl, there is a decline in fluorescence occurring over the same
range as the changes in the far UV CD.
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Figure 33. Percentage change in fluorescence emissions at 308 nm during unfolding 
o f 8. subtilis YqhS protein by guanidine hydrochloride (GdmCl) 
denaturantion. The values have been corrected for Raman scattering
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Figure 34. B. subtilis YqhS protein trimer o f subunits, tyrosine side chains are shown 
in pink.
Two o f  the six tyrosines in the subunit are found at the trimer interface (TyrSO and 
82). Tyr67, 131 and 137 are buried within their individual subunits and Tyrl04 is 
solvent exposed (B. subtilis YqhS numbering system) (Figure 34).
4.3.2 Dynamic light scattering of YqhS in the presence of low concentrations of 
guanidine hydrochloride
Dynamic light scattering was used (2.23) to investigate the quaternary structure and 
any structural changes in the presence o f low concentrations o f  GdmCl and NaCl. 
These experiments were carried out to test whether low concentrations o f  dénaturant 
disrupted the dodecamer o f the YqhS protein to form trimers causing the observed 
increase in fluorescence.
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The YqhS protein was studied at a protein concentration of 0.75 mg/ml in 50 mM 
Tris-HCl (pH 7.0). Where indicated GdmCl and NaCl were added to a concentration 
of 0.5 M. All dynamic light scattering experiments were incubated at 20°C for 30 
minutes prior to analysis. 200 pi of each solution was injected into the dynamic light 
scattering cell.
Table 8. Dynamic light scattering data of B. subtilis YqhS protein
B. subtilis YqhS protein
Radius (mn) Estimated MW 
(kDa)
SOS Error
50 mM 
Tris-acetate
4.7 126 8.89
50 mM
Tris-acetate 4.5 114 12.44
0.5 M GdmCl
50 mM
Tris-acetate 4.6 121 2.49
0.5 M NaCl
The estimated molecular weight of the dodecamer 126 kDa is significantly lower than 
expected (190 kDa) (Table 8), this would give an estimated moleculai’ weight for 
each subunit of only 10.5 kDa, or imply less subunits being involved in the 
quaternary structure. This seems imlikely as the YqhS X-ray crystal structure reveals 
the protein forming dodecamers, the assumptions made about protein density in 
estimating the molecular weight are unlikely to be true for the YqhS protein. The 
presence of 0.5 M GdmCl does not significantly affect the quaternary of the YqhS 
protein.
4.3.3 Interaction of YqhS with dehydroquinate as revealed by fluorescence
To investigate whether dehydroquinate binds to the YqhS protein fluorescence 
binding experiments were performed using N-Acetyl-L-tyrosinamide (NATA) to
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investigate the possible quenching effect of dehydroquinate. Fluorescence 
measurements were carried out using 0.1 mg/ml of protein in 50 mM Tris-acetate (pH 
7.0) at 20°C in a 1 ml volume cell with a 1 cm path length cell and with the slits set at 
5.0 nm bandpass. The dehydroquinate concentration was increased from 0 to 
approximately 6 mM by the addition of lOpl aliquots of solution of 14 mM and 70 
mM dehydroquinate in 50 mM Tris-acetate (pH 7.0). The fluorescence emissions 
values were corrected by using the model compound NATA (5 pM). Samples were 
excited at 280 nm and their emissions were monitored at 308 nm. Emission values 
were corrected for Raman scattering, NAT A quenching and the dilution effect of 
titration.
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Figure 35. Fluorescence binding of B. subtilis YqhS protein corrected using results of 
N-Acetyl-L-tyrosinamide quenching by dehydroquinate and dilution effect.
The cori’ected percentage change in emission values (where 0% is defined to 0 mM 
dehydroquinate) were fitted using a non-linear regression fit and are shown in Figure 
35. The value for B. subtilis YqhS is 4500 pM + 1000. It may be possible to get a 
more accurate measure of the value using isothermal titration calorimetery (ITC).
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4.3.4 Comparison of YqhS with site-directed mutant F23Y YqhS by circular 
dichroism
Far UV CD was used to establish that the secondary structure o f the site-directed 
mutant was not affected by the substitution o f F23Y. Spectra o f 0.1 mg/ml solutions 
o f both the wild type and mutant YqhS protein in Tris-HCl buffer (pH 7.5) were 
measured as described in section 2.22. The F23Y mutant o f YqhS has an identical 
secondary structure to the wild type (Figure 36). The differences in the percentage 
distribution o f secondary structural features were calculated using the SELCON 
procedure (Sreerama and Woody, 1994a) and are shown in Table 9.
Table 9. Secondary structure estimates (%) o f B. subtilis YqhS and YqhS F23Y 
mutant using the SELCON procedure o f Sreerama and Woody (1994a).
Alpha helix Antiparallel 
beta sheet
Parallel beta 
sheet
Turns Other
Wildtype 45.1 9.0 6.7 14.7 24.2
F23Y 45.4 8.5 6.5 14.0 24.3
40000 - I
30000 -
I■o 20000 -
Eq 10000  -
0-
- 10000 -
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Figure 36. The far UV CD spectra o f B. subtilis  wild type YqhS protein (red) and 
mutant F23Y YqhS (blue).
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4.4 Kinetic comparison of wild type and mutant enzymes
Assays of B. subtilis YqhS and the mutant F23Y YqhS were performed in a 1 ml 
quartz cuvette with a 1cm pathlength containing 34 pg of enzyme, 100 pM 
dehydroquinate, 50 niM Tris-acetate buffer; (pH 7.0) at 25°C (2.16.1). The enzymic 
reaction was followed by monitoring an increase in absorbance at 234 nm. The YqhS 
protein was shown to have an extremely low level of catalytic activity (Ar^ at < 10'"^  s’^ ). 
It was only possible to observe this very low activity because of the purity of the 
substrate prepared by Lorna Noble, A. Herbert had previously failed to find activity 
but his substrate was not pure. The site-directed mutant F23Y YqhS shows at least a 
2000-fold increase in activity (Figure 37). ATm and Hnax values were obtained for 
F23Y YqhS by varying the substrate concentration in the assays between 0.1 mM and 
2 mM. The AA2 3 4niin"  ^ was fitted to a non-linear regression plot (2.18) to yield 
values for Æ^cat of 0.18 s"^  and Km of 730 pM.
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Figure 37. Activity assay o f  B. subtilis  YqhS wild type and F23Y mutant measuring 
the increase in absorbance at 234 nm. The stability o f the substrate over the 
time course is shown in red. The wild type B. subtilis YqhS protein in assay 
buffer is shown in green. The wild type YqhS protein is shown in blue and
the F23Y mutant is shown in magenta.
4.5 Detection of YqhS in B. subtilis cell extract
4.5.1 W estern blotting
In order to study whether YqhS is expressed in vivo, western blots were performed 
using antibodies raised against the F23Y YqhS mutant as described in section 2.14.1. 
The antibodies had been raised against the mutant, as there was more o f this protein 
available than o f the wild type. Circular dichroism analysis showed no significant 
differences in secondary structure between the wild type and mutant YqhS (4.3.4). 
The polyclonal antibodies were tested against both the mutated and wild type YqhS 
protein (Figure 38).
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Figure 38. Western blot of purified B. subtilis wild type and F23Y mutant YqhS 
protein using polyclonal antibodies raised against the F23Y YqhS mutant 
protein. Lanes 1,2: purified wild type YqhS, 5 and 1 pg, respectively. Lanes 
3,4: purified F23Y mutant YqhS, 5 and 1 pg, respectively.
B. subtilis was grown in nutrient broth (NB) and Spizizen minimal medium (SMM) 
(2.5.2) for 24 or 48 hours at 37°C. The growth was categorised and checked for 
contamination by further growth on NB agar for 24 hours at 37°C and colonies were 
checked for phenotypic characteristics. 1.5 ml of the B. subtilis culture was 
centrifuged at 16,000 x g for 5 minutes and prepared for SDS PAGE as described in 
section 2.11. Western blots were performed on the SDS PAGE gels as described in 
section 2.14 with polyclonal antibodies raised against the F23Y YqhS and the 
denatured E. coli type I dehydroquinase (2.14.1).
The results of the western blot for the YqhS protein show high affinity binding to a 
protein with a molecular weight of 22.5 kDa; approximately 6 kDa larger than YqhS 
and slightly lower affinity binding to another protein of approximately 39 kDa 
(Figure 39). The western blot for the type I dehydroquinase showed some non­
specific high affinity binding to a protein the same size as the E. coli type I 
dehydroquinase control (25 kDa) (Figure 39).
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Figure 39. Western blots o f  B. subtilis  (derivative 168) cell extract. (A) Using 
antibodies raised against F23Y YqhS protein. Lanes 1,2; purified YqhS and 
F23Y YqhS, respectively. Lanes 3,4: B. subtilis cell extract grown in NB 
medium and minimal medium, respectively. (B) Using antibodies raised 
against E. coli type I dehydroquinase. Lane 1: Boehringer Mannhiem 
marker low-range. Lanes 2,3: B. subtilis cell extact grown in NB medium 
and minimal medium, respectively. Lane 4: purified E. coli type I 
dehydroquinase.
4.5.2 Proteom ics approach
In an attempt to identify the 22.5 kDa protein which had a high affinity to the 
antibodies raised against the YqhS mutant, two approaches were used to separate the
22.5 kDa protein 2D SDS PAGE:- electrophoresis and immunoprécipitation. While 
these methods were being attempted the disruption mutant (YqhSd) was sent by Prof. 
Sato o f the Tokyo University o f Agriculture and Technology. The approaches used
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to separate and identify the 22.5 kDa protein results are described below. There was 
insufficient time to optimise the procedures.
4.5.2.1 2-DE of B. subtilis cell extract
2-DE was carried out as described in section 2.15.1 on samples taken from a 3 ml 
culture of B. subtilis (derivative 168) culture grown in nutrient broth for 48 hours at 
37°C and disrupted by ultrasonication (2.15.1). Characterisation of B. subtilis 
proteins by 2-DE during exponential growth and glucose starvation show a decrease 
in the relative synthesis rate of chorismate mutase (AroA) when limiting amounts of 
glucose were used (0.05%) (Schmid et al., 1997). Four 2-dimensional gels were run: 
two were loaded with approximately 200 pg of B. subtilis cell extract protein (gels 
1,2) and one ‘control’ was loaded with 100 pg of purified B. subtilis YqhS (gifted by
A. Herbert) (gel 3). The fourth gel was loaded with approximately 100 pg of B. 
subtilis cell extract protein and 100 pg B, subtilis YqhS (gel 4). Protein samples were 
separated in the first dimension using a pH 4-7 linear gradient immobilisation strip 
from Amersham Pharmacia Biotech and in the second dimension by 15% (w/v) SDS 
PAGE (2.11).
After the second dimension separation western blots were performed on gels 2, 3 and 
4 using antibodies raised against F23Y YqhS (2.14) and gel 1 was stained with 
Coomassie Blue (2.11.1). The gels and western blots are shown in Figine 40.
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Figure 40.2-dimensional SDS PAGE o f B. subtilis (derivative 168) crude extract (1) 
and purified YqhS protein (2) separated by pH 4 to 7 isoelectric gradient and 
then by SDS PAGE. Western blots using antibodies raised against the YqhS 
mutant (F23Y) on 2-dimensional SDS PAGE: (A) 200 pg o f  B. subtilis 
(derivative 168) crude extract, (B) 100 pg o f purified YqhS protein, (C) 100 
pg o f B. subtilis (derivative 168) crude extract and 100 pg o f  purified YqhS 
protein.
Both the YqhS and 22.5 kDa protein seemed to focus at approximately pH 5.5 
(suggesting that the pi o f  the two protein is similar). However, there was a 6 kDa 
difference in molecular weight. Although gels 1 and 2 were run in parallel in the 
same electrophoresis tank there were slight differences in the way in which they 
separated the proteins. The separation o f  the proteins from the B. subtilis cell extracts 
show some smearing o f the spots; this could be a result o f the ionic strength being too
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high in the B. subtilis growth medium (2.3.1) causing poor focusing o f the isoelectric 
first dimension step. This made the excising spots that had affinity to the F23Y YqhS 
antibodies difficult. Nonetheless, the spots were excised and digested with trypsin
(2.15.3) and prepared for MALDI mass spectroscopy (2.15.4).
4.5.2.2 Protein A immunoprécipitation o f B. subtilis  cell extract
Protein A immunoprécipitation was carried out as described in section 2.15.2 using 
the Pierce Seize™ Classic (A) immunoprécipitation kit. 3 ml o f B. subtilis  (168) 
culture grown in nutrient broth for 48 hours at 37°C was disrupted (2.5.3). 40 pi o f  
F23Y YqhS antibody serum (approximately 60 pg o f antibody) was added to 200 pi 
o f  supernatant and incubated for 1 hour at 20°C. Elution and wash fractions were 
collected and separated by SDS PAGE (Figure 41).
kDa 1 2  3 4
21.5
14.4
Figure 41. SDS PAGE (15% acrylamide) analysis o f protein A immunoprécipitation 
o f  B. subtilis cell extract. Lane 1 : Boehringer Mannhiem marker low-range, 
lane 2 and 3: wash fractions. Lane 4 elution fraction. Lane 5: primary 
polyclonal antibody (immunoglobulin G) raised against YqhS F23Y.
The results from the polyacrylamide gel show that there are several contaminating 
proteins within the antibody serum. The majority o f the proteins found in the wash 
fractions o f the protocol are likely to be from the antibody serum. Without the use o f  
detergent, which was omitted due to possible interaction with the antibody, the 
disruption o f B. subtilis  cells may have been compromised.
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In the elution fractions of the immunoprécipitation the heavy chain (-50 kDa) and 
light chain (-25 kDa) of the antibody ai'e clearly visible. Due to the light chain being 
of a similar molecular weight to the 22.5 IcDa protein the Pierce Seize"'"'^  X Protein A 
immunoprécipitation kit was used to avoid antibody contamination in the elution 
fraction.
The Pierce Seize™ X Protein A immunoprécipitation kit overcomes this problem by 
immobilising the primary antibody to protein A via the Fc region of the antibody, 
using a cross-linking reagent Disuccinimidyl suberate (DSS). Preliminary 
experiments failed to cross-link the primary antibody to protein A (results not shown) 
and this approach to purify YqhS was abandoned.
4.5.2.3 Mass Spectrometry
MADI-tof Mass spectrometry was carried out by Sharon Kelly; this proved 
inconclusive as there were insufficient quantities of peptide to detect.
4.5.3 Disruption mutant (YqhSd)
The complete genome sequence of B. subtilis was published in 1997 (Kunst et ah, 
1997) this revealed approximately 1800 genes with no established function (-43% of 
the entire genome). The International Bacillus Consortium has studied the 
functionality of these genes, using gene disruption techniques followed by the 
monitoring of the effect on cell fitness under different growth conditions. A network 
of 18 European and 12 Japanese laboratories have completed a gene-by-gene 
inactivation procedure of >95% of all the genes with unknown functions (Ogasawara, 
2000; Kobayashi et ah, 2003). This was achieved by using the pMUTIN vectors, 
which allow insertion mutagenesis. Some of the other benefits of the pMUTIN 
vectors are that they possess a reporter lacZ gene, to facilitate the measurement of the 
expression of the target gene and an inducible promoter to allow controlled 
expression of the genes downstream of, and found in the same operon as, the target 
gene (Vagner et al., 1998). The target gene is inactivated by the insertion of the 
pMUTIN vector within the gene in a single crossover event (Figure 42).
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Figure 42. Intergration of pMUTIN vector into a target gene. Genes of the orfl-orfl 
operon are indicated as white boxes. Hatched box corresponds to the 
internal segment of the target gene. The vector is integrated in orp, by a 
single crossover event. Arrows indicate direction of transcription, broken 
arrows denote the promoter of the operon and Pspac, and the lollipop strand 
is for the transcription termination. This figure is from Vagner et al., 1998.
Among the «4,100 genes in B. subtilis only 192 were found to be essential and 
another 79 genes were predicted to be essential. About 80% of the functions that the 
essential genes encode fall into a few large categories; namely, information 
processing, cell envelope, shape, division, and energetics. (Kobayashi et a i, 2003). 
The yqhS gene was not among the gr oup of genes thought to be essential in B. subtilis 
for growth in LB.
Prof. Sato from Tokyo University of Agriculture and Teclmology (part of the 
Japanese Bacillus Consortium) gifted the B. subtilis (168) disruption mutant for YqhS 
(YqhSd). Growth experiments on the YqhSd strain by the Japanese Bacillus 
Consortium had shown that the disruption mutant was able to grow in Schaffer’s 
medium but not in minimal media. Independent growth experiments were performed 
to test these findings (4.5.3.1). The sporulation frequency was found to be >2.0 x 10'^  
(Prof. Sato and Michio Takeuchi personal communication).
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The YqhSd strain given by Prof. Sato was tested for erythromycin resistance by
growing the strain at 37°C for 24 hours in the presence of 1 pg/ml of erythromycin.
The YqhSd strain was then western blotted using the F23Y YqhS antibodies as
described in section 4.5.1.
The western blot of the YqhSd cell extract revealed high affinity for the 22.5 kDa 
protein (Figure 43). This proves that the 22.5 kDa protein is not a modified YqhS 
and is more likely to represent non-specific binding to the antibody.
4  22.5
4 1 6 .5
Figure 43. Western blot of B. subtilis derivative 168 and YqhSd cell extracts using 
antibodies raised against YqhS F23Y protein. Lane 1: purified wild type B. 
subtilis YqhS protein. Lanes 2,3: B. subtilis (derivative 168) cell extract 
grown in NB medium and minimal medium, respectively. Lane 4: B. 
subtilis (YqhSd) cell extract grown in NB medium.
4.5.3.1 Growth experiments on the YqhSd mutant.
Independent growth experiments were performed on the YqhS disruption mutant to 
support growth studies performed by the Japanese B. subtilis Consortium. 100 ml 
cultures were set up from an overnight culture of both the disruption mutant and 
derivative 168 in nutrient broth (NB) and minimal medium (SMM) (Anagnostopoulos 
and Spizizen, 1960) with and without glucose (2.3.1). When glucose was utilised it 
was added to a final concentration of 0.5% (w/v). Cultures were grown under aerobic 
conditions shaking at 200 rpm at 37°C. The initial absorbance at 600 nm was 
calculated to be approximately 0.009. Absorbance at 600 nm was measured of B. 
subtilis growth experiments growth at various time intervals; the results are shown in 
Table 10.
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Table 10. B. subtilis disruption mutant (YqhSd) growth experiment.4
B.subtilis strain Medium Hours of growth Aôoo measurement
YqhSd NB^ 15 1.177
18 1.178
44 0.533'^
WT NB 15 1.418
18 1.420
44 0.680'^
YqhSd SMMV Glucose 15 0.087
18 0.104
44 0.083
WT SMM + Glucose 15 1.289
18 1.386
44 1.479
YqhSd SMM 15 0.025
18 0.058
44 0.062
WT SMM 15 0.169
18 0.212
44 0.266
 ^NB, Nutrient Broth 
'''Carbon starvation 
SMM, Minimal Medium
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There does not appear to be any growth of the disruption mutant (YqhSd) in minimal 
medium and very little growth if any in minimal medium including 0.5% glucose. 
The wild type B. subtilis grows well in minimal medium with 0.5% glucose and only 
very slowly in minimal medium without glucose. Reduction in growth of both the 
wild type and mutant in nutrient broth is thought to be due to carbon starvation 
leading to cell death.
4.6 Inactivation of B, subtilis type I dehydroquinase from cell 
extract
To establish whether the dehydroquinase activity from B. subtilis cell extract was due 
to a type I enzyme, sodium borohydride (NaBH4) reduction and heat treatment 
studies were perfoimed on the extract. Sodium borohydride (NaBH4) was used in an 
attempt to trap the Schiff base intermediate produced by the type I dehydroquinase 
mechanism (Butler et a l, 1974; Chaudhuri et al., 1991 ; Kleanthous et al., 1991).
200 ml cultures were set up of B. subtilis 168, B. subtilis disruption mutant (YqhSd) 
and E. coli DH5a (which possess only a type I dehydroquinase); these were grown at 
37°C for 18 hours in NB and LB, respectively (2.5). Cells were harvested by 
centrifugation at 5,000 x g for 15 minutes, yielding approximately 0.5g wet weight of 
B. subtilis 168 and YqhSd and approximately 0.75 g wet weight of E. coli DH5a. 
Harvested cells were split between potassium phosphate buffer (100 mM; pH 7.0) 
and Tris-acetate buffer (lOOmM; pH 7.0). This was because type I dehydroquinase 
catalytic activity is assayed in phosphate buffer but type II dehydroquinase activity is 
assayed in Tris-acetate since phosphate is a competitive inhibitor of the latter 
enzymes (5.4.5). The re suspended cells were homogenised by a French pressure cell
(2.5.3) in a total volume of 0.75 ml and centrifuged at 16,000 x g for 15 minutes at 
4°C. For the chemical modification experiments a 10 mg/ml solution of NaBH4  (in 
40 mM NaOH) was added 10 seconds after the addition of dehydroquinate and then 
incubated for 20 minutes at 20°C. E. coli cells extracts were diluted 5-fold and B. 
subtilis cells extracts were diluted 1.1-fold, incubated in 1 mM dehydroquinate with 
either 0 mM, 0.1 mM or 0.5 mM NaBH4 . Additional incubations were performed 
using purified E. coli (strain reference code: AB2848/PKD203) type I 
dehydroquinase (gifted by John Greene) and S. coelicolor type II dehydroquinase 
(2.12.1). Incubations of the purified E. coli type I dehydroquinase (0.1 mg/ml) and 5*.
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coelicolor (0.01 mg/ml) were only performed in their assay buffers, in 1 mM 
dehydroquinate followed by the addition of either 0 mM or 0.5 mM NaBH4 .
The volume of each of the incubations was kept equal by the addition of distilled 
water (200 pi total volume). 20 pi of each incubation was assayed for 
dehydroquinate activity by monitoring the increase at 234 nm (2.16.1), using 1 mM 
dehydroquinate in either potassium phosphate or Tris-acetate buffers in a total volume 
of 1 ml. All assays were performed in duplicate.
The results of the chemical modification with NaBH4 are shown in Table 11 below.
There is a 95.5% reduction in catalytic activity of the purified E. coli type I 
dehydroquinase by treatment with NaBH4  in the presence of substrate. The purified 
type II dehydroquinase shows only a 21% reduction in activity. The activities of 
extracts in different buffers could not be compared directly with each other because 
no steps were taken to ensure that the degree of cell lysis was constant. For each 
extract, activities are referred to the value obtained in the absence of added NaBH4 . 
In all cases NaBH4 significantly reduced the catalytic activity of the cell extracts. It 
is likely that the dehydroquinase reaction is catalysed via a Schiff base intermediate 
in B. subtilis, and therefore the type I dehydroquinase from B. subtilis is likely to 
contribute the catalytic activity. The B. subtilis YqhSd strain showed catalytic 
activity, confirming that the YqhS protein is not involved in the dehydroquinase 
reaction.
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Table 11. Sodium borohydride (NaBH4 ) chemical modification experiments on 
E. coli and B. subtilis cell extracts and purified E. coli type I dehydroquinase 
and S. coelicolor type II dehydroquinase.
Buffer (100 
mM; pH 7.0) [NaBH4 ] (mM)
Average
activity
(AA234min“^ )
% Activity 
loss in respect 
to 0 mM 
NaBH4
E. coli cell K phosphate 0 0 .0 3 5 2 2 -
extract 0.1 0 .0 2 0 9 7 4 0 .5
0 .5 0 .0 0 3 7 3 8 9 .4
Tris-acetate 0 0 .0 3 9 9 6 -
0.1 0.02201 45
0 .5 0 .0 0 3 0 6 9 2 .3
B. subtilis 168 K phosphate 0 0 .0 1 5 8 3 -
cell extract 0.1 0 .0 0 2 0 9 8 7
0 .5 0.0 100
Tris-acetate 0 0 .0 1 1 7 8 -
0.1 0.0 100
0 .5 0.0 100
B. subtilis K phosphate 0 0 .0 2 1 3 1 -
YqhSd cell 0.1 0 .0 0 1 8 8 91
extract 0 .5 0.0 100
Tris-acetate 0 0 .0 1 3 2 9
0.1 0.0 100
0 .5 0.0 100
E.coli type I K phosphate 0 5 .4 7 9 -
dehydroquinase 0 .5 0 .2 4 5 6 9 5 .5
S. coelicolor Tris-acetate 0 1 .3 9 9 -
type II 
dehydroquinase 0 .5 1 .1 0 8 21
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The thermostability of type I dehydroquinases (57°C in E. coli) is significantly lower 
than the type II dehydroquinases (82°C in A. nidulans) (Kleanthous et al, 1992). 
This difference in stability was used to explore the properties of the catalytically 
active dehydroquinase in B. subtilis cell extracts. Cell extracts of E. coli and B. 
subtilis were prepared as described previously. 200 pi of each cell extract was 
subjected to heat treatment of 65°C for 5 minutes. Assays were performed using 20 
pi of sample and 1 mM dehydroquinate in both potassium phosphate and Tris-acetate 
buffers, 1 ml volume. Upon heat treatment of the B. subtilis and E. coli cell extract 
there was a complete loss of catalytic activity (data not shown). This study also 
points towards the catalytic activities observed in B. subtilis cell extracts being 
entirely contributed by the type I dehydroquinase from B. subtilis.
4.7 Chapter summary
B. subtilis YqhS was shown to have an extremely low level of catalytic activity and is 
therefore not a functional dehydroquinase. The site-directed mutant F23Y of YqhS 
shows at least 2000-fold increase in activity from the wild type, confirming the 
importance of this residue. F23Y YqhS displays a Km of 730 pM and of 0.18 s’*; 
kcJKm is 2.5 X 10^  M'^s‘*. Compared with other type II dehydroquinases such as S. 
coelicolor {Km of 100 pM and c^at of 120 s'*; kç^JKm is 1.2 x lO*’ M’*s’*) this is still an 
extremely low level of activity. Although, it is broadly within the range observed for 
the type II dehydroquinases from Helicobacter pylori {Km of 205.75 pM and k^ nt of 
0.94 s'*), M. tuberculosis {Km of 170.8 pM and kcat of 5.17 s'*) and Neurospora crassa 
{Km of 70 pM and kcat of 0.08 s'*) (Hautala et al., 1975, Kleanthous et al., 1992); there 
must be other factors involved in improving the catalytic efficiency of the high 
activity DHQases. The 3-dimensional structuie shows that the potential active site is 
much shallower in the B. subtilis enzyme than in any other functional type II 
dehydroquinase.
The type I dehydroquinase is the catalytically active dehydroquinase as shown by 
inactivation experiments (4.6) chemical modification using NaBH4  to react with an 
essential lysine in type I DHQ forming a Schiff base. Heat treatment of the cell 
extract also suggested that a type I DHQase was the active DHQase in B. subtilis.
If YqhS is expressed although catalytically compromised, it must still confer some 
evolutionary advantage indicating a possible second function for AroQ. DNA
Page 141
CHAPTER 4 B. subtilis YqhS
microarray experiments in B. subtilis showed higher levels of the inRNA for the yqhS 
(the Type II DHQase) than for aroC (the Type I DHQase) (personal communication 
from Rick W. Ye). Direct investigation of the expression of the YqhS protein using 
antibodies proved to be inconclusive. This does not mean that the YqhS protein is 
not expressed; YqhS may be expressed under different conditions than those 
investigated here. Further western blot experiments of B. subtilis cell extract under 
different growth and stress conditions including heat shock, salt and ethanol stress 
and glucose and phosphate starvation may provide direct evidence of expression. It 
should be noted that the B, subtilis microarray experiments were conducted with 2 x 
YT medium, while the western blot experiments were conducted using Nutrient 
broth. This difference only came to light late during the investigations and a direct 
comparison should be performed. It would also be useful to carry out western blots 
on B. subtilis cell extracts that have been exposed to different stress conditions. The 
YqhS protein is extremely thermostable and retains 50% of its secondary structure in 
6 M GdmCl (4.3.1.1). It is possible that it may play a role in heat or salt stress 
response. The high resolution 3D X-ray crystallography structme (D. Robinson, 
2003) shows that there is a large cavity in the middle of the YqhS dodecameric 
structure which is also seen in all other type II dehydroquinases. This could provide a 
possible clue to the proposed second function of type II dehydroquinases. There are a 
number of conserved side chains within the cavity of the dodecamer, including His85, 
Glu59 and Asp64 {S. coelicolor DHQase numbering system); it is unclear whether 
these side chains are pmely structural or ai'e involved in an as yet unknown function. 
This cavity may be suitable to assist protein folding even though it is not 
hydrophobic; thus YqhS could be a molecular chaperonln or a heat shock protein. If 
YqhS is expressed in response to either heat or salt stress, it could also be linked to 
the formation of endospores.
B. subtilis can differentiate to form heat-resistant endospores in response to starvation 
of carbon, nitrogen or phosphorus. Spore formation can be divided into a basic 
sequence of morphological changes: at the start of differentiation (stages 0 to II) there 
is one cell type; two complete cliromosomes are formed, an asymmetrically sited 
septum is formed separating the two genomes of the cell. In the second phase (stages 
II to III) the differentiation becomes fixed and the two distinct genomes start to 
function differently. The junction of the septum and the outer surface of the
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sporangium migrates to the pole of the sporangium and the developing forespore is 
then engulfed by the mother cell. At stage III B. subtilis has irreversibly 
differentiated into two different cell types, and the forespore can only return to 
vegetative growth by spore formation and then germination. The forespore develops 
resistance and dormancy properties to form the mature spore within the mother cell 
(stages III to VII). The cortex and primordial germ cell wall are formed (stage IV) 
followed by the development of a proteinaceous spore coat around the forespore at 
stage V. The two final stages are the matuiation of the spore (stage VI) and the 
release of the mature spore by the lysis of the mother cell (stage VII) (Errington, 
1993).
The inactivation procedure using pMUTIN vector system incorporates the lacZ gene
(2.8.3) as part of the disruption of the target gene. The Japanese Bacillus consortium 
have used this gene during growth experiments on the disruption mutant YqhSd to 
monitor the expression of the tai'get operon. YqhSd shows an increase in p- 
galactoside activity during exponential growth, this indicates that the open reading 
Eame in which yqhS is situated is expressed.
The yqhS gene is located in the genome close to a series of genes which when 
mutated block sporulation after engulfment {spoIIIAA-AH) (Sharp and Pogliano, 
1999). Directly downstream of the yqhS gene is a gene encoding for a Xaa-Pro 
dipeptidase followed by a gene encoding for elongation factor P. Directly upstream 
of the yqhS is a conserved protein of unknown function (yqhT). The arrangement of 
these genes is the same is in B. anthracis and B. halodurans both of which possess a 
type II dehydroquinase. Oceanobacillus iheyensis possess a type I dehydroquinase, 
but also possesses the genetic region containing the genes encoding for the Xaa-Pro 
dipeptidase, elongation factor P and conserved protein of unloiown function; however 
the gene encoding for a type II dehydroquinase is not present. This seems to suggest 
that the Bacillus family members that possess a type II dehydroquinase share a 
common ancestor which has had the yqhS gene inserted into this region without the 
incorporation of any other genes. Studies on the SpoIIA gene (Piggott et al, 1984) 
revealed that polycistronic transcription units are involved in sporulation of B. 
subtilis. This helps to organise and regulate the complex process of sporulation. 
YqhS may be within the polycistronic unit that transcribes the spoUIAA-AH genes. It 
is still possible that YqhS performs some role during sporulation, although first level
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phenotype analysis of the YqhSd strain by the Japanese Bacillus consortium, reveals 
that the YqhSd strain is able to produce spores. The shlkimate pathway genes; aroE, 
H, B and F  are also grouped together (Kunst et al 1997) and may also be expressed as 
a polycistronic transcription unit; however it should be noted that the aroA 
(chorismate mutase) and C (type I DHQase) are not grouped. The location of the 
type I dehydroquinases in B. subtilis, O. iheyensis and B. stearothermophilus are not 
analogous.
B. subtilis contains several different cj factors which play an important role in 
reprogramming the cell in response to different environmental conditions. Vegetative 
growth is controlled by c*, other responses included the formation of an endospore 
controlled by <7^ , and motility, chemotaxis and autolysin controlled by
<7*^ and the expression of general stress proteins controlled by a® (Horsburgh et 
a/.,2001). Stress response is activated by two discrete stress classifications: energy 
stresses such as carbon, phosphorus or oxygen limitation and environmental stresses 
such as acid, ethanol, heat or salt stress (Akbar et ah, 2001). In several studies of 
stress response in B, subtilis particularly in relation to YqhS has not been 
identified as being involved including; microarray profiles of B. subilis grown under 
anaerobic conditions (Ye et aL, 2000) and high resolution 2-DE monitoring the 
changes in expression levels of proteins under different stress conditions: salt, heat, 
ethanol, oxidative stress and glucose starvation. This latter comprehensive study of 
general stress proteins in B. subtilis and a® mutants was performed by Bernhart et al. 
(1997). The 2-DE studies identified 42 general stress protein which require a®, but 
seven which did not. It is possible that YqhS is expressed in stress conditions that 
have not been characterised and is not regulated by a®.
Expression of the disrupted gene was found to increase at the end of exponential 
growth in the enriched medium. It has been confirmed that, unlike the wild-type 
strain of B. subtilis, the yg/zY-disputed mutant will not grow on minimal medium with 
either glucose or citrate as a carbon source. While the B. subtilis wild type is able to 
growth on minimal medium with glucose and shows poor growth on citrate as a 
carbon source. B. subtilis growth experiments on TCA cycle intermediates as the 
sole carbon source show that citrate is a viable carbon source for B. subtilis as 
measured by optical density at 600 nm and involves the Mg^^-citrate transporter CitM
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(Warner and Lolkema, 2002). The disruption mutant and wild type both grow very 
well on nutrient broth. Although nutrient broth does not contain major amounts of 
carbohydrate or fatty acids, growth on nutrient broth by amino acid degradation 
provides energy and allows incorporation of many preformed polymer precursors. 
Energy produced via the tricarboxylic acid (TCA) cycle oxidation provides 
precm’sors for gluconeogenesis which is essential to supply glycerol, hexoses, 
hexosamines and pentoses. The disruption mutant must have the gluconeogenic 
pathway and at least some reactions of TCA cycle as the YqhSd strain is operating to 
degrade amino acids (Dr. Fixter, personal communication). Analysis of the B. 
subtilis genome revealed nine genes associated with citrate regulation, transport and 
metabolism.
Thus although YqhS protein is functional, the precise role of this protein is still 
unclear. Auxotrophic studies on the disrupted mutant should be performed, in order 
to establish the precise nature of the YqhSd strain and to define more clearly the role 
of the YqhS protein in B. subtilis. These studies might provide the opportunity to 
dissect out an additional function for proteins with the type II DHQase structure. 
This study offers an insight into how new functions may evolve in existing protein 
families.
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CHAPTERS KINETIC AND STUCTURAL STUDIES 
OF TYPE II DEHYDROQUINASES FROM 
DIFFERENT BACTERIAL SPECIES
5.1 Introduction
The type II dehydroquinase (DHQases) which have been characterised kinetically 
appeal' to fall into two main groups. The enzymes from organisms such as S. 
coelicolor and Aspergillus nidulans have relatively high values of kc^ x, in the range 
100 to 1000 s'* at pH 7.0 and 25°C (Kleanthous et ah, 1992; Kiell et aL, 1996). By 
contrast, the enzymes from Helicobacter pylori, M. tuberculosis and Neurospora 
crassa have much lower values of /ccat in the range 10 s'* or lower (Hautala et aL, 
1975; Bottomley et aL, 1996a; Price et aL, 1999). There appeal's to be no obvious 
correlation between the values of kcan and Km for these enzymes. Sequence 
alignments of these show strict sequence conservation of all the amino acid residues 
implicated in catalysis (Appendix C; Error! Reference source not found.) with the 
exception of Ser 56 which is a thieonine in H  pylori (S. coelicolor numbering of 
amino acids). Comparisons of the orientations of the residues within the active site 
by X-ray crystallographic data (Figure 44) shows there are no large differences in the 
orientation of the residues within the active site, apait from the finding that the lid 
domain (residues 19 to 26 in M tuberculosis DHQase) of two of the lower activity 
species {H pylori and M tuberculosis) is not resolved.
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Glu 104
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g Arg 113Asn II
Hl« 85
Figure 44. Overlay o f subunits from Streptomyces coelicolor (green), Mycobacterium  
tuberculosis (orange) and Helicobacter pylori (blue). Residues thought to be 
involved in catalysis are highlighted using the numbering system from S. 
coelicolor. Dehydroshikimate is bound in the active site.
The activity o f Aspergillus nidulans and M tuberculosis DHQases were shown to be 
pH-dependent, activity increased with pH (Kleanthous et al., 1992; Harris et a i ,  
1996a) over the range 6.3 to 9.0. Above pH 8.0 it is possible that a deerease in the 
stability o f  the substrate may affect the interpretation o f the results. In this chapter, 
the pH-dependenee o f the activities o f S. coelicolor, H.pylori and M  tuberculosis 
type II DHQases and the B. subtilis YqhS F23Y mutant were investigated over a pH 
range o f 6.5 to 8.0, in order to characterise the differences in catalytie properties in 
greater detail.
It had been originally speculated that the differenees in the levels o f catalytie activity 
were due to variations in flexibility o f the structures especially within the lid domain
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of the active site. Unfolding experiments on S. coelicolor and M tuberculosis 
DHQase showed a complete loss in activity of the S. coelicolor enzyme at 3.75M 
guanidinuim chloride (GdmCl) but also revealed a significant activation of the M 
tuberculosis enzyme by low concentrations of GdmCl (0.5-1.OM) at pH 7.5 in 
Tris-HCl (Price et ah, 1999). This type of activation in the presence of moderate 
concentrations of dénaturant had been previously observed in a number of systems 
including Thematoga maritima glyceraldehyde 3 phosphate dehydrogenase which is 
activated by 300% in 0.5M GdmCl (Rehaber and Jaenicke, 1992) and adenylate 
kinase from rabbit muscle which shows a 60% increase in activity in IM urea (Zhang 
et ah, 1997). Human phenylalanine hydroxylase is transiently activated by 10 and 
100-minute incubations of between 0 and 4 M urea in the absence of the substrate L- 
phenylalanine (Kleppe et ah, 1999). It has been suggested that the activation by 
dénaturants of dehydroquinases may be due to increasing conformational flexibility at 
the active site (Price et ah, 1999). Dénaturation experiments using GdmCl and Urea 
(NaCl was used as a control) were performed to investigate the relative stability and 
activity of type II DHQases from S. coelicolor, H.pylori and M. tuberculosis and the 
YqhS F23Y mutant from B. subtilis. The structural stability of H. pylori type II 
DHQase towards dénaturation was further characterised using fluorescence and 
circular dichroism. During the dénaturation experiments it was observed that there 
appeared to be a difference in the effect of chloride anion on the activities of the high 
and low kcat families of DHQase. This apparent effect of chloride ions was 
investigated further by performing activity studies in the presence of different anions: 
parallel studies were carried out on the effect of urea in place of GdmCl.
The effect of phosphate on type II DHQases was first chai'acterised during 
experiments comparing the steady-state parameters of the two types of DHQase 
(Kleanthous et ah, 1992). Preliminary results obtained by Deka (1993) indicated that 
phosphate behaves as a competitive inhibitor of the type II DHQase from A. nidulans, 
with SL K[ of 10 mM at pH 7.0 and 25'^C. The effect of the polyanionic ligands 
sulphate and phosphate on the type II DHQases of M. tuberculosis, K  pylori, S. 
coelicolor and the B. subtilis YqhS F23Y mutant was investigated.
All kinetics assays were carried out as described in section 2.16.1 in 50mM Tris 
acetate pH 7.0 unless otherwise stated.
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5.2 Structural comparison of Type II dehydroquinases
Sequence alignments demonstrate high homology between the type II DHQases from 
different bacterial species. The primary structures of type II DHQases are strongly 
eonserved with 13 % of residues invariant and 65 % conserved over the 47 sequences 
shown in Appendix C; Error! Reference source not found.. The H. pylori, A. 
nidulans, M. tuberculosis DHQases and the B. subtilis protein YqhS show a 
percentage identity of 43, 56, 44, and 47% respectively, to the S. coelicolor DHQase. 
Using the S. coelicolor numbering system for amino acids all of the residues thought 
to be involved in catalysis are conserved in these DHQase apart from serine 56, 
which is a tlireonine in H. pylori and tyrosine 28 which as already highlighted in 
chapter 4 (4.1) is a phenlyalanine in B. subtilis YqhS. The subunit of the type II 
DHQases has a flavodoxin-like fold (Burnett et al., 1974). The C terminal a-helix of 
H. pylori is significantly extended compared to the other DHQases discussed in this 
chapter. The overlay of the structures of S. coelicolor, M. tuberculosis and H. pylori 
DHQase (Figure 44) shows that there is no significant difference in the orientation of 
the residues involved in catalysis. There are subtle differences at the floor of the 
active sites of the type II DHQase X-ray structures. Amino acid side chains at 
positions 81 and 82 (SCDHQase numbering system) are found on the floor of the 
active site and are highly conversed as either a glycine or alanine. Ala81 is thought 
to cause a steric clash with the oxime inhibitor in the SCDHQase (Table 5). It is also 
noteworthy that the flexible loop that forms a lid to the active site (residues 21-31) is 
not resolved in the H. pylori or the M tuberculosis DHQases which are both of which 
are low Aicat enzymes. This region may be more flexible in these two bacterial species, 
although there are no indications fr om the primary structure as to why this might be 
the case nor whether this extra flexibility may contribute to the lower activity of these 
enzymes.
5.3 Unfolding of Type II dehydroquinase from H. pylori
The type II DHQases from both S. coelicolor and M. tuberculosis have both been 
studied by unfolding experiments in the presence of GdmCl (Kleanthous et a l, 1992; 
Price et al., 1999). A dénaturation curve of the H. pylori was determined using 
concentrations of GdmCl from OM to 6M. 0.2 mg/ml of enzyme was incubated at
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room temperature for 24hrs. The samples were then analysed using far UV circular 
dichroism, tluorescence and by measuring catalytic activity (2.22; 2.21; 2.16.1).
5.3.1 Structural analysis using circular dichroism
o0)■DE
a>
0.5
0 M GdmCl 
0.5 M GdmCl
1 M GdmCl
2 M GdmCl
3 M GdmCl
4 M GdmCl
5 M GdmCl
6 M GdmClr
2 5 0
T
2 6 0
W ave leng th  (nm)
Figure 45. Far UV circular dichroism spectra o f  the unfolding o f H. pylori type II 
DHQase by guanidine hydrochloride (GdmCl) see figure insert for 
concentration o f GdmCl.
CD spectra show the changes in secondary structural features. H. p y lo ri DHQase is 
very stable in GdmCl and shows approximately 40% o f the native CD signal at 
225nm in 6M GdmCl. At low concentrations (up to 2M) GdmCl there is some 
evidence for a modest increase in secondary structure (Figure 32). It could be 
possible that this may reflect a change in the quaternary structure with dissociation o f  
the dodecamer into trimers, but no further experiments have been undertaken to 
check this suggestion.
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5.3.2 Structural analysis using fluorescence
320
300
280
H  260
240
220
200
2 30 1 5 64
[GdmCl] (M)
Figure 46. Fluorescence data o f  the unfolding o f  H. p y lo r i  type II dehydroquinase by 
guanidine hydrochloride (GdmCl). Values are corrected for Raman 
scattering.
Fluorescence scans were carried out on H. p y lo r i  DHQase with low concentrations o f  
dénaturant; guanidine hydrochloride. H. p y lo r i  DHQase does not possess any 
tryptophans so the fluorimeter was set up to selectively excite tyrosine residues at a 
wavelength o f  280 nm. The fluorescence data show no large-scale changes in 
emission at 308 nm with an increase in GdmCl concentration. At 0.5M GdmCl there 
is a minor rise in emission; the overall trend is slight increase in emission with 
GdmCl concentration (Figure 46). This indicates the environment o f  each o f  the 
tyrosines is not significantly altered and the tertiary structure is unchanged by low  
concentrations o f GdmCl. This is consistent with the CD data, which show that the 
H. p y lo r i  DHQase is extremely stable towards the dénaturant.
5.3.3 Catalytic activity
At low levels o f  GdmCl (0.5 M and 1 M) there is a significant increase in enzyme 
activity. It was originally hypothesised that this increase in activity was due to either 
an increase in flexibility in the structure or was a consequence o f  the dodecameric
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quaternary structure dissociating into trimers (Price et ah, 1999). This is explored 
further in section 5.4.2.
5.3.4 Structural analysis using dynamic light scattering
To investigate any structural changes in the presence of low levels of GdmCl,urea, 
sodium chloride, sodium phosphate (pH 7.0) and sodium sulphate, dynamic light 
scattering was used to monitor any changes in quaternary structure. Two catalytically 
different DHQases, S. coelicolor and H. pylori were studied at a protein concentration 
of 0.5 mg/ml. Each protein sample was incubated at 20°C for 1 hour with the test 
reagents in 50 mM Tris acetate buffer pH 7.0. 200 pi of each solution was injected 
into the dynamic light scattering cell.
The estimated molecular weight of S, coelicolor DHQase is much lower than the 
actual value as determined by White et ah, (1990). This is likely to be due to the 
assumptions about the density and shape of the protein made by the software of the 
DynaPro^ "^^  system (2.23). There is only a slight change in the radius of the protein 
and the estimated moleculai' weight in the presence of the low levels of dénaturant 
and salt tested. This is not thought to be significant as the SOS (sum of squai'es) is 
increased in the presence of all the reagents tested which is likely to be due to a slight 
aggregation (Table 12).
The H. pylori results show large amounts of aggregation in the presence of all the 
reagents tested. In the presence of Tris acetate buffer pH 7.0 the estimated molecular 
weight is much closer to the actual molecular weight than with the value obtained 
from the S. coelicolor dynamic light scattering data (Kwak et al., 2001). In the 
presence of 0.5 M urea and 0.17 M sodium sulphate it was not possible to acquire 
enough counts to make any measurements and the SOS of all the results was >5.0 so 
their data are likely to be unreliable (2.23).
The dynamic light scattering data do not show any evidence that type II DHQases 
dissociate into trimers in the presence of low levels of dénaturant. All of the reagents 
tested seem to cause aggregation of the low activity DHQase of H. pylori.
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Table 12. Dynamic light scattering data for type II dehydroquinases in the 
presence of various denatui ants and salts.
S. coelicolor dehydroquinase H. pylori dehydroquinase
Radius Estimated SOS Radius Estimated SOS
(nm) MW (kDa) EiTor (nm) MW (kDa) Error
[50mM]
Tris 4.4 106 1.788 5.8 209 8.190
acetate
[0.5 M] 
GdmCl 4.4 104 5.548 7.4 383 25.124
[0.5 M] 
Urea 4.7 128 2.399
- - -
[1.0 M] 
Urea 4.8 129 4.271
* *
[0.5 M] 
NaCl 4.7 128 2.525
* *
[0.28 M] 
NaPi 5.3 166 7.472 6.3 254 13.682
[0.17 M] 
Na2S04 4.9 142 3.725
- - -
5.3.5 Structural analysis using differential scanning calorimetry (DSC)
Differential scanning calorimetry was used to determine the thermal stability of the 
bacterial type II DHQases from S. coelicolor, M, tuberculosis and H. pylori, the YqhS 
protein from B. subtilis was also tested. Experiments were earned using 0.1 mg/ml of 
protein in 100 mM Tris acetate buffer (pH 7.0) in the Biophysical Chemistry
Insufficient counts 
Sample aggregation.
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Laboratory, University of Glasgow (Prof. Cooper). All the proteins were stable to 
over IOO°C whereupon all the protein samples aggregated (data not shown).
5.4 Kinetic characterisation of type II dehydroquinases
5.4.1 pH dependence of the kinetic parameters of type II dehydroquinases
The pH dependence of the kinetic parameters was studied in four type II DHQases; S. 
coelicolor, M. tuberculosis, H  pylori, and B. subtilis protein YqhS mutant F23Y. 
DHQase activity was measured as described in section 2.16.1. Reactions were 
initiated by the addition of enzyme (0.015 pg, 0.5 pg, 3 pg, and 40 pg of S. 
coelicolor, M. tuberculosis, H. pylori, and B. subtilis protein YqhS F23Y 
respectively). Assays were performed over a series of pH values from 6.5 to 8.0. 
Data at each substrate concentration were measured in quadruplicate.
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Figure 47. Steady-state kinetics pH-dependence studies effect on (A) Acat and (B) A'm 
o f type II DHQases from S. coelico lor  (green), H. py lori (blue), M  
tuberculosis (orange). A, nidulans (purple) and B. subtilis YqhS F23Y 
mutant (red) (A. nidulans data from Dr. Deka 1993).
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Table 13. pH-dependence steady-state kinetics studies 
DHQases (A. nidulans data Irom Deka (1993).
on bacterial type II
pH S. coelicolor d e h y d r o q u in a se
Aat(s'‘) ± ^m(liM) ± WAm(s-' M'h
6.5 84.85 2 .92 81.99 8.58 1.03 xlO^
7.0 124.79 2 .78 99 .17 7.67 1.26x10®
7.3 205 .24 5.31 157.44 11.91 1.30x10®
7.5 260 .04 6.76 2 29 .92 16.05 1.15x10®
7.8 416.03 16.33 341 .48 31.21 1.23 X I0®
8 . 0 4 80 .76 21.13 428 .18 43.03 1.13x10®
H. pylori d eh y d i'o q u in a se
6.5 0.51 2 .92 173.05 15.35 2.95 xlO^
7 .0 0.94 2 .24 205.75 13.78 4 .55x10^
7.3 1.31 3 .66 281 .87 17.94 4.66  xl(P
7.5 2 . 8 8 6 .54 469.71 25 .74 6 .08 xlO^
7.8 3.06 15.07 779 .40 41.23 3 .93 xiO^
8 . 0 3.76 12.24 999 .05 32 .00 3 .76x10^
M. tuberculosis dehydroquinase
6.5 2.72 3 .08 18.84 2 .39 1 .44x10^
7 .0 5 .17 3 .00 2 3 .79 1.97 2.18x10®
7.3 7 .30 4 .72 4 5 .16 3 .96 1.62x10®
7.5 8 .50 10.09 54.83 8.87 1.64x10®
7.8 8 .76 6.33 58.98 5.46 1.56x10®
8 . 0 11.38 19.50 87 .98 18.44 1.45x10®
A. nidulans dehydroquinase
6.5 579 Nl) 116 NU 4.99x10®
7.0 973 .2 ND 153 ND 6.36  xlO®
7.3 1326.6 ND 163 ND 8.14x10®
7.5 1981.8 ND 2 29 ND 8.65 xlO®
7.8 3285.3 ND 382 ND 8.60x10®
8 . 0 3224.1 ND 4 64 ND 6.95 XlO®
B. subtilis YqhS F23Y m u tan t
7.0 0 .194 0 .0089 731 .79 77.66 2 .65 xlO^
7.5 0 . 2 1 0 .0034 765 .26 28.22 2 .7 7 x 1 0 ^
8 . 0 0.33 0 .0448 1310.85 335 .60 2.51 xlO=
Not determined.
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The results show that there is a dramatic increase in as the pH increases (Figure 
47A) with approximately a seven-fold increase in catalytic activity between pH 6.5 
and 8.0 in all the DHQases tested. Similar results were obtained for the A. nidulans 
enzyme (Deka, 1993) (Table 13). As the pH dependence of Acat is similar in all the 
DHQases tested it is likely that they all share the same catalytic mechanism. There is 
also an increase in as pH increases although the relationship between pH and Km 
varies across the DHQases tested (Figure 47B) (Table 13).
The hydroxyl of free tyrosine (as a free amino acid) has a pAT^  of 10.0 and therefore 
would be expected to be fully protonated at pH 7.0: therefore its environment must 
significantly shift the pKa of tyrosine 28 to allow proton abstraction. The proximity 
of arginine 113 and to a lesser extent arginine 23 would be expected to have a 
significant effect on the pK„ of tyrosine 28 (Roszak et al., 2002), as has been shown 
to be the case in human aldose reductase (Tarle et ah, 1993). This is consistent with 
the pH dependence data which show; an increase in activity with increasing pH, 
specifically related to the increased deprotonation of tyrosine 28.
5.4.2 Stopped flow assay experiments
To investigate any differences in the pre-steady state kinetics of bacterial type II 
DHQases stopped flow experiments were performed on S. coelicolor, H. pylori and 
B. subtilis (F23Y) DHQases. Assays were performed using an Applied Photosystems 
Stopped flow apparatus. No lag or burst phase was observed for HPDHQase or 
SCDHQase (data not shown).
5.4.3 Effects of salts on catalytic activity
Low concentrations of GdmCl were shown to increase the catalytic activity of two 
type II DHQases significantly during unfolding experiments (5.3.3) this effect had 
been previously documented for the M. tuberculosis enzyme (Price et ah, 1999). 
Further experiments were carried out using low concentrations of GdmCl, urea and 
sodium chloride on both the high Acat {S. coelicolor) and low /ccat (M tuberculosis, H  
pylori, B. subtilis F23Y) type II DHQases (Figure 48, Table 13).
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Figure 48. Catalytic activity o f S. coelico lor  (green), H. py lori (blue), M tuberculosis 
(orange) DHQase and B. subtilis  YqhS F23Y mutant (red) in the presence o f  
low concentration dénaturants and salt (A) GdmCI (B) Urea (C) NaCl.
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There is a 240% increase in activity of H. pylori DHQase at 0.5 M GdniCI and a 77% 
increase in activity of M  tuberculosis DHQase at 1.0 M GdmCl. The same effect 
was not observed with the higher Æ^cat DHQase from S. coelicolor and the B. subtilis 
mutant F23Y where low GdmCl concentrations lead to a small decrease in activity 
(Figure 48A). These experiments were repeated using comparable concentrations of 
urea and sodium chloride. As urea is not as strong a dénaturant as GdmCl the 
concentration chosen was double that of the GdmCl used in the assays. The catalytic 
activity of the M tuberculosis DHQase increased by 27% in 1.0 M urea, but the H. 
pylori DHQase did not increase significantly in low concentrations of urea. The S. 
coelicolor and the B. subtilis mutant F23Y DHQases both showed a decline in 
catalytic activity as the concentration of urea increased (Figure 48B). All four 
enzymes were also assayed using low levels of sodium chloride and the activity of the 
DHQases followed the same trend as the GdmCl assay results (Figure 48C). The M 
tuberculosis and H, pylori DHQases showed a 150% (0.5 M NaCl) and 288% (1.0 M 
NaCl) increase in catalytic activity respectively. The S. coelicolor and the B. subtilis 
mutant F23Y DHQases showed a decrease in catalytic activity as the concentration of 
sodium chloride increased. The catalytic parameters of the bacterial DHQases 
studied in this chapter in the presence of 0.5 M GdmCl and of sodium chloride are 
shown in Table 14. All assays were performed in duplicate or in the case of B, 
subtilis (F23Y) quadmplicate.
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Table 14. Catalytic kinetic parameters of bacterial type II DHQases in the 
presence of 0.5 M NaCl and GdmCl.
Bacterial strain 
of type II 
DHQase
Salt tested 
[0.5 M] kcat(s-')
± Kyn (pM) ± kcat ! KjnM‘ s^'^
S. coelicolor No salt 124.79 2.78 99.17 7.67 1.26 XlO*
NaCl 78.97 2.54 201.89 19.90 3.91 xlO^
GdmCl 96.92 7.27 339.94 56.20 2.85 XlO*
H  pylori No salt 0.94 2.24 205.75 13.78 4.55 xlO^
NaCl 3.52 0.07 306.85 19J4 1.15x10^
GdmCl 3.76 0.07 418.05 23.07 8.99x10^
M. tuberculosis No salt 5.17 3.00 23.79 1.97 2.18x10*
NaCl 5.44 0.11 36.26 3.01 1.50x10*
GdmCl 4.20 0.08 36.89 3.22 1.14x10*
B. subtilis No salt 0.194 0.009 731.79 77.66 2.65 xlO^
(F23Y) NaCl 0.097 0.006 930.3 112.0 1.05x10^
GdmCl 0.071 0.004 780.5 91.4 9.16x10^
The kcst of H. pylori DHQase (low Aicat enzyme) shows a significant increase in the 
presence of both 0.5 M NaCl and 0.5 M GdmCl (Table 14). The kcat of the M 
tuberculosis DHQase (low A:cat enzyme) shows a moderate increase in the presence of 
0.5 M NaCl and a small decrease in the presence of 0.5 M GdmCl. The effect on the 
Kya is similar between the two low A:cat enzymes; the iCm increases by approximately 
the same order of magntude in the presence of both NaCl and GdmCl. This evidence 
suggests that the increase in activity in the M  tuberculosis and H. pylori DHQases is 
not due to increased flexibility caused by low concentrations of dénaturant as 
previously thought, and is more likely to be due to a salt effect on the turnover of the 
substrate.
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The activity of the S. coelicolor DHQase and B. subtilis YqhS F23Y mutant enzyme 
both decrease in the presence of both 0.5 M NaCl and 0.5 M GdmCl. The Km of the 
S. coelicolor DHQase is increased approximately 2-fold in the presence of 0.5 M 
NaCl and 3-fold in the presence of GdmCl (Table 14). The Km of the B. subtilis 
enzyme is less affected by both 0.5 M NaCl and 0.5M GdmCl. The Km of the B. 
subtilis enzyme increased by 1.3-fold in the presence of NaCl. There was only a 
moderate increase in the ATm of the B. subtilis enzyme in the presence of 0.5 M 
GdmCl.
Originally thought to be devoid of life the Dead Sea is native to a number of 
halophilic archaea including Haloarcula marismortui, the enzymes malate 
dehydrogenase and 2Fe-2S protein ferredoxin of this halophilic archaeon were 
studied by Mevai'ch et al.  ^2000. Halophilic enzymes require high salt concentrations 
for catalytic activity and stability and it is argued that high negative surface charge of 
halophilic proteins make them more soluble and renders them more flexible at high 
salt concentrations.
The effect of the chloride ions and other salts on type II DHQases was investigated 
using a number of salts from the Hofmeister series. The Hofmeister series was 
originally drawn up on the basis of the effects of various ions on the solubility of 
proteins (Hofmeister, 1888; Collins and Washabaugh, 1985). It has been shown that 
the salts of this series can alter enzyme activity by disrupting the organised structure 
of protein macromolecules (Baldwin, 1996). Bovine liver p-galactosidase and sweet 
potato p- amylase among others were found to be inliibited by the higher ranking of 
anions of the Hofmeister series (Warren and Cheatmn, 1966). Acetoacetic 
decarboxylase from C acetobutylicium is also inhibited by anions in a mamrer which 
follows the pattern of the Hofmeister series and the size of anion (Fridovich, 1963). 
The effect of the series of salts on the catalytic activity of the type II DHQase was 
compared to a control in the absence of added salt. The salts used were sodium 
bromide, sodium chloride, potassiimi chloride, sodium fluoride, sodium acetate, 
GdmCl and sodium thiocyanate; urea was added as a control. The DHQases were 
incubated for 1 hour in each of the salts tested prior to the activity measurements. 
The ionic strength was kept constant; 0.5 M in all assays and all the assays were 
performed at pH 7.0 with 1 mM dehydroquinate. The pH was adjusted for the NaF 
and NaAc assays to pH 7.0 with glacial acetic acid. The ionic strength (7) is defined
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as half of the total sum of the concenti ation (ci) of every ionic species in the solution 
(i) times the squai’e of its charge (zi). The equation for the ionic strength of a solution 
is shown below:
/  = 0.5Z(CjZj^)
The relative catalytic activity of the two low /ccat species of DHQases (M tuberculosis 
and H. pylori) increased significantly in sodium bromide, sodium chloride 
(previously observed), potassium chloride, sodium fluoride and GdmCl. The M 
tuberculosis DHQase also showed a significant increase in relative catalytic activity 
in the presence of sodium acetate and sodium sulphate. The 5. coelicolor DHQase 
was inliibited by all the salts tested, as was the B. subtilis F23Y DHQase with the 
exception of a 41% increase in relative catalytic activity in the presence of sodium 
acetate and no significant change in activity in the presence of sodium fluoride. All 
the DHQases tested were inhibited by sodium thiocyanate (Figure 49). None of the 
DHQases follow the precise pattern of the Hofmeister series. The interactions of salts 
and macromolecules appears to be very complex; ionic species can potentially affect 
hydrogen bonds, hydrophobic interactions and electrostatic interactions. Interestingly 
there seems to be a correlation between a rise in catalytic activity in the low kcat type 
II DHQases and the presence of chloride ions. Detailed studies of M  tuberculosis 
DHQase X-ray crystallographic data have revealed chloride binding sites.
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Figure 49. The affect o f salts from the Hofmeister series on the catalytic activity o f S. 
coelicolor (green), B. subtilis YqhS F23Y mutant enzyme (red), H. py lori 
(blue), and M tuberculosis (yellow) dehydroquinases.
5.4.4 Temperature effect on catalytic activity
Preliminary steady-state kinetics experiments were carried out on SCDHQase, 
MTDHQase and HPDHQase at 37°C. Both MTDHQase and HPDHQase showed an 
increase in activity at 37°C, while SCDHQase showed a minor decrease (data not 
shown).
5.4.5 Characterisation of effects of phosphate and sulphate on type II 
dehydroquinases
The inhibitory effect o f polyanions; sodium sulphate and sodium phosphate on type II 
DHQases was used to give an insight into the differences in substrate specificity o f  
the low and high enzymes. Preliminary results (Frederickson et al., 1999) had 
indicated that phosphate behaves as a competitive inhibitor o f the type II DHQase 
from A. nidulans, with a Kj o f 10 mM at pH 7.0 and 25°C. Studies o f  
bisulphonamides by Arrow therapeutics (2001) revealed moderate inhibition o f type 
II DHQase and dehydroquinate synthase. The anti-microbial effect was also tested 
and shown to have an inhibitory effect on growth on methicillin resistant 
Staphylococcus aureus. Theorell and Nygaard (1954) have also documented the
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strong inhibitory effect of polyanions in flavoprotein systems. The inhibition is 
caused by the tendency of these anions to interact with positive groups of the protein, 
which are essential for the attachment of FMN. Polyanions have been shown to be 
bind more strongly to proteins than monovalent anions (Theorell and Nygaard, 1954).
These studies were extended to other type II enzymes for the polyanionic ligands 
sulphate and phosphate using a combination of kinetic and structural approaches.
Kinetic parameters were obtained by varying substrate concentrations over the 
appropriate range (between 20 pM and 2 mM) in the presence and absence of sodium 
phosphate or sodium sulphate.
Table 15. Inhibtion by polyanions on the kinetic properties of type II DHQases
Enzyme kcat (s'b Km (pM) Ki (phosphate) (mM)
Ki (sulphate) 
(mM)
SCDHQase 124.79 99.17 7 11
HPDHQase 0.94 205.75 9 9
MTDHQase 5.17 23.79 4) V
BSYqhS (F23Y) 0.194 731.79 9 Y
In the presence of phosphate, a complex pattern is observed in which Fmax and are both raised; see 
Figure 51 A.
 ^ In the presence of sulphate, the remains essentially unchanged, but the dependence of on 
sulphate concentration is markedly non-linear, indicating that the anion may bind to multiple sites on 
the enzyme.
In the presence of sulphate, The is not significantly affect, while decreases as the 
concenti ation of sulphate increases, indicating non-competitive inhibition.
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Figure 50. Inhibition o f S. coelicolor  and H. p y lori type II dehydroquinases by 
phosphate and sulphate. A: Lineweaver-Burk plot for inhibition o f  
SCDHQase by phosphate. B: Ratio o f K^/Km  vs. [phosphate] for 
SCDHQase. C: Lineweaver-Burk plot for inhibition o f SCDHQase by 
sulphate. D: Ratio o f K^/Km  vs. [sulphate] for SCDHQase. E: Lineweaver- 
Burk plot for inhibition o f HPDHQase by phosphate. F: Ratio o f vs.
[phosphate] for HPDHQase. G; Lineweaver-Burk plot for inhibition o f  
HPDHQase by sulphate. H: Ratio o f K^/Km  vs. [sulphate] for HPDHQase. 
Km and Km^  values are the Michaelis constants for dehydroquinate in the 
absence and presence o f  either phosphate or sulphate.
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Figure 51. Inhibition o f M  tuberculosis type II dehydroquinases and B. subtilis YqhS 
(F23Y) by phosphate and sulphate. A; Lineweaver-Burk plot for inhibition 
o f MTDHQase by phosphate. B: Ratio o f K^IK^  vs. [phosphate] for 
MTDHQase. C: Lineweaver-Burk plot for inhibition o f MTDHQase by 
sulphate. D; Ratio o f KmlK^ vs. [sulphate] for MTDHQase. E: 
Lineweaver-Burk plot for inhibition o f B. subtilis YqhS (F23Y) by 
phosphate. F: Ratio o f Km/Km vs. [phosphate] for B. subtilis  YqhS (F23Y). 
G: Lineweaver-Burk plot for inhibition o f B. subtilis YqhS (F23Y) by 
sulphate. Km and Km values are the Michaelis constants for dehydroquinate 
in the absence and presence o f  either phosphate or sulphate.
The effects o f phosphate and sulphate on the kinetic properties o f DHQase are shown 
in Table 15, Figure 50 and Figure 51. The polyanions both behave as simple 
competitive inhibitors with respect to dehydroquinate for SCDHQase and HPDHQase 
(Figure 50 A-H). In contrast, in the case o f M tuberculosis DHQase, the effects o f  
the anions were more complex. Although sulphate did not change the Tmax, and thus 
appeared to act as a competitive inhibitor (Figure 5IC), the dependence o f the Km on 
the anion concentration did not follow the expected linear model for simple 
competitive inhibition. In the presence o f phosphate, both Vmsx and Km were 
increased (Figure 51 A). These results indicate that the anions may bind to more than 
one site in M  tuberculosis DHQase, leading to multiple effects on the kinetic 
properties o f  the enzyme.
Phosphate is also a simple competitive inhibitor o f B. subtilis (F23Y) YqhS (Figure 
5 IE). The inhibition o f B. subtilis (F23Y) YqhS by sulphate is more complex; the Km
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is not significantly altered at all concentrations o f sulphate tested while the Tmax 
decreases with an increase in sulphate concentration. Both Lineweaver-Burk plot 
(Figure 51G) and direct non-linear fitting point towards sulphate being a non­
competitive inhibitor o f the YqhS mutant enzyme. This would indicate that sulphate 
binds at a distinct site from dehydroquinate in the YqhS mutant enzyme. However, in 
view o f the limited amount o f  data collected and the low activities observed, it would 
be inappropriate to over interpret these data.
R |9  G26
R108R113
Figure 52. Comparison o f the two active sites o f the two DHQases. Solid Ribbon 
respesentation o f the active sites o f (A) phosphate (PI) bound within the 
active site o f the S. coelicolor  DHQase. (B) M tuberculosis DHQase with 
sulphate ions (SI and S2) bond within the active site. Amino acid residues 
important for ligand binding are shown in stick and coloured according to 
atom type, hydrogen bonds are shown as dashed lines coloured magenta 
(Evans et a i ,  2002).
The crystal structures o f & coelicolor  and M  tuberculosis DHQase in complex with 
phosphate and sulphate respectively, were compared in order to try and interpret the 
efïects o f these polyanions on the kinetic parameters o f the enzymes. The protein 
folds are very similar and overlay well. The M  tuberculosis DHQase structure has 
two sulphates in the active site compared with the single phosphate in S. coelicolor  
DHQase, this is consistent with the more complicated kinetics seen in the former 
enzyme. Unexpectedly, the single phosphate bound to S. coelicolor  DHQase does
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not con'espond to either of the sulphates bound in the active site of M. tuberculosis 
DHQase. This finding could be interpreted structurally as the result of the differences 
between the two ligands. The phosphate ion possesses a protonated oxygen 
(hydroxyl) while sulphate does not, this protonated oxygen of the phosphate could 
bind in the analogous position to the Cl hydroxyl of the substrate while this 
conformation would not be as favourable for sulphate. However, the structure of the 
S. coelicolor DHQase structure with sulphate bound has been solved at 2.8 Â 
resolution and the anion occupies exactly the same position as is observed in the 
higher resolution phosphate structui'e (Roszak et a l, 2002). Figure 52 shows a 
comparison of the two active sites of the two DHQases. The phosphate bound within 
the active site of the S. coelicolor DHQase (Figure 52A) forms several hydrogen 
bonds with key catalytic residues and occupies an analogous position to the 
carboxlyate and Cl hydroxyl of the substrate. In the structui’e of M tuberculosis 
DHQase (Figure 52B), the SI sulphate is located in this region, but adopts a different 
conformation from the PI phosphate seen in the S. coelicolor enzyme. The SI 
sulphate forms hydrogen bonds with the catalytically important residues SeiT03 and 
Asn75 representing the common position of two of the oxygens of the phosphate 
anion. However, HislOl hydrogen bonds to a water molecule rather than the 
sulphate, and the catalytically important tyrosine in the lid domain does not close 
over the active site and interact with the sulphate. Instead Argl9 has moved much 
further into the active site than observed in the S. coelicolor DHQase structures, and 
is able to form a hydrogen bond with the sulphate. The second sulphate ion also 
interacts with this arginine and also with residues at the N-terminal end of the flexible 
lid domain.
5.5 Chapter summary
Type II DHQases fall broadly into two categories: high and low enzymes. Protein 
sequence alignments and analysis of the 3-dimensional X-ray structui’es of type II 
DHQases show high homology between the structures of the high and the low 
activity DHQases. They also seem to share several biophysical properties including 
high stability in the presence of dénaturant and no observed lag or burst phase using 
stopped-flow kinetics. pH dependence studies provided evidence that all the type II 
DFIQases tested shared a common catalytic mechanism. However, studies on M 
tuberculosis and A. nidulans type II DHQase performed by Harris et al. (1996b)
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showed significant differences in solvent and substrate isotope effects between these 
enzymes. The relationship between the VJV^ ratio and the fraction of ^H in the 
solvent of the assay (n) {Vn is the rate of reaction when the a fraction of deuterium 
(^H) in the solvent is n and Vo is the rate when ?? = 0) suggests that a single proton 
contributes to the isotope effect in the MTDHQase, whilst the results for A. nidulans 
enzyme suggest that at least two protons contribute to the observed effects. Substrate 
isotope effects also reveals differences in Vmm and Fmax/X,n between the two enzymes. 
The step in the mechanism that contributes to the substrate isotope effect is thought to 
occur at different points on the free-energy profile of the MTDHQase and A. nidulans 
dehydroquinase reactions; the highest point and the transition state with the highest 
energy, respectively (Harris et al., 1996a). Unfortunately it was not possible to 
determine pXa values for the DHQases tested as there were problems caused by 
substrate instability at pH values higher than 8.0 (L. Noble, personal communication).
It was originally thought that subtle structural changes especially in the lid domain 
caused by low levels of dénaturant were responsible for the observed increases in the 
catalytic activity in the presence of IM GdmCl. The 3-dimensional X-ray structures 
of two low enzymes (MTDHQase and HPDHQase) show that both have 
disordered lid domains. The lid domain is thought to be more flexible in these 
enzymes. Analysis of the protein sequence of the lid domain of all the type II 
DHQases tested shows no significant differences between the amino acid side chains 
which would account for the extra flexibility in this domain (Appendix C; Error! 
Reference source not found.). Unfolding studies using urea as a dénaturant 
indicated that increased activity caused by guanidine hydrochloride is not due to an 
increase in flexibility, but rather to the presence of chloride ions. In contrast B. 
subtilis YqhS mutant (F23Y), a low enzyme, does not show an increase in activity 
in the presence of low concentrations of chloride. This indicates that not all low k^ ai 
enzymes show the same chloride effect. However it should be noted that the B. 
subtilis YqhS enzyme is not a true DHQase (CHAPTER 4) and it is possible that 
different factors are responsible for the low catalytic activity of the YqhS (F23Y) that 
are not involved in the evolution of the other low kcat DHQases.
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Figure 53. 3-dimensional structure o f  M  tuberculosis dehyroquinase in complex with 
2,3-anhydro-quinic acid and chloride ions. (A) M tuberculosis DHQase 
dodecamer, secondary structural features are represented in flat ribbon and 
strands, subunits are individually coloured, chloride ions are shown as 
yellow balls. (B) Interactions o f  chloride ions (CIl, 2) at subunit interface; 
amino acids highlighted in green are involved in the coordination chloride 1 
(ClI) and highlighted in magenta are residues which interact with chloride 2 
(C12). Catalytic side chains (HlOl and E99) are represented by their 
electrostatic charge. (C) The potential stabilisation o f the minor loop 
domain by two chloride 2 ions involving 5 subunits. 2,3-anhydro-quinic 
acid (F A l) is shown as a ball and stick representation while the catalytic side 
chains are represented as colour-coded stick models (carbon atoms are 
shown in green, oxygen atoms shown in red and nitrogen atoms shown in 
blue). Amino acids are labelled according to the M tuberculosis numbering 
system and numbers are coloured according to their respective subunit.
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Several differences between the type II DHQases have been identified in this study. 
Low concentrations of chloride have been shown to increase the catalytic activity of 
both MTDHQase and HPDHQase while the same concentration of chloride lowers 
the catalytic activity of SCDHQase and B. subtilis YqhS (F23Y). Chloride ions are 
present in the X-ray structure of the M tuberculosis enzyme in complex with the 
inhibitor 2,3-anliydro-quinic acid (FAl); as a result of the crystallisation conditions 
used to obtain crystals for diffraction. In total there are 18 chloride ions within the 
dodecamer (Figure 53A), 1.5 per subunit. The chloride ions are found in two distinct 
orientations within the dodecamer. Six chloride ions (choride 1, Cll) are located at 
subunit interfaces (Figure 53B) and form hydrogen bonds with the imidazole rings of 
a pair of histidine residues (His 106), V ail24 and Val 126 are approximately 4.5 Â 
(using the M tuberculosis numbering system for amino acids) from neighbouring 
subunits. The other twelve chloride ions (chloride 2, C12) are located behind the 
minor loop domain of the active site (Figure 53C); this loop domain contains the 
catalytic residue ArglOS, responsible for the localised pXa effect on Tyr24 (thought to 
be involved in proton abstraction, CHAPTER 3). Chloride 2 forms hydrogen bonds 
with Ai’g ll3  and is 4 À away from P h e lll both of which are located on the minor 
loop domain, but interact with different chloride 2 ions. P ro ll6  from the 
neighbouring subunit is 3.7 Â away from chloride 2 and possibly forms weak Van der 
Waals interactions. The main chain amide group of TyiT16 from the same 
neighbouring subunit is 5 À away from the chloride 2 ion.
Chloride 1 is thought to have a role in the stabilisation of the quaternary structure of 
MTDHQase. It is also possible that chloride 1 has some indirect affect on the 
catalytic residues HislOl and Glu99 (likely candidates to be involved in donation of a 
proton to the hydroxyl at Cl of dehydroquinate, CHAPTER 3) on the neighbouring 
P"Strand (Figure 53B). Two C12 ions are thought to be involved in an increase in the 
stability of the minor loop domain of the active site. The orientation of ArglOB is 
important for catalytic activity and the extra stability of the minor loop domain may 
account for the moderate increase in activity observed in MTDHQase in the presence 
of 0.5 M chloride ions.
The B-factors of Cll and C12 in the X-ray structure of M. tuberculosis are 37 and 28 
Â, respectively giving an indication of their mobility and consequently order in the 
structure. This suggests that C12 is more precisely located and therefore more likely
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to be involved in the increase in catalytic activity. In contrast Cll interacts weakly 
with V ail24 and 126 and the indirect effect on HislOl and Glu99 is less likely. C12 
may bind more tightly so be present at low chloride concentrations and therefore 
represent the site of binding for chloride.
Without 3-dimensional structural data on the binding of chloride to SCDHQase it is 
difficult to propose a reason for the reduction in catalytic activity observed. In the 
SCDHQase 3-dimensional structui'es reported by Roszak et ah, (2002) histidine 
residues (H ill,  H106 in MTDHQase) from neighbouring subunits make the largest 
single contribution (83 Â^) to the buried surface area at the dimer interface. As in the 
MTDHQase structure the two imidazole rings of the histidines point toward each 
other, restricting the size of the solvent cavity, which is occupied by water. In the 
presence of chloride ions it is conceivable that these interactions maybe disrupted 
causing the observed decrease in catalytic activity.
The polyanions, sulphate and phosphate were found to be simple competitive 
inhibitors with respect to dehydroquinate for SCDHQase and HPDHQase as 
previously observed in A. nidulans (Frederickson et aL, 1999). In contrast the effect 
of polyanions on MTDHQase was more complex. The results of MTDHQase kinetic 
studies in the presence of phosphate indicated that the anions bind to more than one 
site, leading to multiple effects on the kinetic properties of the enzyme. Phosphate is 
a simple competitive inhibitor with respect to dehydroquinate and sulphate is 
surprisingly a non-competitive inhibitor for B. subtilis YqhS (F23Y) protein, although 
it should be noted that enors associated in measuring the low activity of the YqhS 
mutant and the limited amount of data that was collected may have affected these 
data. The X-ray crystallographic data on the enzymes fiom S. coelicolor and M 
tuberculosis with phosphate and sulphate bound respectively identify significant 
differences in both the mode of binding and number of polyanions bound by the two 
enzymes. The differences in binding of the anion to the carboxylate recognition site 
of the enzymes may account for the relative potencies of several rationally designed 
inhibitors (Frederickson et ah, 1999). A greater understanding of the differences in 
binding of known inhibitors of type II DHQases may lead to fuither selectivity.
Analysis of the crystal structure of S. coelicolor DHQase with various ligands bound 
in the active site, such as phosphate, the transition state analogue 2,3 -anhydro-quinic 
acid and dehydroshikimate (R23A mutant SCDHQase) reveals that the main chain
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amide nitrogens of Seri 08 and He 107 to bond to the carboxylate group. Phosphate, 
which is a competitive inhibitor of S. coelicolor DHQase, mimics the carboxylate 
group. Seri 08 binds to the carboxylate of dehydroquinate. Seri 08 is probably 
responsible for substrate recognition and orientation (Roszak et al., 2002; Evans et 
fl/., 2002; 3.5).
Four sulphate molecules were identified in the MTDHQase structure, with two lying 
in the active site of the enzyme. Neither binding position of the sulphate molecules 
was analogous to the location of the phosphate molecule in the SCDHQase structure. 
The catalytic lid domain is disordered as in the apoenzyme structure. The first 
sulphate molecule (SI, Figure 52) in the active site is positioned in the carboxylate 
binding site as identified from the SCDHQase-inliibitor complexes, the second 
sulphate molecule (S2 , Figure 52) interacts with the amide nitrogens of residues 17- 
19 and the side chain of Argl9. The binding of a second anion in the position of the 
lid domain of the M. tuberculosis DHQase structure may help to explain the complex 
kinetic effects of the polyanions observed for this enzyme. The finding that the 
sulphate anion does not occupy the same position as the Cl hydroxyl and carboxylate 
of the substrate helps to explain differences in the inhibition of type II DHQases. A 
number of selective inhibitors have been synthesized by Frederickson et al., (1999) 
including the transition state analogue 2,3 -anhydroquinic acid and its oxime 
derivative. These inhibitors contain all the structural features of the substrate and 
transition state respectively, with the exception of the C3 carbonyl which is absent. 
The K{ values for these inhibitors were two-fold and nine-fold lower respectively for 
SCDHQase than for MTDHQase therefore polyanions do not bind as tightly to 
MTDHQase. As the of MTDHQase is lower than SCDHQase, polyanions are less 
effective inhibitors of MTDHQase than SCDHQase. This suggests that while 
recognition of the Cl carboxylate and hydroxyl is the major component necessary for 
the specific binding of substrate to SCDHQase, the C3 carbonyl also plays a 
significant role in substrate binding in MTDHQase, quite possibly by interacting with 
Argl9.
The differences between sulphate and phosphate with respect to both the potency and 
type of inhibition suggest that the X-ray structures of SCDHQase in complex with 
phosphate and MTDHQase in complex with sulphate may not be directly comparable. 
However, a low resolution X-ray structui’e of SCDHQase in complex with phosphate.
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shows phosphate occupies the same location as sulphate in the SCDHQase-sulphate 
structure. The effects of the two poly anions on HPDHQase are analogous to 
SCDHQase. It would be valuable to produce a 3-dimensional structure of 
HPDHQase in complex with polyanions or either a higher resolution structure of 
SCDHQase-phosphate or MTDHQase in complex with sulphate.
During the course of evolution, the catalytic activity of an enzyme is presumably 
optimised by an organism to suit its environment. The availability of the substrate 
and the relative need for the product govern the catalytic parameters. H. pylori and 
M. tuberculosis are both human pathogens which grow at 37°C in contrast to S. 
coelicolor and A. nidulans which both grow at lower fluctuating temperatures found 
in soil where the concentration of quinate (utilised in the catabolic quinate pathway) 
is high.
The effect of salts and polyanions on type II DHQases is complex and does not seem 
to fall into a simple pattern with low and high ÂTcat enzymes. The type of inhibition of 
type II DHQases by polyanions can vary and structural data indicate that mode of 
binding can differ. It would be beneficial to extend this study by analysing type II 
DHQases from other species, for example the Campylobacter jejuni DHQase which 
has been cloned by Prof. Hunter and co-workers at the University of Strathclyde 
(CHAPTER 7). In view of the complexity of effects observed, it is unlikely that one 
single factor is important in determining whether a DHQase has a low or high c^at- 
Rather it is likely that a vaiiety of factors including the flexibility of the active site 
and the nature and orientation of the residues involved in substrate binding and 
catalysis have been employed during evolution in order to match the catalytic 
properties of each enzyme with the metabolic needs of the particular organism.
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CHAPTER 6 HAEMOPHILUS INFLUENZAE
SHIKIMATE DEHYDROGENASE AND RELATED 
YdiB PROTEIN
6.1 Introduction
Shikimate dehydrogenase coded by the aroE gene is present as a monomer in E. coli 
(ECAroE) (Chaudhuri and Coggins, 1985) and exclusively uses NADPH as a 
cofactor (Yaniv and Gilvarg, 1955). In plants shikimate dehydrogenase occurs as a 
bifunctional enzyme (on a single polypeptide chain) with a type I dehydroquinase 
(Koshiba, 1978; Polley, 1978;Mousdale et al., 1987; Deka et al., 1994) this enzyme 
also requires NADPH as a cofactor. Fungi such as Aspergillus nidulans possess a 
pentafimctional arom polypeptide (Charles et a l, 1985), the C terminal domain of 
which carries the shikimate dehydrogenase activity. The organisation of the enzymes 
of the shikimate pathway within different organisms is described further in section 
1.1.3.
Quinate dehydrogenase (qutB) catalyses the conversion of quinate to dehydroquinate, 
which is then connected to protocatechuate via the catabolic quinate utilisation 
pathway (1.2). This pathway shares two metabolites of the shikimate pathway, 
namely dehydroquinate and dehydroshikimate (Giles et ah, 1967; Hawkins et al., 
1993). Some shikimate dehydrogenases are also able to catalyse the quinate 
dehydrogenase reaction. To date tlrree independent families of quinate/shikimate 
dehydrogenases have been identified. The first group are NAD^ dependent 
dehydrogenases and are widespread amongst microorganisms (Lopez Barea and 
Giles, 1978; Hawkins et al., 1993), the second is found in gymnosperms such as 
Pinus taeda and utilises NADPH as a cofactor (Ossipov et al., 2000), whilst the third 
use pyrrolo-quinoline (PQQ) as a cofactor and are almost exclusively found in gram- 
negative bacteria and are often membrane-associated dehydrogenases (Duine, 1991).
Protein sequence analysis of AroE from E. coli using BLAST (Altschul et al., 1997) 
identified approximately 150 sequences, predominantly designated as putative 
shikimate dehydrogenases (Appendix C; Error! Reference source not found.). The 
BLAST analysis also revealed that shikimate dehydrogenases have significant 
sequence homology to NAD^-dependent quinate/shikimate dehydrogenases.
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Several organisms including E. coli, H. influenzae and Deinococcus radiodurans 
possess a second analogue of the shikimate dehydrogenase denoted as YdiB function 
unknown. The existence of a second shikimate dehydrogenase could affect the 
design of potential drugs directed at AroE as YdiB may compensate for any 
inhibition of AroE. There ai e significant differences in sequence between AroE and 
YdiB in the N-terminal region, which is thought to be involved in the binding of the 
Cl carboxylate of dehydroshikimate and in forming the dimer interface (Michel et 
al., 2003). Based on the N-terminal region the YdiB proteins broadly fall in to two 
groups (6.1.1). The first group, which includes the E. coli YdiB protein (ECYdiB), 
are more closely related to the majority of the AroE proteins than the second group, 
which includes one of the proteins in this study namely YdiB from H. influenzea 
(HIYdiB). The differences between the two groups are discussed in detail below.
pH dependence studies on the bifunctional plant shikimate dehydrogenase family 
have been performed including Pisum sativum (Balinsky and Davies, 1961a; Dennis 
and Balinsky, 1972), Camellia sinensis L. (Sanderson, 1966) and Finns taeda 
(Ossipov et al., 2000). These showed the rate of the reverse reaction (foiTuation of 
dehydroshikimate from shikimate) to be maximal at pH 10.0-10.6. The overall trend 
of pH dependence points towards a similar mechanism being adopted in each of the 
enzymes tested. pH dependence experiments on Phaseolus aureus showed an 
optimum rate at pH 8.0 although the enzyme was only partially purified (Nandy and 
Ganguli, 1961). pH dependence experiments performed on the crude ECAioE 
(Yavin and Gilvarg, 1955) indicated a pH optimum of 8.5. The difference in the pH 
optima for the plant and bacterial enzymes could be due to the fact that the bacterial 
enzyme was not fully saturated with the cofactor (Balinsky and Davies, 1961b).
The catalytic properties of ECAioE and EC YdiB were determined for the reaction in 
reverse direction (shikimate to dehydroshikimate) in lOOmM Tris HCl (pH 9.0) by 
Michel et al., (2003). ECAroE oxidises shikimate exclusively using NADP^ as a 
cofactor with a Xnadp of 0.056 mM, Xshk of 0.065 mM and the Aicat was found to be 
260 s '\  Unusually EC YdiB is able to oxidise both shikimate and quinate with either 
NAD"  ^or NADP^ as the cofator. The Xnad and Xnadp were found to be 0.087 mM 
and 0.1 mM respectively using shikimate as substrate and 0.116 mM and 0.5 mM 
respectively using quinate as substrate. The cofactor also has an effect on the binding 
of the substrate in the presence of NAD^. The Kshk and Xqut values are 0.0205 mM
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and 0.041 mM respectively, while in the presence of NADP^ the values are much 
higher 0.12 mM (Kshk) and 0.555 mM (Xqut)- Using shikimate as a substrate the 
activity of EC YdiB is -1700-fold lower than ECAroE with kcat values of 0.0624 and 
0.156 s'^  using NAD"  ^ and NADP^ as substrate respectively. The catalytic activity 
with quinate is also extiemely low for both NAD^ and NADP^ (kcat- 0.0416 and 
0.0625 s '\  respectively).
The E. coli ydiB and aroE proteins share 25% sequence identity, and X-ray structures 
of both the proteins have been reported (Michel et a l, 2003). Despite there being 
relatively low sequence homology between E. coli AroE and YdiB, the two enzymes 
have highly similar 3-dimensional structures and adopt the same fold. The EC YdiB 
protein has an extended loop region (residues 176-182), which is typical of the first 
group of YdiB proteins. It is unclear what role the extended loop region plays in the 
protein, since X-ray structural data show that the loop is not close to either the 
substrate or the cofactor. Dynamic light scattering experiments on the EC YdiB 
revealed that it has a hydrodynamic radius consistent with a globular protein of 
approximately 60 kDa, indicating that EC YdiB occui'S as dimers (Michel et al., 
2003). The dimer interface contains several hydrophobic residues that are not present 
in the monomeric ECAroE.
6.1.1 Substrate binding domain and reaction mechanism
To date there is no X-ray structure of a substrate analogue bound to any enzyme of 
the shikimate dehydrogenase family. The active site has been identified by the 
position of the nicotinamide ring of the cofactor. The presence of a sulphate or 
phosphate ion within the substrate-binding pocket of the ECAroE and ECYidB, and a 
DTT molecule in the ECAroE structui’e are the result of the crystallisation conditions 
(Figure 54). These reagents give clues to the orientation of the substrate in the 
enzyme binding site. The X-ray structui’es reveal a closed conformation only in the 
presence of the DTT molecule (ECAroE, molecule A) and it is proposed that the 
conformational change which closes the central cleft occurs on substrate binding 
(Michel et al., 2003). Studies on glyceraldehyde-3-phosphate dehydrogenase from 
rabbit muscle provided strong evidence for ligand-induced conformational changes 
which cause negative cooperatively in binding of cofactors of different subunits 
(Flenis and Levitzki, 1980). Chemical modification experiments of ECAroE
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(Chackrewarthy, 1995) identified Lys65 and His 13 as either being involved in the 
catalytic mechanism or being close to the binding site for shikimate.
H s 13
Ser 14
Ser 16
Tyr215
Gin 244
r  NADPH
Asp 102
Figure 54. X-ray structure o f ECAroE-NADP^ complex substrate binding pocket 
with bound sulphate (81) and DTT molecules represented as ball and stick 
(carbon atoms in green), highlighted protein side chains are colour coded 
according to the type o f  amino acid and labelled according to the ECAroE 
sequence. The proposed position o f dehydroshikimate is represented by the 
red ghost overlay.
The N-terminal domain is involved in substrate binding and recognition and typically 
the sequence pattern for shikimate dehydrogenase (AroE) is G-N-P-l-X-[H,q]-S-K-S- 
P (where X is variable). The ECYdiB was chosen for further analysis as it is closely 
related to the AroE group and represents one group o f YdiB proteins characterised by 
the sequence pattern [M,i]-[A/G]-[Y,t]-P-I-H-S-[L,k]-S-P within the N-terminal 
region. HIYdiB represents the second group, the substrate binding domain deviates
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quite considerably from the AroE shikimate dehydrogenases with the N-terminal 
sequence being: C-[M/I]-S-L-[A,s]~[A,g]-R-P. However, there are similarities 
between these regions, the S-[L,k]-S and C-[M/I]-S sequences in ECYdiB and 
HIYdiB, respectively may perform the same role in these proteins, it would be 
valuable to produce an X-ray structure of HIYdiB to determine the orienation of 
specific residues. The second group of YdiB proteins also has a highly conserved 
insertion of four amino acids after the substrate binding domain: [R,t,a,q]-F-H-N.
Using stereo specifically labeled cofactors and substrate it was possible to determine 
that hydride transfer takes place fi'om the A-side of the nicotinamide ring of NADPH 
(Dansette and Azerad, 1974), which is consistent with the orientation of the cofactor 
in the X-ray structure of both ECAroE and ECYdiB (Michel et ah, 2003). The C3 of 
either dehydroshikimate or quinate must be positioned to accept/receive the hydrogen 
from C4 of the nicotinamide ring.
The conserved serine side chains near the N-terminus of the AroE enzymes (SI4 and 
SI6  in ECAroE) are expected to be involved in the binding of the carboxyl at Cl. 
Tyr215 of ECAroE is also thought to establish an additional hydrogen bond with the 
carboxylate group (Figure 54). The serine and tyrosine residues are present in the 
HI AroE and ECYdiB, but there are significant differences in the HIYdiB substrate- 
binding pocket. There is only one conserved serine residue in the N-terminal domain 
and an alanine side chain replaces the tyrosine side chain. The C5 hydroxyl of the 
substrate is expected to form hydrogen bonds with a glutamine residue (Q244 in 
ECAroE) present in all the shikimate dehydrogenase family.
The invariant residues Lys65 and Asp 102 are the most likely candidates to donate a 
proton to the C3 carbonyl of the substrate, as they are orientated toward the substrate- 
binding pocket in which the DTT molecule is present (Figure 54). Another contender 
for the role of proton donor is Hisl3; this residue was highlighted by pH dependence 
of the inactivation of ECAroE by diethylpyrocarbonate (DEPC), which is a histidine- 
specific reagent (Chacki’ewarthy, 1995). However, in the X-ray structure His 13 is not 
correctly orientated to perform this role and is some distance away from the cofactor 
(Michel et ah, 2003).
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6.1.2 Binding specificity of the cofactor
Interestingly unlike most dehydrogenases that utilise NAD or NADP as a cofactor 
(Carugo and Argos, 1997a), the shikimate dehydrogenase family does not show a 
strong preference for either cofactor. NAD and NADP are stereochemically similar 
the only difference being a phosphomonoester on the C2 of the ribose attached to the 
adenine ribose of NADP. They both show different biochemical reactivities with 
NAD"  ^ behaving being almost exclusively involved in oxidative catabolism and 
NADPH serving as a reductant, confined with few exceptions to the reactions of 
reductive biosynthesis (Carugo and Argos, 1997a).
The comparison of the cofactor binding sites within the shikimate dehydrogenase 
family is of interest as it reveals the structural features necessary to discriminate 
between NADP and NAD, The amino acid sequence of ECAroE between residues 
121 and 151 exhibits the characteristic ‘finger prinf of an ADP-binding pap-fold 
(Anton and Coggins, 1988). The charge of the side chain of the residue in the final 
position of this ‘fingerprint’ determines whether the enzyme is able to accommodate 
the 2’ phosphate group of the adenosine moiety (Wierenga et a l, 1986). Chemical 
modification experiments using PGO on ECAroE revealed that an arginine side chain 
either forms part of, or is situated close to, the NADP binding site (Chacki*ewarthy, 
1995). The protein sequences (Appendix C; Error! Reference source not found.) of 
the H. influenzae homologues were analysed using the X-ray structure data for 
ECAroE and ECYdiB (Figure 55). An invariant arginine side chain stacks against the 
A face of the adenine ring of the cofactor. The B face of the adenine ring is 
orientated by a serine side chain in the NADPH-dependent ECAroE (SI90) and H. 
influenzae shikimate dehydrogenase (HIAroE S I89). This is replaced by a valine in 
the NAD-dependent ECYdiB (V206) and an isoleucine in H. influenzae YdiB protein 
(HIYdiB 1185). The substitution of the serine to valine causes a shift in the position 
of the A face arginine and affects the arrangement of the adenosine moiety 
recognition and binding loop (Michel et al., 2003). Ilel85 of the HIYdiB could also 
cause a shift in the position of this loop.
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Arg150
i
IGly134
Figure 55. Comparison o f the cofactor recognition and binding site o f  ECAroE (A) 
and ECYdiB (B). NADP^ and NAD^ are represented as ball and stick 
(carbon atoms in green), protein side chains colour coded according to the 
type o f amino acid and labelled according to their appropriate protein 
sequence. The protein backbone and secondary structural features are 
represented by a solid ribbon.
In the ECAroE structure the invariant arginine side chain (R150) also forms an 
“electrostatic clamp” with another arginine (R154) and plays a crucial role in the 
binding o f the adenosine phosphate o f  NADP (Michel et a i ,  2003). Argl54 is 
replaced by a lysine in both the H. influenzae AroE and YdiB. The X-ray structure o f  
the ECAroE-NADP^ complex (Figure 55A) shows that the invariant asparagine 
residue (N149) forms a hydrogen bond with the hydroxyl group at the 0 3 ’ position o f  
the adenosine ribose. In the ECYdiB-NAD^ complex (Figure 55B), the asparagine 
side chain (N 155) adopts a different position and together with an aspartic acid side 
chain (D158 in ECYdiB), forms hydrogen bonds to the 0 2 ’ hydroxyl o f the 
adenosine ribose. In the HIYdiB sequence A rgl50 and A snl49 are in the reverse 
order (Argl51 and A snl52, HIYdiB numbering o f amino acids) this may cause shifts 
in the orientation o f the residues around this region.
NADP binding is thought to be favoured by the HIAroE as it retains a threonine 
(Thrl51) which creates a polar environment for the phosphate group o f  the adenosine 
moiety. In the ECYdiB this residue is replaced by a phenylalanine (PheI60) which 
creates a neutral environment for the 0 2 ’ hydroxyl group o f NAD^(Michel et a i .
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2003). HIYdiB possess a valine in place of the threonine that could potentially affect 
the polar environment of the phosphate-binding pocket, since the valine side chain is 
hydrophobic. However, due to the difference in the order of the amino acid residues 
this is unlikely.
The binding of the nicotinamide and pyrophosphate moieties of the cofactor should 
be analogous in ECAroE and ECYdiB. The amide group of the nicotinamide ring is 
hydrogen bonded to an invariant glycine side chain and a methionine or cysteine side 
chain in ECAroE and ECYdiB respectively. Both the K  influenzae homologues 
possess a methionine in this position.
Throughout the shikimate dehydrogenase family the pyrophosphate moiety binds to a 
glycine rich loop (residues 126-131 in ECAi’oE) (Michel et al., 2003). The sequence 
pattern is a modification of the canonical pattern identified in NAD’^ -dependent 
dehydrogenases (Carugo and Argos, 1997b). Interestingly the group of YdiB 
proteins (which includes HIYdiB) with a lower sequence homology to the Ai'oE, has 
a conserved serine (SI27) and a methionine (M l30) within the pyrophosphate 
binding motif; however detailed analysis of both the X-ray structures suggests that 
this is unlikely to affect binding of the pyrophosphate moiety. The glycine rich loop 
also forms a hydrogen bond with the 0 3 ’ hydroxyl group of the adenosine ribose 
unit.
6.1.3 Inhibitor and analogue studies of shikimate dehydrogenase
Balinsky and Davies (1961b) performed inhibitor studies using a variety of phenolic 
compounds. These studies revealed that the Pisum sativum bifunctional enzyme 
bound to the substrate by means of the Cl carboxyl and the hydroxyl groups at C4 
and C5 and identified vanillin, gallic acid and p-hydroxybenzoic acid as inhibitors. 
On the basis of this evidence, Baillie et al., (1972) synthesized various novel 
dehydroshikimate analogues from l,6-dihydroxy-2-oxoisonicotinic acid (Figure 56). 
The analogues were tested for inhibition of the Pisum sativum enzyme and couch 
grass enzyme. Several of these analogues were found to be reversible competitive 
inhibitors with K{ values ranging from 0.07-0.8 mM for the Pisum sativum enzyme. 
Intriguingly compounds found to be competitive in the reverse direction for the 
bifunctional enzyme of Pisum sativum such as l,6-dihydroxy-2-oxoisonicotinic acid, 
were shown to have no inhibition in the forward reaction despite the structure of the
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compound being more closely related to dehydroshikimate than to shikimate (Baillie 
et ah, 1972). This anomaly was attributed to the difference in the binding of the 
substrate in the presence ofNADP^ and NADPH (Dowsett et aL, 1972).
Several structural analogues of shikimate were tested as possible inhibitors of the 
Pisum sativum bifunctional enzyme. Methyl vanillate, syringate and p- 
hydroxybenzaldehyde (Figure 56) were found to be competitive inhibitors (73, 61 and 
17% loss in activity respectively) these studies highlighted the importance of the C4 
hydroxyl for substrate binding and revealed that substitutions larger than -OCH3 in 
the C3 position and -CO 2 H in the Cl position were not inhibitory because of steric 
hindrance to binding (Dennis and Balinsky, 1972).
Gallic acid, thought to be an inhibitor of the plant bifunctional enzyme of Pisum 
sativum, has been shown to be a substrate for the production of hydrolysable tannin 
synthesis. In the case of mountain birch (Betula pubescens ssp. czerepanovii) 
shikimate dehydrogenase (Ossipov et al., 2003) these studies used HPLC to analyse 
the concentration of gallic acid formed from dehydroshikimate. Assays were stopped 
by the addition of 6  M HCl followed by centrifugation.
Product inhibition and isotope studies on the Pisum sativum bifunctional enzyme and 
the dissociation constants of the cofactor of this enzyme have shown an ordered BiBi 
mechanism with NADP likely to bind first followed by dehydroshikimate (Dowsett et 
ah, 1972; Balinsky e/a/., 1971).
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Figure 56. Substrate analogues and inhibitors of the shikimate dehydrogenase family.
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Substrate analogues which lacked either the C5 or both the C5 and C4 hydroxyl 
groups were tested on ECAroE by steady state kinetics in the forward direction (Bugg 
et aL, 1988). On removal of the C5 hydroxyl group (producing 5-deoxy-analogue 
Figure 56) only moderate specificity was lost between the substrate and the enzyme, a 
1.56-fold increase in Æm and 25% reduction in kcat. There is a substantial increase in 
Km to 17 mM (a 189-fold increase) on the removal of both the C5 and C4 hydroxyl 
group (dideoxy analogue Figure 56) (Bugg et aL, 1988), Apparent binding energies 
(AGapp) were calculated from the ratio kcJKm for each of the analogues. AGapp can be 
used as an approximation of the true enzyme-substrate binding interaction and the 
classification of hydrogen bond interactions which fall into two groups: uncharged 
(2.0-7.5 kJ mol"^) and charged (12.5-25 kJ mol'^) donor/acceptor interactions (Fersht, 
1988). The removal of the C-4 hydroxyl group gives a AGapp value of 29.0 kJ mol'^ 
suggesting that the C4 hydroxyl forms important hydrogen bond interactions with a 
charged residue such as a lysine or a cysteine (Bugg et aL, 1988), X-ray data suggests 
that this is most likely to be Lys65 (Michel et aL, 2003).
6.2 Construction, over expression and purification of H, influenzae 
shikimate dehydrogenase and the related YdiB protein
6.2.1 Purification of Æ influenzae shikimate dehydrogenase
The pTB361 aroE construct was gifted by S. Campbell (University of Glasgow). The 
aroE construct was transformed into E. coli over-expression strain BL21 (DE3) 
pLysS (2.10). Cell growth was monitored by measuring A^ oo; once the absorbance 
had reached 0.6, the expression of protein was induced by addition of 0.8 mM IPTG. 
The time course of the induction is shown in Figure 57. The pTB361 H. influenzae 
aroE construct was grown for a further 6  hours after induction, yielding 10.4 g wet 
weight of cells from 11 x 0.5 litres of LB medium. Shikimate dehydrogenase was 
purified using the methods of Chaudhuri and Coggins, (1985) and Maclean et aL, 
(2000), as outlined in section 2.12.3. The elution profile of the DEAE Sephacel 
column is shown in Figure 58. The final purification step (ADP affinity column) was 
omitted as the protein was considered to be of a sufficient purity after gel filtration on 
Sephacryi 200 (Figure 59). The enzyme was then dialysed against 50mM Tris HCl, 
200 mM KCl, 50% glycerol (v/v) and stored at -20°C. The protein concentration 
was 18 mg/ml as determined by absorption at 280 nm (2.13).
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Figure 57. SDS PAGE analysis o f  the time course o f expression o f H. influnzae 
shikimate dehydrogenase (HIAroE) in pTB361-BL21 (DE3) pLys S 
construct. Lane 1 : Boehringer Mannhiem marker low-range, lanes 
3,5,7,9,11 and 13; Control without 0.8 mM IPTG from 0-6 hours. Lanes 
2,4,6,8,10,12 and 14: Induced by addition o f 0.8 mM IPTG from 0-6 hours 
(one hour increments).
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Figure 58. The elution profile from DEAE Sephacel column during purification o f H. 
influenzae shikimate dehydrogenase (HIAroE). Absorbance at 280 nm 
represented by green triangles. Shikimate dehydrogenase activity is shown 
as blue cirlces. Fractions that were pooled are shown between the dash 
black lines.
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Figure 59. SDS PAGE of Sephacryi 200 fractions during purification of H. 
influenzae shikimate dehydrogenase. Lane 1 : Boehringer Mannhiem marker 
low-range, lane 2: E. coli pTB361 aroE-BL2\ (DE3) pLys S construct crude 
extract. Lanes 3-8: fractions 50 to 75 with (5 fraction increments) eluted 
from Sephacryi 200. Lanes 9-15: fractions 80 to 87 eluted from Sephacryi 
200.
6.2.2 Cloning and over-expression of H. influenzae of YdiB protein
'IhQydiB gene was cloned from H. influenzae genomic DNA (2.2.4) using PCR (2.6).
Two PCR primers were designed by S. Campbell and are shown below:
PI. 5’ TATAAGGAGACCATATGATCAACAAAG 3’
P2. 5’ AACACAATGTACCAGATCTTTATTTC 3’
The PCR primers were designed with mismatches incorporated into them to (shown 
in bold) to add in endonuclease restriction sites, Nde I and Bgl II respectively, at 
either end of the ydiB gene. The mismatches did not effect the sequence of the gene. 
The PCR reaction contained 0.5 ng of genomic DNA as the template for 
amplification, 50 pmol of each primer PI and P2, 0.2 mM of each dNTPs, 5 units Taq 
DNA polymerase (Promega), 1:10 dilution of lOx Taq reaction Buffer (500 mM KCl, 
100 mM Tris-HCl, pH 9.0, 1.0% Triton® X-IOO) an additional 0.5 pi of 50 mM 
MgS0 4  in a total volume of 50 pi made up with sterilised water.
The BioRad Gene Cycler program included 3 elements: a hot start at 95°C for 7 
minutes, 35 cycles of amplification consisting of an annealing temperature of 54°C
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for one minute, an extension period of 1 minute at 72°C and a dénaturation step of 
95°C for 1 minute followed by annealing for 1 minute and elongation for 7 minutes. 
4 pi of PCR product was separated and analysed by agarose gel electrophoresis using 
XIV DNA marker (Roche) (Figure 16). Fragments of the appropriate size were 
purified by extraction from the gel (2.7.4).
1 2 3 4 5
Figure 60.1% DNA agarose gel of H. influenzae PCR. Lane I: XIV DNA marker 
(Roche), lanes 2-5: 4 pi of PCR product.
Originally the primers were designed to ligate the ydiB gene directly into an 
expression vector. This approach was found to be unreliable as it was difficult to 
confirm whether the PCR product had been digested properly prior to ligation. The 
pUni/V5-His-TOPO® Echo^^ Cloning system from Invitrogen was utilised to clone 
the PCR product containing the ydiB gene. The TOPO® cloning reaction included 1.5 
pi of gel purified PCR product (50 ng), 1 pi of pUni/V5-His-TOPO® (I ng) and I pi 
of salt solution (1.2 M NaCl; 0.06 M MgCb) in a total volume of 6  pi made up with 
sterilised water. TOPO® cloning reactions were incubated at 20°C for 25 minutes. 
2pi of the TOPO® cloning reaction was transformed into E. coli competent cells 
strain; PIRI (supplied by Invitrogen). The transformation protocol is described in 
section 2.8.2 and then checked by restriction digest with endonucleases: Nde I, Sac I 
and Bgl II. Once the pUni/V5-His-TOPO® construct had been generated, it was
ligated into pTB361 using the restriction sites Nde I and Sac I. The ligation reaction 
consisted of approximately 5 ng of digested vector, 80 ng of digested insert DNA 
{ydiB gene), I unit of T4 DNA ligase with lxT4 ligase buffer (Boehringer 
Mannheim) with sterilised water added to a total volume of 20pl. The reaction was 
incubated for 16 hours at room temperature. lOpl of the ligation reaction was
Page 190
CHAPTER 6 H. influenzae Shikimate dehydrogenase
transformed into JM109 competent cells (2.8.2). Plasmid purifications were 
performed on colonies resistant to tetracycline (12.5 pg/ml). Restriction digest 
analysis was used to identify successful ligations. The pTB361 ydiB construct was 
sequenced by the University of Glasgow Functional Genomics Sequencing Facility 
(2.9).
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Figure 61. SDS PAGE analysis of the time course expression of expression of H. 
influnzae shikimate dehydrogenase related protein YdiB (HIYdiB) in 
pTB361-BL21 (DE3) pLysS construct. Lane 1; Boehringer Mannhiem 
marker low-range, lanes 3,5,7,9 and 11 : Control without 0.8 mM IPTG from 
0-6 hours. Lanes 2,4,6,8,10 and 12: Induced by addition of 0.8 mM IPTG 
from 0-6 hours (one hour increments). Lanes 13 and 14: overnight control, 
and induced, respectively. Lane 15: Promega low-range protein molecular 
weight marker.
The pTB361 H. influenzae ydiB construct was transformed into the over expression 
strain BL21 (DE3) pLysS (2.10). Cell growth was monitored by A^ oo; once the 
absorbance had reached 0 .6 , the expression of protein was induced by addition of 0 . 8  
mM IPTG: Figure 19 shows the time course of the induction. The pTB361 H. 
influenzae ydiB construct was grown for a further 6  hours after induction, yielding 
15.25 g wet weight of cells from 11 x 0.5 litres of LB medium.
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6.2.3 Purification of YdiB protein
The purification protocol of H. influenzae YdiB was based on the protocol described 
in section 2.12.3. The H. influenzae YdiB protein has a significantly different 
predicted pi (8.59) from the E. coli shikimate dehydrogenase (predicted pi = 5.35), 
for which the protocol had been optimised. Therefore several of tlie steps were not as 
effective when applied to the purification of K  influenzae YdiB. The ammonium 
sulphate cuts for HIYdiB were optimised as follows. 100ml of induced the H. 
influenzae ydiB construct (BL21 (DE3) pLysS) was centrifuged at 5,000 x g for 15 
minutes and resuspended in 5 ml of extraction buffer (2.12.3.1). Cells were lysed 
using a French pressure cell at 3,500 psi. 0.1 mg of DNase was added and the lysate 
was stirred on ice for 30 minutes. The lysate was then centrifuged at 40,000 x g for 
30 minutes. Samples of the resulting soluble and insoluble fractions were taken for 
analysis on SDS PAGE. Benzamidine was added to the soluble fraction to a final 
concentration of 1 mM and then solid ammonium sulphate was added to increase the 
concentration from 10% to 55% saturation in 5% increments. At each level of 
saturation the solution was stirred for 15 minutes at 0°C and then centrifuged at
40,000 X g for 15 minutes. The supernatant was collected for further analysis. 20 pi 
samples were taken after each centrifugation of both the supernatant and resuspended 
pellet, so that analysis by SDS PAGE could be performed (Figure 62). Most of the 
H. influenzae YdiB protein precipitates between 20% and 25% saturation (NH4)2 S0 4 . 
This is significantly different from the E. coli shikimate dehydrogenase protein 
purification which utilised (NH4 )2 S0 4  cuts between 30% and 55% saturation.
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Figure 62. SDS PAGE analysis o f  ammonium sulphate saturation experiment. Lane 
1: Boehringer Mannhiem marker low-range, lanes 2,4,6 , 8  and 10: 
supernatant fractions o f (NH4 )2S0 4  saturations from 10% to 30% saturation. 
Lanes 3,5,7,9 and 11: redissolved pellets o f (NH4)2S0 4  saturations from 10% 
to 30% saturation (5% increments). Lanes 12 and 13: E. coli H. influenzae 
YdiB construct crude extract control and induced, respectively.
The E. coli shikimate dehydrogenase protein purification also included an anion 
exchange step on DEAE Sephacel; this purification step was omitted from the YdiB 
protein purification since preliminary experiments revealed that YdiB did not bind to 
the column.
The purification o f H. influenzae YdiB was performed as follows; cells were lysed 
and centrifuged as described in section 2.5.3. The soluble supernatant was adjusted 
to 25% saturation (NH4)2 SO4 and centrifuged as described in section 2.12.3.2. The 
resulting precipitate was re-dissolved in 0.5 M NaCl 100 mM Tris-HCl pH 7.0 (buffer 
A) and dialysed overnight in the same buffer. The dialysed soluble protein was then 
concentrated to a volume o f 2 0  ml and applied to an affinity chromatography column 
(2 ’,5’-ADP Sepharose) that had been pre-equilibrated in buffer A at a flow rate o f  
lOml/hour. The column was washed in 100 ml o f  buffer A and 4 ml fractions o f the 
eluant were taken. A 20 ml portion o f ImM NADP^ in buffer A (flow rate o f  
1 ml/hour: 1ml fractions) was then applied to the column to elute the YdiB protein. 
Fractions were assayed as described in section 6 . 6  except; 100 mM sodium carbonate 
buffer (pH 10.6) was used instead o f the 100 mM glycine-Tris-NaOH buffer (pH 10.0) 
later used in kinetic analysis. The capacity o f the column was not large enough and
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consequently a large fraction of the YdiB protein did not bind to the affinity column. 
This meant that fractions with activity were found before and after the NADP’*’ 
elution step (data not shown). In the future it will be preferable to use a larger 
column of the same material or a less expensive option could be to use a Resource Q 
or Plienyl-Sepharose column. Fractions containing shikimate dehydrogenase activity 
were pooled and concentrated to a volume of 2 ml and applied to a Sephacryi 200 
(gel filtration) column (165 x 2.5 cm diameter), which had been equilibrated in 100 
mM Tris-HCl, pH 7.5 containing 0.5 M NaCl (buffer B) at a flow rate of lOml/hour; 
5ml fractions were collected. The protein was eluted using buffer B. The A2 8O of the 
eluant was monitored and assays for shikimate dehydrogenase activity were 
performed: Figure 63 shows the elution profile. Samples that possessed shikimate 
dehydrogenase activity were analysed by SDS PAGE (Figure 64) to assess the level 
of purity of the YdiB protein; appropriate fractions were pooled and concentrated to 
approximately 10 mg/ml. The concentration of Tris-HCl (pH 7.5) was adjusted to 
300 mM. The concentrated YdiB protein was divided into two aliquots; to one an 
equal volume of glycerol was added prior to storage at -20°C. The second aliquot 
was concentrated by using a 0.5 ml Vivaspin 500 centricon with a 10 kDa cut-off 
(Viva Science) which was centrifuged at 16,000 x g for 15 minutes at 4°C. The 
concentrated solution was then adjusted to 300 mM Tris-HCl (pH 7.5), 15mg/ ml 
YdiB protein and used in crystallisation screens (6.4).
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Figure 63. Elution profile o f the purification o f H. influenzae shikimate 
dehydrogenase related protein YdiB (HIYdiB) on Sephacryi 200 column. 
The A 280 o f the eluant is shown as green triangles. Shikimate dehydrogenase 
activity is shown as blue cirlces. Fractions that were pooled are shown 
between the dash black lines.
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Figure 64. SDS PAGE analysis o f Sephacryi 200 elution fractions. Lane 1 ; 
Boehringer Mannhiem marker low-range, lanes 2-15; S200 fractions 80 to 
94.
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6.3 Dynamic light scattering of HIAroE and HIYdiB
Dynamic light scattering was used (2.23) to investigate the quaternary structure and 
any structural changes in the presence cofactor, substrate and the potential inhibitor 
vanillin. The ECAioE has been shown to be a monomeric protein by gel filtration 
(Chaudhuri and Coggins, 1985) and by dynamic light scattering analysis (Maclean et 
aL, 2000). Dynamic light scattering of ECYdiB indicated that the predominant 
species was ~60 kDa indicating that ECYdiB forms dimers. This was confirmed by 
size exclusion cliromatography where the apo protein eluted as a single species of 64 
kDa (Michel et aL, 2003). Sequence analysis of both the H. influenzae AroE and 
YdiB proteins reveal hydrophobic side chains in the same positions as ECYdiB 
suggesting that both HIAroE and HIYdiB form dimers.
The HIAroE protein was studied at a protein concentration of 2.5 mg/ml in 50 mM 
Tris-HCl, 200 mM KCl (pH 7.0). The HIYdiB protein was analysed at a protein 
concentration of 1 mg/ml in 300 mM Tris-HCl (pH 7.0). Where indicated NADP^ 
was added to a concentration of 2 mM, shikimate and vanillin were added to a final 
concentration of 4 mM. All protein-ligand experiments were incubated at 20°C for 5 
minutes prior to analysis. 2 0 0  pi of each solution was injected into the dynamic light 
scattering cell.
The estimated molecular weight of HIAroE in the presence of NADP^ and shikimate 
is -32 kDa which is consistent with HIAroE being monomeric in a similar fashion to 
the ECAroE protein (Maclean et aL, 2000). Without NADP^ and shikimate the sum 
of squares (SOS) increased significantly; this is likely to arise fiom aggregation of the 
enzyme. In the presence of NADP^ and vanillin the SOS shows the data to be 
umeliable reflecting greater polydispersity of the protein, (Table 8 ).
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Table 16. Dynamic light scattering data of H. influenzae shikimate 
dehydrogenase and YdiB protein^.
H. influenzae shikimate H. influenzae YdiB protein
dehydrogenase
Radius Estimated SOS Radius Estimated SOS
(nm) MW (kDa) Error (nm) MW (kDa) Error
300 mM
ND ND ND 3.5 60 1.326
Tris-HCl
50 mM
Tris-HCl, 
200 mM 29.9 11041 131.1 ND ND ND
KCl
2 mM 
NADP ND ND ND 3.3 54 0.583
2 mM
NADP^,
2.7 32 6.49 3.3 55 0.678
4 mM
Shikimate
2 mM
NADP^,
4 87 60.28 ND ND ND
4 mM
Vanillin
The estimated molecular weight of HIYdiB in buffer is 60 kDa (Table 8 ), consistent 
with the formation of dimeric units as observed for ECYdiB (Michel et aL, 2003). In 
the presence of NADP and shikimate the hydrodynamic radius of HIYdiB is slightly 
reduced which is most probably be due to a closing of the protein conformation
' ND = Not determined.
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caused by the binding o f the ligands. Various closed conformation are seen in the X- 
ray structure o f ECAroE and ECYdiB (Michel et a i ,  2003). The diameter o f the 
ECYdiB in 300 mM Tris HCl is approximately 70 A in the presence o f 2 mM NADP^ 
and 4 mM shikimate the diameter decreased to 6 6  A.
6.4 Crystallization of HIAroE and HIYdiB
AroE and YdiB from H. influenzae have been crystallized by the sitting drop vapour- 
diffusion method at 20°C (2.24). Crystallisation trails were set up with protein 
freshly purified. The HIAroE and HIYdiB were concentrated to 20 mg/ml by using a 
0.5 ml Vivaspin 500 centricon with a 10 kDa cut-off (Viva Science). 1 pi o f  HIAroE 
in I mM NADP, 200 mM KCl, 50 mM Tris HCl, (pH 7.0) was added to 1 pi each of  
the crystallisation reagents to be tested, trials o f HIAroE with 0.5 mM vanillin 
included in the primary buffer were also set up. The primary buffer for HIYdiB was 
1 mM NADP, 300 mM Tris HCl (pH 7.0). Sparse screen matrices o f  HIAroE were 
set up using a comprehensive range o f conditions including commercial screens such 
as Wizard II (Emerald Biostructures), and local sparse screen matrices such as Magic 
50, M-screen, N-screen and CAS screen (Hampton research) overall a total o f 672 
crystallisation conditions were set up. The sparse screen matrices Wizard 1, Wizard 
II, M- screen and magic 50 were set up for HIYdiB, overall a total o f 312 
crystallisation conditions were set up.
Figure 65. Crystals o f HIAroE 10 mg/ml HIAroE in I mM NADP, 200 mM KCl, 
50 mM Tris HCl, (pH 7.0). Formed by the sitting-drop vapour diffusion 
method (A). 0.2 M sodium nitrate, 20% (w/v) PEG 3350 yielded large 
needle forms. (B) Small rhombus shaped crystals were found in 0.1 CaCb, 
10% (w/v) PEG 8000, 0.1 M HEPES (pH7.5) without vanillin.
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Several conditions gave promising results for HIAroE, 0.2 M sodium nitrate, 20% 
(w/v) PEG 3350 yielded large needle forms both in the presence and absence of 0.5 
mM vanillin (Figure 65A). Small rhombus shaped crystals were found in 0.1 CaCh, 
10% (w/v) PEG 8000, 0.1 M HEPES (pH7.5) (Figure 65B) without vanillin.
HIYdiB crystallised under several different conditions as summarised in Table 17.
Table 17. Crystallisation conditions for HIYdiB.
Crystallisation screen Crystallisation conditions Morphology of crystals 
(number)
Wizard 1 (6 ) 
Wizard 11 (36)
M-Screen (2)
M-Screen (76)
M-Screen (82)
Magic 50 (20)
30% (w/v) PEG 3000, 
0.1 M citrate (pH 6.0)
0.2 M NaCl, 10% (w/v) 
PEG 3000,
phospho/citrate buffer 
(pH 4.2)
0.1 M LiS0 4 , 10% (w/v) 
PEG 8000, 0.1 M acetate 
(pH 4.6)
0.2 MgC12, 15% (w/v) 
PEG 4000, 0.1 M acetate 
(pH 4.57)
30% Mono-methylether 
PEG 2000, 0.1 M citrate 
(pH 5.38)
0.2 (NH4)2S04, 25%
(w/v) PEG 4000, 0.1 M 
acetate (pH 4.6)
Large needle like crystals
Large cubic crystals 
(Figure 6 6 )
Large hexagonal prisms 
(Figure 6 6 )
Large cubic crystals
Large needle like crystals
Small cubic crystals 
some precipitation
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;
Figure 66. Crystals o f H. influnzae shikimate dehydrogenase related protein YdiB 
(HIYdiB) 10 mg/ml in 1 mM NADP, 300 mM Tris HCl (pH 7.0). Formed 
by the sitting-drop vapour diffusion method (A) 0.2 M NaCl, 10% (w/v) 
PEG 3000, phospho/citrate buffer (pH 4.2). (B) 0.1 M LiS0 4 , 10% (w/v) 
PEG 8000, 0.1 M acetate (pH 4.6). (C) 0.1 M Li2S0 4 , 0.1 M acetate buffer 
10% (w/v) PEG 8000, (pH 5.0 and 5.2). (D) 0.2 M MgCE, 0.1 M acetate 
buffer 10.5% and 12% (w/v) PEG 4000, (pH 5.0).
HIYdiB crystallised predominately in the presence o f low concentrations o f NaCl, 
Li2S0 4  or MgCL salts, 10-25% (w/v) PEG 3000-8000 and in either acetate or citrate 
buffer at a pH o f between 4 to 5. Three optimisation matrices were set up for 
HIYdiB. In the first optimisation the protein drop size was adjusted, under the 
crystallisation conditions already determined. The 1: 1 pi ratio o f protein solution to 
crystallisation reagent was repeated and ratios of, 1.5: 1.5 pi, 2: 2 pi and 1: 2 pi were 
also set up. Most o f the conditions o f optimisation 1 still yielded crystals o f various 
sizes. The second optimisation matrix varied both the concentration o f  PEG 8000 
from 4-14% (w/v) and the pH from 4.4 to 5.2 (0.1 M Li2S0 4 , 0.1 M acetate buffer) 
across 24 wells, yielding irregular cubic crystal forms in 10% (w/v) PEG 8000, pH
5.0 and 5.2 (Figure 6 6 ). Crystals were also found in 12% (w/v) PEG 8000 pH 5.2. 
The third optimisation matrix varied both the concentration o f PEG 4000 from 10.5-
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18% (w/v) and the pH from 3.8 to 5.0 (0.2 M MgCh, 0.1 M acetate buffer) over 24 
wells, yielding small cubic crystal forms in 10.5% and 12% (w/v) PEG 4000, pH 5.0 
(Figure 6 6 ). Optimisations were not carried out on HIAroE as K. Stewart continued 
this part of the project.
Protein crystals were tested by X-ray diffraction at the Daresbury syncln'otron on 
Beam Line 9.6 by B. Lohkamp and A. McEwen. Preliminary diffraction experiments 
showed that HIYdiB crystals diffracted to approximately 8.0 Â. These crystals were 
more than 2  months old and it is possible that newer crystals may diffract 
significantly better.
6.5 Structural comparisons using circular dichroism
The CD spectrum of the HIAroE and HIYdiB was recorded in both the near UV and 
far UV at protein concentrations of 1.38 mg/ml and 0.5 mg/ml respectively and in 
cells of 0.5 cm and 0.02 cm path length respectively in 50mM potassium phosphate 
buffer pH 7.0. From the far UV CD spectra it was clear that the secondary structures 
of HIAroE and HIYdiB aie very similar (Figure 67A). The is a slight increase in the 
peak at 195 nm is likely to be due to higher content of alpha helix in HIAroE. The 
secondary stmctinal contents were calculated using the SELCON procedure 
(Sreerama and Woody, 1994b) and are shown in Table 18.
Table 18. Secondary structure estimates (%) using the SELCON procedure of 
Sreerama and Woody (1994b).
Alpha helix Antiparallel 
beta sheet
Parallel beta 
sheet
Turns Other
HIAROE 3Z6 10.5 9.2 15.7 31.6
HIYdiB 28.1 12.4 8.4 16.8 34.1
The near UV CD spectrum shows differences in the environments of the aromatic 
amino acids between HIAroE and HIYdiB. There are no tryptophan side chains in 
the HIYdiB sequence; this is reflected in the near UV CD where there is only a low 
signal at 290 nm compared with the HIAroE which possesses three tryptophan side 
chains, which contribute to the signal at 290 nm (Figure 67B).
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Figure 67. CD spectra o f HIAroE (red) and HIYdiB (blue) in 50mM potassium 
phosphate buffer pH 7.0. (A) Far UV CD spectra o f  H. influenzae analogues 
(0.5 mg/ml; 0.02 cm path length). (B) Near UV spectra UV o f H. influenzae 
analogues (1.38 mg/ml, 0.5 cm path length).
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Overall the HIYdiB structure has more aromatic residues than HIAroE, although the 
HIAroE signal is substantially stronger this is could either be due to a greater 
structui'al rigidity in the tertiary structure or neighbouring aromatic side chains that 
are quenching each other’s signal. It would be interesting to use CD to study the 
effect of NADP on the tertiary structure in solution, since changes in the tertiary 
structure could corTespond to formation of the closed conformation obser-yed in the 
X-ray structure of HIAroE-complexed with NADP^ and DTT. However the strong 
absorption by NADP^ at 260 nm could complicate the interpretation of the CD 
spectra.
6.6 Kinetic Comparisons of AroE and YdiB enzymes
At physiological pH (7.0) the reaction equilibrium favours production of shikimate 
over dehydroshikimate, i.e. the direction of the biosynthetic route of the shikimate 
pathway. However it is more convenient to follow the reverse reaction at the non- 
physiological pH (10.0), because dehydro shikimate is not readily available.
Steady-state kinetics experiments were performed on HIAroE and HIYidB. The
formation of dehydroshikmate from shikimate or the formation of dehydroquinate 
from quinate was monitored by measuring the formation of the reduced form of the 
cofactor (NADH or NADPH) by observing the increase in absorbance at 340 nm 
(2.16.2). Assays were performed in a 1 ml quartz cuvette, 1 cm path length with 
lOOmM glycine adjusted to pH 7.0 with 2 M Tris and then additionally adjusted to 
pH 10.0 with 10 M NaOH (assay buffer) at 25°C using either 0.05-5 pg of HIAroE or 
1-10 pg of HIYdiB. All assays were performed in duplicate. The concentrations of 
cofactors: NAD^ and NADP^ and the substrates shikimate and quinate were both 
varied in systematic fashion to give a matrix of 25 two-substrate assays. Stock 
solutions of substrates were made up in assay buffer and adjusted to pH 10.0. The
concentration range of each of the substrates is summarised in Table 19,
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Table 19. Summary of concentration ranges used for two substrate assays 
performed on HIAroE and HIYdiB the range in conjunction with the other 
substrate present (*) (mM).
Shikimate Quinate NADP NAD
NADP
(mM)
NAD
(mM)
NADP
(mM)
NAD
(mM)
SHK
(mM)
QUIN
(mM)
SHK
(mM)
QUIN
(mM)
HIAroE 0.025-
1.5
0.07-
1 .
1 0 -
2 0 0
2 0 -
2 0 0
0.025-
1.5
0.05-
1.5
5-20 2.5-20
HIYdiB 5-80 5-60 N/A N/A (0.05-
1.5
N/A 5-20 N/A
Double reciprocal graphs (2.18) were plotted for all of the two-substrate matrices. In 
addition and Xm values were determined by hyperbolic regression fits of 
individual groups of assays where one substrate was kept constant (substrate A) and 
the other varied (substrate B). These values were converted to give the intercept and 
slope values using the as two substrate steady-state kinetics equations shown below 
(Price and Stevens, 1999):
Intercept ;
Slope
1
K,.
The intercept and slope values were plotted against the reciprocal values of the 
concentration of substrate A (Figure 6 8 ). The final kinetic parameters were 
calculated from the intercept and slope of the secondary plots, as shown in the 
equation below. Values of were calculated from the actual Emax values using the 
extinction coefficient for NAD(P) of 6270 M'  ^ cm'* and the theoretical molecular 
weights of HIAroE (29.76 kDa) and Hi YdiB (29.9 kDa). The results of the steady- 
state kinetic analysis of H. influenzae AroE and YdiB are summarised in Table 20.
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f.. _ X Slope
Determination of K' values from double reciprocal plot data (Price and Stevens, 
1999).
11 -
I 9- * DC
7-
6 -
0.04 0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20 0.22
1/[NAD"]
Figure 6 8 . Steady state kinetics double reciprocal plot of H. influenzae shikimate 
dehydrogenase (HIAroE) with NAD^ and shikimate.
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Table 20. Steady-state kinetic analysis of H. influenzae shikimate dehydrogenase 
(HIAroE) MW = 29.76 kDa.
Km (mM) K' (mM) pmol/min/jig \xg of Enz.
c^at
s-^
c^at/
M"^  s"‘
Shikimate NADP^ 0.0196 - - - - 9.92 xlO^
NAD^ 8.558 - - - - -
Shikimate
(+NADP^) 0.18 0.09075 391.87 0 . 1 194.37 1.08 xlO*
Shikimate
(4-NAD' )^ 0.18 0.0925 719.94 0.05 357.09 1.98x10^
Quinate NADP^ 0.024 - - - - 2.07x10^
NAD'*' 16.946 - - - - 4.60x10^
Quinate
(+NADP-") 89.7 98.7 100.13 0.5 49.66 5.54x10^
Quinate
(+NAD'") 18.94 77.49 15.71 5 7.79 4.11 xlO^
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Table 21. Steady-state kinetic analysis of H. influenzae shikimate dehydrogenase 
related protein (HIYdiB) (MW = 29.9 kDa).
Km (mM) K' (mM) pmol/min/pg pg of Enz.
c^at
S'*
kcdfKxw 
M"* S'*
Shikimate NADP’" 0.3761 - - - - 5.09 xlO^
NAD+ 13.58 - - - - 4.46 xlO*
Shikimate
(+NADP+) 64.15 6.989 38.44 1 19.15 2.99x10^
Shikimate
(+NAD’")
11.85 25.04 1 . 2 2 1 0 0.61 5.11 xlO*
Quinate NADP’" * - - - - -
NAD" * - - - -
Quinate
(+NADP")
* - - 1 0 - -
Quinate
(+n a d Q
* - - 1 0 -
HIYdiB only exhibited a very low level of catalytic activity with quinate as substrate 
in the presence of either cofactor. Assays were performed using 100 mM quinate, 
either 10 mM NADP^ or 15 mM NAD’*’ and 10 pg of HIYdiB in the standard assay 
buffer. The AAg^omin'  ^ was 0.005 (approximately 5 x 103 s'*) and 0.0024 
(approximately 2 x 10'  ^s'*), for NADP^ and NAD"*" respectively so it was not possible 
to obtain kinetic parameters for HIYdiB with quinate as a substrate.
* 0.005 AA3 4 omin'^  for lOmM NADP lOOinM Quinate lOgg of enzyme.
* 0.0024 AA3 4 omin'^  for lOmMNADF lOOmM Quinate lOgg of enzyme.
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The inliibitory effect of vanillin on HIAroE was investigated. The concentration of 
the cofactor was kept constant (1.5 mM) while both shikimate and vanillin were 
varied to generate data for a Lineweaver-Burk plot. Preliminary experiments 
revealed that vanillin absorbed substantially at 340nm. Figure 69 shows the 
absorbance spectrum of 0 . 1  mM vanillin at pH 9.0 showing that the absorbance at 
340 nm is 1.2 using a cuvette with a 1 cm path length. Further inhibition studies were 
performed using a cuvette of 4 mm path length and monitoring the increase in 
absorbance at 366 nm. No inhibitory effect was observed for vanillin at a 
concentration of 0.1 mM (note the absorbance of 0.1 mM vanillin at 366nm in a 4 
mm path length was 0.58). These inhibition experiments were not performed using a 
layer of toluene to stop the oxidation of vanillin as described by Balinsky and Davies, 
(1961b). It might be possible to use this method to study higher concentrations of 
vanillin and observe an inhibitory effect. However, inliibition studies on the P. 
sativum shikimate dehydrogenase revealed a K\ value of 93 pM for vanillin (Balinsky 
and Davies, 1961b), the concentration of vanillin (0.1 mM) used in the inhibition 
studies on HIAroE would be expected to have some inhibitory affect.
1 4
1.2 -
1 .0 -
0) 0 .8 -oc
s 0 .6 -im.o
0 . 4 -< -
0 .2 -
0 .0 -
-0 .2 -
200  25 0  300  350
Wavelength (nm)
400
—r~ 
45 0
Figure 69. Absorbance spectrum of 0.1 mM vanillin at pH 9.0, 1 cm path length.
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6.7 Fluorescence binding experiments of H, influenzae shikimate 
dehydrogenase
To investigate whether the HIAroE follows a BiBi ordered mechanism like the 
bifunctional P. sativum (Dowsett et ah  ^ 1972) fluorescence binding experiments were 
performed using shikimate in the absence of NADP^. Fluorescence measurements 
were carried out in 100 mM glycine-NaOH buffer (pH 10.0) at 20°C in a 1 ml volume 
cell with a 1 cm path length cell and with the slits set at 5.0 nm bandpass. The 
shikimate concentration was increased from 0 to 540 pM by the addition of lOpl 
aliquots of solution of 3 or 15 mM shikimate. Shikimate was not found to quench 
any emission at 312 nm and there it was not necessary to correct the fluorescence 
results by using a model compound such as N-Acetyl-L-tyrosinamide. Samples were 
excited at 290 nm and their emissions were monitored at 312 mn. Emission values 
were corrected for both Raman scattering and the dilution effect of titration.
1 8 - ,
0  16 -
S !  1 4 -  
CO15 1 2 -  CO  1 0 -  w
«  8 -  E
Ul 6 -<3
^  4  -
■D
U
O
0 ICO 300 40 0 500200 600
[Shikimate] (pM)
Figure 70. Fluorescence binding of H. influenzae shikimate dehydrogenase (HIAroE) 
corrected for Raman scattering and dilution effect.
The coiTected percentage change in emission values (where 0% is defined to 0 mM 
shikimate) were fitted using a non-linear regression fit and are shown in Figure 35. 
The iCsHiK value for HIAroE in the absence of NADP'*' is 82 pM ±11. The Kshik.
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value is comparable to the i '^sHiK observed in the steady state kinetics results (90 
pM). This shows that shikimate is able to bind to HIAroE irrespective of the 
presence of NADP^. Further evidence that the mechanism of HIAroE is not ordered 
in contrast with the BiBi mechanism of P. sativum (Balinsky et a l, 1971).
6.8 Chapter summary
HIAroE and HIYdiB are both NADPH-dependent dehydrogenases. However, they 
are both able to utilise shikimate in the presence of NAD^ and HIAroE is able to 
utilise quinate in the presence of both cofactors. HIAroE appears to bind NADP^ 
(Znadp 20 pM) more tightly than NAD^ (^nad 8500 pM). This is consistent with the 
results of sequence analysis that revealed similar residues within the cofactor 
recognition site to those in the NADP-dependent ECAroE ( A n a d p  56 pM). On this 
basis ThiT51 in HIAroE is likely to play an important role in cofactor recognition. 
HIYdiB also appears to bind more tightly to NADP"*" (.^nadp 380 pM) than NAD"*" 
(Znad 1400 pM). It is probable that the cofactor-recognition site of HIYidB is 
broadly similar to both ECAroE and HIAroE. The hydrophobic valine side chain 
(VI54) could be responsible for some of the loss in binding affinity observed in 
HIYdiB compared with HIAioE. However, it is also possible that V ail54 could be 
orientated to face away from the cofactor, with some alterations in the relevant part of 
the amino acid sequence of HIYdiB, a 3-dimensional X-ray structure would clearly 
resolve these issues.
Since HIAroE is able to catalyse the reduction of both shikimate and quinate, it is 
possible to assign HIAroE as a putative shikimate/quinate dehydrogenase. The Xshik 
values for HIAroE in the presence of either cofactor are identical (180 pM). The 
HIAroE K' values for shikimate {K' of -90 pM) with either cofactor are lower than 
the K s h i k  values. This was unexpected as it was originally thought that binding of the 
cofactor would aid the binding of substrate, although substrate binding maybe related 
to the release of the product, as there is a trade off between binding specificity and 
catalytic activity. The fluorescence studies revealed that shikimate is able to bind to 
HIAroE irrespective of the presence of a cofactor with a K s h i k  of 82 pM which is 
very close to the K' value reported. On this basis it would appear that the enzyme 
mechanism is not ordered as in P. sativum (Balinsky et a/., 1971). It is thought that 
the non-cooperative binding observed may be related to product release as tight
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binding of the enzyme-cofactor-substrate complex could decrease the turnover of the 
enzyme (personal communication from Prof. Paul Engel, University College Dublin).
The catalytic activities of HIAroE in the presence of shikimate with either NADP"*" 
(^ cat 194 s'^) or NAD^ (Âicat 357 s'^) are comparable; the Aicat of HIAroE may reflect the 
precise binding mode of the cofactor. The 2-fold difference in may be explained 
in part if the release of the cofactor is the limiting factor within the catalytic reaction, 
as the Xnad(p) is higher for NAD"*" than NADP^. Release of the product has been 
shown to be the rate-limiting step in a number of dehydrogenases such as lactate 
dehydrogenase (Price and Stevens, 1999; Südi, 1974a; 1974b).
The catalytic properties of HIAroE for quinate in the presence of either NADP^ (Æçat 
50 s'*) or NAD"*" (Aicat 8  s'*), do not follow the same pattern as for oxidation of 
shikimate. The HIAroE Xquin values for quinate in the presence of either NADP”*' 
and NAD^ are 90 and 19 mM respectively. In these circumstances it appears that the 
release of dehydroquinate may be the limiting factor in this catalytic reaction. In 
contrast to the HIAroE K' values for shikimate the HIAroE K' values for quinate (99 
and 78 mM in the presence of NADP^ and NAD^, respectively) are higher than the 
Kquin values, suggesting that the cofactor promotes binding of quinate although the 
high K  values point to weak binding of this substrate. The ECAroE catalyses the 
oxidation of both shikimate and quinate, but the catalytic activities are much lower 
than for HIYdiB. Interestingly the catalytic activity of ECYdiB in the presence of 
NAD'*' is higher for quinate and lower for shikimate, the reverse of the trend observed 
in HIAroE. ECYdiB is unlikely to be a true quinate/shikimate dehydrogenase due to 
its extremely low catalytic activity with quinate as substrate, although the true 
substrate of this protein may share some of the same structural features of both 
dehydroshikimate and quinate.
The analogue HIYdiB is only able to catalyse the oxidation of shikimate, and 
although the catalytic activity is higher than for ECYdiB it is unlikely that HIYdiB is 
a true shikimate dehydrogenase, since the c^at values of 19 and 0.6 s'* are 10 and 600- 
fold (for NADP'*’ and NAD" ,^ respectively) lower than for HIAroE. Interestingly 
shikimate appears to bind tighter to HIYdiB in the presence of NAD^ (Xshik 12 mM) 
than NADP^ (Xshik 64 mM). A similar pattern is observed with the HIAroE-quinate 
results, where tighter binding is accompanied by lower catalytic activity. The 
extremely low catalytic activity obseiwed using quinate as substrate in the presence of
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either NAD"*" or NADP^ is likely to result from differences in the amino acid sequence 
near the N-terminus. The kinetic data suggests that the true substrate of HIYdiB and 
the other members of this subset of the shikimate dehydrogenase family are unlikely 
to possess a carboxylate and a hydroxyl group at CL The conserved insert of four 
amino acids near the N terminus ([R,t,a,q]-F-H-N) may well play some catabolic role 
possible in binding some small hydi’ophobic group. A 3-dimensional X-ray structure 
would be valuable in discovering the true substrate of HIYdiB. The preliminary 
crystals obtained here could provide the basis for such a structural determination. 
Equally screening a series of dehydroshikimate analogues could identify the 
important components for binding which could be used in a wide search for the true 
substrate.
It would be beneficial to study the conversion of dehydroshikimate to shikimate 
(forward reaction). This could be achieved either by performing a coupled assay with 
a dehydro quinase enzyme or dehydroshikimate could be chemically synthesized via 
the dichloro-dicyano-benzoquinone (DDQ) oxidation of commercially available 
shikimate as described by T. Bugg (1989). pH dependence profiles of both the 
forward and reverse reactions of shikimate dehydrogenase would be very valuable. 
The pi of HIYdiB is 8.59 and protein incubated at a high pH (10.0) and at a high 
protein concentration (-10 mg/ml) for extended periods of time (>4 hours) tended to 
precipitate. It is therefore possible that these non-physiological conditions may have 
affected the kinetic properties of HIYdiB. In the future it would be informative to 
repeat these experiments at pH 7.0.
The inhibition studies of HIAroE show no inhibitory effect of vanillin. Most of the 
previously reported inhibition studies were performed on the plant bifunctional 
enzymes such as that from Pisum sativum, where several analogues including vanillin 
were found to be competitive inhibitors. The substrate-binding domain of these 
bifunctional enzymes may well adopt a different conformation from that of the 
bacterial shikimate dehydrogenases. Gallic acid was found to be a competitive 
inhibitor of the Pisum sativum enzyme (Baillie et al., 1972), but recent studies have 
shown it to be a substiate of the mountain birch bifunctional enzyme which is 
involved in the formation of hydrolysable tannins (Ossipov et aL, 2003). It is 
possible that these early studies were complicated by the high absorbance of many of 
these potential inhibitors, although Balinsky and Davies (1961b) did take measiues to
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limit the oxidation of vanillin and some other potential inhibitors. Further 
crystallisation trials of both HIAroE and HIYdiB should be performed with other 
potential inhibitors such as p-hydroxybenzaldehyde acid; with an aim of obtaining a 
tertiary complex of the enzyme. This would shed light on the mode of binding of the 
substrate to the enzymes.
The protein purification method used for HIYdiB (pi of 8.59) could be further 
developed; instead of using an anion exchange column at pH 7.5, a cation exchange 
mono or resource Q column at pH 7.5 could be used. This is likely to increase the 
purity, and yield of the protein purification, although it should be noted that the 
protein obtained from the method described (6.2.3) was of a high purity as judged by 
SDS-PAGE.
The existence of two isoforms of shikimate dehydrogenases in many bacterial species 
evokes evolutionary and metabolic questions, and also affects the design of any 
potential inhibitors. The location of the aroE gene within the H  influenzae genome 
is between a gene coding for a DNA-3-methyladenine glycosidase I and a conserved 
hypothetical protein of function unknown. The loci of the ydiB gene is close to a 
serine acetyltransferase and a conserved hypothetical protein. The location of these 
genes within the E. coli genome is different; the aroE gene is surrounded by genes 
with unknown or putative functions and ydiB (subset more closely related gene to 
aroE) is located between a gene thought to encode an amino acid transport protein, 
and the aroD gene coding for a type I dehydroquinase. It is postulated that this ydiB- 
aroD cluster is the ancestral precursor to the bifunctional enzyme found in plants and 
some bacteria (Michel et ah, 2003). Since H. influenzae possesses a type II DHQase 
rather than a type I DHQase a bifunctional enzyme would not be expected.
The dynamic light scattering data shows that HIYdiB forms dimers of approximately 
60 kDa, in contrast to HIAroE which is apparently monomeric. A site-directed 
mutagensis strategy could be used to identify the key residues likely to be involved in 
dimer formation, especially residues Leu9, Met40 and Phe42 in ECYdiB.
The crystallisation trails of HIAroE and HIYdiB, yielded encouraging results. Only a 
few crystals were tested at the Daresbury synchi’otron and it is expected that fuither 
X-ray diffraction experiments using fresher crystals will give a better diffraction 
pattern. The X-ray structure of HIYdiB is currently on hold at the Protein Data Bank
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(PDB identifier: INPY) fhttp://www.rcsb.org/pdbA submitted by Korolev et al. at the 
Feinberg School of Medicine, Northwestern University, Chicago this data should be 
very useful in understanding the precise nature of the substrate-binding pocket in the 
enzyme.
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In this chapter I would like to highlight some of the major conclusions concerning the 
bacterial type II dehydroquinases and shikimate dehydrogenases.
Site-directed mutagenesis of the active site residues of SCDHQase: R113A, H106A, 
E l04A, S I08A and Y28F all significantly decrease the catalytic activity of the 
enzyme (Table 7 page no. 108). The mutation Y28F and R113A gave the largest 
effects with 4700-fold and 2190-fold reductions in Aicat- CD evidence confirmed that 
none of the mutations significantly altered the secondary or tertiary structure of the 
enzyme (Table 6  page no. 106). This indicates that the enzyme structure was not 
significantly altered and strongly suggests that the mutations altered the catalytic 
mechanism of SCDHQase. pH studies of SCDHQase, HPDHQase, MTDHQase and 
B. subtilis YqhS mutant F23Y show that as pH increases from 6.5 to 8.0 there is a 
seven-fold increase in catalytic activity (Æcat) (Figure 47 page no. 155). This implies 
that all of these type II DHQases share a common catalytic mechanism. This is 
confirmed by the 3-dimensional X-ray structure data for each of the type II DHQases 
which show that the key active site residues are all an*anged in a similar manner in 
each structure (Figure 44 page no. 147). The two exceptions to this statement are: (1) 
HPDHQase possesses a threonine in the place of serine 108 and (2) the precise 
orientation of tyrosine 28 {S. coelicolor numbering system) thought to be involved in 
proton abstraction, varies among the structures. In the low c^at enzymes (HPDHQase, 
MTDHQase) the lid domain in which this tyrosine residue is situated is not ordered. 
It was hypothesised that these structures were more flexible in the lid domain and this 
may account for the lower activity observed in these type II DHQases compared with 
the high c^at enzymes SCDHQase and the QutE from A. nidulans. However, 
dénaturation studies with low concentrations of urea did not confirm this proposal. 
There was a significant difference in the effect of chloride ions; 0.5 M chloride 
decreased the catalytic activity of the high enzyme from SCDHQase and 
increased the catalytic activity of low c^at enzymes, HTDHQase and HPDHQase. The 
exact role of the flexibility of the lid domain in promoting catalysis remains to be 
established.
More evidence is needed including characterisation of at least another high Aicat 
enzyme. Prof. Iain Hunter at the University of Strathclyde has recently produced a
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construct of the Campylobacter jejuni type II DHQase. It is not yet known whether 
the C. jejuni enzyme will be in the high /^ cat category. However, analysis of its 
sequence shows that the C. jejuni DHQase overall has higher homology to 
HPDHQase and B. subtilis YqhS than to the two high c^at enzymes SCDHQase andrt. 
nidulans QutE. Out of the five DHQases analysed MTDHQase had the lowest 
homology to C. jejuni DHQase. The lid domain of the C jejuni is slightly different 
from the other DHQase studied in the present work. Biochemical analysis of the C 
jejuni DHQase may help explain some of the reasons for the low and high Aicat type II 
DHQases. It is likely that environmental factors may influence the level of catalytic 
activity observed in different type II DHQases. S. coelicolor and A. nidulans are 
both saprophytes found in soil and function at different temperatures according to the 
weather where as M tuberculosis and H, pylori are found in humans and operate 
specifically at mammalian body temperatures. The temperature and concentration of 
quinate in the two environments differ considerably. All enzymes must make a ‘trade 
off between and Aicat to maximise efficiency within the cell. If the availability of 
a particular substrate is low in the environment of the microorganism in question then 
it would be expected that the Km would also be low, at the expense of the c^at- This 
seems to be the case for M  tuberculosis {Km 23 pM at pH 7.0) but not H. pylori {Km 
200 pM at pH 7.0).
Further crystallographic studies ai*e required on the mutants of SCDHQase. This 
would be especially true for the E l04A mutation this should reveal the exact role of 
this residue is still unclear. It may also be possible to soak substrate into crystals of 
the E l04A mutant, giving more infomiation on the mode of substrate binding. It 
would also be useful to study the kinetic parameters of various inliibitors of type II 
DHQase like vinyl fluoride (Frederickson et al, 2002) and the effect of polyanion 
binding on the SI08A mutant.
The presence of two types of DHQase raises several evolutionaiy questions. To date 
B. subtilis is the only organism known to possess genes homologous to both type I 
and type II DHQases. This is of interest as it may offer an insight into how new 
functions may evolve in existing protein families. Other members of the Bacillus 
family are split between either possessing either a type I or type II DHQase (Figure 
24 page no 113). There does not seem to be any evolutionary or environmental 
pattern to the distribution of the two types of enzyme. This suggests that there has
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been gene transfer between microorganisms, as evolutionary distinct organisms 
possess genes encoding for DHQases, which have high identity. This may have 
occurred by the ability of bacteria to acquire plasmid DNA from other bacterial 
species by conjugation (Heinemami, 1991). Analysis of the genomes of Bacillus 
family members reveals that when the type II DHQase is present it is found in the 
same location. In Oceanobacillus iheyensis possess a type I DHQase the region in 
which the type II DHQase would be found is analogous apart from the absence of the 
type II DHQase. This suggests that Bacillus family members that possess a type II 
DHQase share a common ancestor which acquired the type II DHQase without any 
other genes. The start codon of the yqhS gene is GTG, which is quite rare in B. 
subtilis 9% of genes start with this codon (Kunst et aL, 1997); this also suggests that 
the yqhS gene has been acquired. It seems likely that B. subtilis originally possessed 
only a type I DHQase, as NaBH4 experiments showed this to be the active form of the 
enzyme. The organisation of shikimate pathway enzymes in B. subtilis is quite 
different from that in any organism studied to date.
B. subtilis YqhS was shown to have an extremely low level of catalytic activity and is 
therefore not a functional DHQase. The site-directed mutant F23Y of YqhS shows at 
least 2000-fold increase in activity from the wild type. The increase in activity is 
comparable with the decrease in activity observed in the Y28F mutant of SCDFIQase, 
confirming the importance of this residue. The extremely low catalytic activity 
obseiwed of the F23Y B. subtilis YqhS protein shows that other factors must be 
important in optimising catalytic efficiency. It seems that the YqhS protein may 
represent a case of divergent evolution (Geiit and Babbitt, 2001) and that YqhS must 
have another function that may be common to other type II DHQases, as there is such 
high identity between the B. subtilis YqhS and other functional type II DHQases. 
The growth experiments with minimal medium performed on wild-type B. subtilis 
(derivative 168) and the disruption mutant (dYqhS) established the importance of the 
yqhS gene under these conditions. Unlike the wild-type strain of B. subtilis, the yqhS 
disputed mutant will not grow on minimal medium with either glucose or citrate as a 
carbon source (Table 10 page no. 137). Presently auxotrophic studies are underway 
in an attempt to establish the nature of the disruption mutant, in order to define more 
clearly the role of the YqhS protein in B. subtilis. Quaternary structural analysis 
reveals a large cavity formed by the assembly of the tetramer of trimer s. There are
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several conserved residues within the cavity of type II DHQases including His 85, 
Glu59 and Asp64 (Appendix C; Error! Reference source not found.) (S. coelicolor 
numbering system). This cavity may be involved in the second fiinction. However, 
no homologous motifs were found using the 3-dimensional motif modelling program 
PINTS ('http://www.russell.embl.de/pintsA.
The paralogs; H. influenzae shikimate dehydrogenase (HIAroE) and the H. influenzae 
shikimate dehydrogenase related protein (HIYdiB) are both NADPH-dependent 
dehydrogenases although they are able to catalyse reactions in the presence of NAD^. 
The function of HIYdiB is still unclear as the catalytic activity of the HIYdiB protein 
is significantly lower than the HIAroE enzyme for all the substrates tested (Table 20; 
Table 21 page no, 206, 207). Using fluorescence quenching it has been shown that 
shikimate can bind to HIAroE in the absence of the cofactor. The Xshik value for 
HIAroE in the absence of NADP'*' is 82 pM ±11. This K s h i k  fluorescence value is 
equivalent to the K  value observed in the steady state kinetics results (90 pM). 
HIAroE is likely to follow a random sequential mechanism rather than the ordered 
BiBi mechanism proposed for bifunctional plant enzymes such as bifunctional P. 
sativum (Dowsett et aL, 1972).
The YdiB family of proteins seem to comprise two groups that may have diverged 
from the shikimate dehydrogenases. The E. coli YdiB protein (ECYdiB) is an 
NAD’*'-dependent dimer and catalyses the oxidation of both shikimate and quinate, 
placing it in the quinate-shikimate dehydrogenase catergory (1.4.1). The HIYdiB 
protein is an NADP^-dependent dimer with an unknown function. The N terminal 
region is thought to be very important in the binding of the substrate and sequence 
analysis gives small clues about the substrate-binding pocket. HIYdiB was able to 
catalyse the oxidation of shikimate but not of quinate. The structures of shikimate 
and quinate are similar, with quinate possessing an extra hydroxyl group at Cl. It can 
be hypothesised that the substrate of HIYdiB does not have a hydroxyl group in this 
position. However, assays should be performed in the forward direction at a more 
physiological pH. Additional fluorescence binding studies should be performed on 
HIYdiB to establish whether quinate is able to bind to the enzyme. The X-ray 
structure of HIYdiB is currently on hold at the Protein Data Bank (PDB identifier: 
INPY) (http://www.rcsb.org/pdb/I: this 3-dimensional structure may reveal more 
detail about the substrate binding pocket.
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The emergence of bacterial resistance to established antibiotics in hospital-acquired 
infections is a matter of ever-growing concern. In particular Staphylococcus, 
Enterococcus and Streptococcus aureus and M. tuberculosis, have all evolved 
resistant strains over the last few years (Nachega and Chaisson, 2003). The 
appearance of glyphosate resistance in Goose grass is also a matter of concern for the 
production of food to an ever-increasing world population (Baerson et al, 2002). For 
these reasons, there is an urgent need for new antibacterial and herbicide agents, 
particularly those that act on novel targets. The discovery of several paralogs of the 
shikimate pathway enzymes such as the YdiB protein, in a vaiiety of bacterial and 
plant species raises questions about using shikimate pathway inhibitors as antibiotics. 
Where possible it may be beneficial to study the binding properties of potential 
antibiotics to these paralogs, so that organisms that are not being targeted are not 
affected.
There are several important factors in designing inhibitors for type II DHQase. The 
Cl carboxylate group is very important for conect binding of the substrate and 
inhibitors. It is thought that only one alanine side chain in SCDHQase (AlaSl) is 
responsible for the differences in binding affinity of the oxime inliibitor observed 
between MTDHQase (Xi 20 pM) and SCDHQase {K\ 500 pM). The C. jejuni 
DHQase also possess a alanine in the same position. It would be interesting to 
perform studies of the inhibition of C  jejuni DHQase by oxime. It also may be 
worthwhile to test some of the inhibitors of DHQase on shikimate dehydrogenases 
and vice versa, since the substrate of the two enzymes have very similar structures.
In conclusion this study has highlighted a number of important aspects of shikimate 
pathway enyzmology, and indicated a number of directions for further investigation.
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Buffer Composition per litre
General buffers and solutions
10% SDS 100 g SDS
0.5M Tris acetate 60.6 g Tris base
Adjust to desired pH with glacial acetic
acid.
0.5M EDTApH8.0 186.1 gEDTAAHiO
~20gNaOH
Adjust pH with NaOH, EDTA will not go
into solution until pH is raised to about
8 . 0
Agarose gel electrophoresis buffers for analysis of DNA
TAE (50x) 242 g Tris base
57.1 ml glacial acetic acid
100 ml 0.5 M EDTA, pH 8.0
TBE (lOx) 54 g Tris base
27.6 g boric acid
20 ml 0.5 M EDTA, pH 8.0
Composition per 10 ml
Agarose DNA loading buffer (lOx) 25 mg bromophenol blue
3 ml glycerol
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Buffers for preparing E. coli competent cells
Composition per 500 ml
RFl 37.28 g KCl
1 . 1  gCaCL-OHzO
50 ml IM potassium acetate
4.9g MnCL AHgO
75 ml glycerol
Adjust pH to 5.8 with glacial acetic acid
and filter sterilise.
RF2 2.1 g MOPS
0.4 g KCl
8 . 2  g CaCL'ôHzO
75 ml glycerol
Adjust pH to 6 . 8  with glacial acetic acid
and filter sterilise.
SDS-PAGE Buffers and solutions for analysis of proteins
Composition per litre
30% acrylamide/ 0.8% bis-acrylamide 300 g acrylamide
8  g bis-acylamide
Separating gel buffer (2.5x) (1.875 M 227.1 g Tris base
Tris-Cl, 0.25% SDS) 2.5 g SDS
Adjust pH to 8 . 8  with HCl.
Stacking gel buffer (5x) (0.5 M Tris Cl, 60.5 g Tris base
0.25% (w/v) SDS) 2.5 g SDS
Adjust pH to 6 . 8  with phosphoric acid.
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SDS-PAGE Buffers and solutions for analysis of proteins
Composition per litre
Eletrophoresis Buffer (lOx) 60.5 g Tris base 
144.1 g glycine 
5gSDS
pH should be 8 . 8  without adjustment.
Composition per 10 ml
SDS-PAGE sample buffer 2.25 mllMTris-Cl, pH 6 . 8  
5 ml glycerol 
0.5gofSD S 
5 mg Bromophenol blue
2.5 ml dithiothreitol (DTT)
Coomassie staining solution 0.5 g coomassie brillant blue R-250 
400 ml Ethanol 
Dissolve, then add;
1 0 0  ml glacial acetic acid 
500 ml water
Destaining solution 1 0 0  ml ethanol
1 0 0  ml glacial acetic acid
800 ml water
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Western transfer and immunodetection buffers and solutions
Composition per litre
Transfer buffer (CAPS) 2 2 . 1  g cyclohexylaminopropane sulfonic
acid (CAPS) (100 mM)
100 ml of Methanol (10% v/v)
pH should be 11.0 without adjustment.
PBS (lOx) 71.7ml0.5MK2HPO4
28.3 ml 0.5M KH2PO4
8 .8 gNaCl
pH should be 7.2 without adjustment.
Composition for 500 ml
Blocking and antibody buffer 250 ml PBS
0.25 ml Tween-20
15 g milk powder (Marvel™)
Bradfords Reagent 0.5 mg/ml Coomassie Blue G
25% (v/v) methanol
42.5% (v/v) Phosphoric acid
pH -0.01
The solution is stable indefinitely in a
dark bottle at 4°C.
Lowry reagents (A) 2% (w/v) Sodium potassium tartrate
(B) 1% (w/v) CUSO4 5 H2 O
(C) 0.1 M NaOH, 2% (w/v) NazCOs
mixed in a ratio of 1 :1 :1 0 0 , respectively.
Folin reagent 50% (v/v) folin
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Amersham Biosciences (formally Amersliam and Pharmacia), 800 Centennial 
Avenue, P.O. Box 1327, Piscataway, NJ 08855-1327, USA, + 1-732-457-8000
Applied Biosystems, Division Headquarters, 850 Lincoln Centre Drive, Foster City, 
CA 94404, U.S.A. + 1-650-638-5800, http://www.annliedbiosvstems.com/
Beckamn Coulter (UK) Ltd, Oakley Court, Kingsmead Business park, London Road, 
High Wycombe, Buckinghamshire, HP 11 lJU 0044 0 1494 441181
www.beckman.com
BioRad Laboratories Ltd, BioRad House, Maylands Avenue, Hemel Hempstead, 
Hertfordshire, HP2 7TD, 0800 181134, www.bio-rad.com
Clare chemical research, 24B station St, Ross on Wye, HR9 7AG, England, UK. +44 
1989 565049.
Emerald Bio Agriculture Corporation, 3125 Sovereign Dr. Suite B, Lansing, MI 
48911-4240, USA 001 517 882 7370 www.emeraldbio.com
F. Hoffinann-La Roche Ltd., Group Headquarters, Grenzacherstrasse 124, CH-4070 
Basel, Switzerland, +41-61-688 1111, httn://www.roche.com/
Fisher Scientific UK Ltd., Bishop Meadow Road, Loughborough, Leicestershire 
LE 11 5RG, UK, 01509 231166, E-mail: info@fisher.co.uk. httn ://www. fisher.co.uk/
Hampton Research, 27632 El Lazo Road, Suite 100, Laguna Niguel, CA 92677-3913, 
USA 001 949 425 1321 www.hamntom-esearch.com
JASCO (UK) Ltd, 18 Oak Industrial Park, Chelmsford Road, Great Dunmow, CM6  
IXN, 44 (0) 1371 876988, Email : inbox@iasco.co.uk. www.iasco.co.uk
Millipore (Amicon is a subsidiary) (UK) Limited, Units 3&5 The Courtyards, Hatters 
Lane, Watford, WD18 8 YH, 0870 900 4645, www.millinore.com/
MWG Biotech (UK) Ltd., Mill Court, Featherstone Road, Wolverton Mill South, 
Milton Keynes, MK12 5RD, United Kingdom, + 44 - 19 08 - 525 -  500, E-mail 
info@mwg. co. uk.
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New England Biolabs (UK) Ltd., 73 Knowl Piece, Wilbury Way, Hitchin, 
Hertfordshire, SG4 OTY, United Kingdom, 0800 318486, E-mail: info@nk.neb.com. 
http://www.neb.com/
Pierce Scientific (pait of Perbio), Knutpunkten 34, SE-252 78 Helsingborg, Sweden, 
+46 42 26 90 90, E-mail: info@perbio.com. http : // www. perbio. com/
Promega UK Ltd, Delta House, Chilworth Research Centre, Southampton SO 16 7NS 
Phone : 0800 378994, www.promega.com
Proxeon Biosystems (formally Pro tana), Staermosegaardsvej 6 , DK-5230 Odense M, 
Denmark, (+45) 6557 2300,E-mail: info@proxeon.com, www.proxeon.com
Sigma-Aldrich Company Ltd, The Old Brickyard, New Rd, Gillingham, Dorset, SP8  
4XT, Phone : 0800 717181, www.sigmaaldrich.com
Stratagene, Gebouw California, Hogehilweg 15, 1101 CB Amsterdam Zuidoost, The 
Netherlands http://www. stratagene.com/
Thermo Orion, Corporate Office, 166 Cummings Centre, Beverly, MA 01915, 
United States, +1 978-232-6000, Email: info@thermoorion.com.
http ://www. thermo. com/.
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Figure 71. S. coeîicolor type II dehydroquinase (SCDHQase) aligned
against representatives of type II dehydroquinases. The secondary structural 
features of SCDHQase are shown at the top of the alignment the alpha (a) and 3 m 
(q) helices are represented as helices and beta strands (|3) represented by arrows, 
and p turns are marked TT. Sequences important in this study are highlighted in 
yellow; residues targeted for site-directed mutagenesis are highlighted in green.
This sequence alignment was created using tlie following sequences (organism, 
designated function) fi’om GeneBank; Streptomyces coelicolor (S. coelicolor), 
Bradyrhizobium japonicum  (B. Japonicum), Agyobacterium tumefaciem  (A. 
tumefaciens), Bnicella suis (Brucella suis). Brucella abortus 
(Brucella abortus), Brucella melitensis (Brucella melitensis), Mesorhizobium loti 
(Mesorhizobium loti), Smorhizobium meliloti (S. ineliloti), M agmtospirillum  
magnetotacticum  (M. magnetotacticum). Pseudomonas fluorescens (P.
fluorescens), Pseudomonas aeruginosa (R aeruginosa), Corynehacterium  
glutamicum (C. glutamicum), Caulobacter crescentus (C. crescentus).
Pseudomonas putida  (Pseudomonas_putida), Pseudomonas syringae 
(Pseudomonas syringae), Xylella fastidiosa  (Xylella fastidiosa), Xanthomonas 
campestris pv. (X. campestris), Xanthomonas axonopodis pv. (X. axonopodis), 
Ralstonia solanacearum  (R. solanacearum), Nitrosomonas europaea (N.
europaea), Actinobacillus pleuropneumoniaQ (A.jpleuropneumoniae),
Pasteurella multocida (P. niultocida), Haemophilus influenzae (H. influenzae),
Vibrio cholerae (Vibrio cholerae), Vibrio parahaemolyticus (V.
_parahaemoiyticus), Emericella nidulans (Emericella nidulans), Buchnera 
aphidicola str. (B. aphidicoia), Bacillus halodurans (Bacillus halodurans).
Bacillus subtilis (Bacillus subtilis), Bacillus anthracis (Bacillus anthracis), 
Deinococcus radiodurans (D. radiodurans), Bacteroides thetaiotaomicron (B. 
__thetaiotaomicron), Campylobacter jejuni (Campylobacterjejuni), Geobacter 
metalUreducens (0. metallireducens). Bifidobacterium longum (B. longum), 
Tropheryma whipplei (Tropheryma whipplei), Coiynebacternm  
pseudotuberculosis (C.pseudotuberculosis), Mycobacterium leprae (M. leprae), 
Mycobacterium tuberculosis (M. tuberculosis), Helicobacter pylori 
(Helicobacter_pylori), Fusobacterium nucleatim  (F. nucleatum), Clostridium  
perfringens (C._perfringens), Thermotoga maritima (T. maritima),
Thermoanaerobacter tengcongensis (T. tengcongensis), Neurospora crassa 
(Neurospora_crassa), Chlorobium tepidum (Chlorobium tepidum) and 
Streptomyces hygroscopicus (S. hygroscopicus).
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Figure 72. E. coli shikimate dehydrogenase (ECAroE) aligned against
representatives o f  the shikimate dehydrogenase family. The secondary structural 
features o f  ECAroE are shown at the top o f  the alignment the alpha (a) and 3|o (q) 
helices are represented as helices and beta strands (p) represented by arrows, and P 
turns are marked TT. Sequences important in this study are highlighted in yellow; 
shikimate dehydrogenases are highlighted in green; type 1 and type 2 YdiB proteins 
are highlighted in blue and pink, respectively. This sequence alignment was created 
using the following sequences (oi^anism, designated function) from GeneBank: E. 
coliYAl AroE (E, coli AroE), Salmonella typhimunim (S._typhimurium_AroEl), 
Salmonella enterica (S._enterica__AroE), Yersiniapestis (Y._pestis_AroE),
Haemophilus influenzae (H._influenzae_AroE), Pasteurella multocida (P. 
_multocida_AroE), Haemophilus somnus (H. somnus AroE), Actinobacillus 
actinomycetemcomitans (A. actinomycet. AroE), Vibrio cholerae (V. 
cholerae_AroE), Vibrio vulnificus (Y. vulnificus AroE), Pseudomonas syringae (P. 
syringae Hypo), Azotobacter vinelandii (A. vinelandiiJBypo), Nitrosomonas 
europaea (N.europaeaQuin/Shik), Neisseria polysaccharea (N.poIysacchareaAroE), 
Neisseria flavescens (N._flavescens__AroE), Neisseria meningitides (N.
ineningitidesAroE), Neisseria gonorrhoeae (N._gonorrhoeae_AroE), Buchnera 
aphidicola (B. aphidicola AroE), Legionella^pneumophila (L. pneumophila Hypo), 
Helicobacter pylori (H._pylori AroE), Escherichia coli (E. coli YdlB), Salmonella 
typhimurhm (S. Jyphimuriuni YdiB), Listeria monocytogenes (L, jnonocyto . 
AroEFam), Listeria monocytogenes (L. monocyto. YdiB), Listeria innocua (L. 
innocua oxidoreduct), Synechocystis sp. PCC 6803 (Synechocystis AroE), 
Magnetococcus sp. MC-1 (Magnetococcus Hypo), Listeria monocytogenes (L, 
m onocytogenes^roE), Bacillus anthracis (B.antliracisQuin/Shik), Bacillus subtilis 
(B._subtilis_AroE), Leuconostoc mesenteroides subsp, mesenteroides (L. 
mesenteroid. FIypo), Lycopersicon esculentum (tomato) (L. esculentum BiFAroE), 
Deinococcus radiodurans (D. radioduransAroE), Pseudomonas fluorescens (P. 
fluorescens Hypo2), Rhodobacter sphaeroides (R. sphaeroides Hypo), 
Corynebacterhm diphiheriae (C._diphtheriae_AroE), Pseudomonas putida (P. 
_putida_AroEFam), Mycobacteriumjsmegmatis (M._smegmatis_YdiB), Brucella 
melitensis (B. melitensis Quin/Shik), Haemophilus influenzae (H.
influenzae YdiB), Actino actinomycetemcomitans (A._actinomycet_YdiB),
Pasteurella multocida (P .jnu ltocidaY diB ), Pseudomonas putida (P. 
jputida_Quin/Shik), Pseudomonas fluorescens (P,_fIuorescens_Hypol), Deinococcus 
radiodurans (D._radiodurans_YdiB), Mycobacterium_smegmatis (M.
smegmatis AroE), Yersinia pestis (Y._pestis_YdiB), Salmonella enterica subsp. 
enterica serovar Typhi (S._enterica_YdiB), Corynehacterium diphtheriae (C. 
diphtheriae YdiB), crassa (N. crassa QuinDHG) and Emericella
nidulans (A. niduIans QuinDHG).
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